About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
1548 genotypes with 2185 annotations displayed of selected term and subterms
Searched Term: increased malignant tumor incidence
Allelic Composition
(Genetic Background)		 Annotated Term Reference
A4gnttm1Jnaka/A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka) 		increased gastric adenocarcinoma incidence J:184485
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N)) 		increased hepatocellular carcinoma incidence J:21232
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J) 		increased hepatocellular carcinoma incidence J:217802
Abcb4tm1Bor/Abcb4tm1Bor
(CAnNCrl.12P2(FVB)-Abcb4tm1Bor) 		increased hepatocellular carcinoma incidence J:217802
Abraxas1tm1.1Bwng/Abraxas1+
(involves: 129S6/SvEvTac * C57BL/6NCrl * FVB/N) 		increased histiocytic sarcoma incidence J:269823
increased lung adenocarcinoma incidence J:269823
Acot12em1Holi/Acot12em1Holi
(involves: C57BL/6J * C57BL/6N) 		increased hepatocellular carcinoma incidence J:335836
Acox1lampe1/Acox1lampe1
(involves: C57BL/6J) 		increased hepatocellular carcinoma incidence J:174942
Acox1tm1Jkr/Acox1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6J) 		increased hepatocellular carcinoma incidence J:35794
Acp3tm1Pivi/Acp3tm1Pivi
(B6.Cg-Acp3tm1Pivi) 		increased prostate gland adenocarcinoma incidence J:207558
Actbtm1(PyVT)Arge/Actb+
(involves: 129S1/Sv) 		increased mammary adenocarcinoma incidence J:87544
Actbtm1(PyVT)Arge/Actb+
Waptm1(cre)Arge/Wap+
(involves: 129S1/Sv) 		increased mammary adenocarcinoma incidence J:87544
Actbtm2(Tag)Arge/Actb+
(involves: 129S1/Sv) 		increased sarcoma incidence J:87544
Actbtm2(Tag)Arge/Actb+
Tg(Hsp70-1-cre)1Arge/0
(involves: 129S1/Sv * C57BL/6J * CBA) 		increased leiomyosarcoma incidence J:87544
Ahrtm1Yfk/Ahrtm1Yfk
(involves: 129S/SvEv * C57BL/6J) 		increased urinary bladder carcinoma incidence J:179919
Aicdatm1(cre)Mnz/Aicda+
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased medulloblastoma incidence J:153656
increased skin squamous cell carcinoma incidence J:153656
Akt1Gt1Pnt/Akt1Gt1Pnt
Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Akt1Gt1Pnt/Akt1Gt1Pnt
Tg(MMTV-PyVT)634Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Tg(MMTV-PyVT)634Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Akt3tm1Mbb/Akt3tm1Mbb
Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Akt3tm1Mbb/Akt3tm1Mbb
Tg(MMTV-PyVT)634Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Albtm1(cre/ERT2)Mtz/Alb+
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6) 		increased cholangiocarcinoma incidence J:192740
Albtm1(cre/ERT2)Mtz/Alb+
Krastm4Tyj/Kras+
Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae) 		increased cholangiocarcinoma incidence J:254370
increased hepatocellular carcinoma incidence J:254370
Alktm1.1(ALK*F1174L)Heno/Alk+
Tg(Mpz-cre)94Imeg/0
Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * SJL) 		increased neuroblastoma incidence J:294092
Alktm1.1(ALK*F1174L)Heno/Alktm1.1(ALK*F1174L)Heno
Tg(Mpz-cre)94Imeg/0
Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * SJL) 		increased neuroblastoma incidence J:294092
Alktm1.1Ics/?
Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J) 		increased neuroblastoma incidence J:261033, J:228124
Alktm2.1Ics/?
Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J) 		increased neuroblastoma incidence J:261033, J:228124
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129S/SvEv * C57BL/6) 		increased ovarian carcinoma incidence J:128934
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2.1Rob
Smad5tm1Huy/Smad5tm1Huy
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		increased ovarian carcinoma incidence J:128934
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
(involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6) 		increased ovarian carcinoma incidence J:128934
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
Smad9tm1Jfm/Smad9tm1Jfm
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6) 		increased ovarian carcinoma incidence J:128934
Anxa7tm1Pll/Anxa7+
(B6.Cg-Anxa7tm1Pll) 		increased hepatocellular carcinoma incidence J:93685
ApcM1Tno/Apc+
(either: B6JJcl.B6(D2JJcl)-ApcM1Tno or (involves: C57BL/6 * C57BL/6JJcl * DBA/2JJcl)) 		increased mammary adenocarcinoma incidence J:218227
increased osteosarcoma incidence J:218227
ApcMin/Apc+
(involves: AKR/J * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:10209
ApcMin/Apc+
(involves: C57BL/6J) 		increased mammary adenocarcinoma incidence J:94108
ApcMin/Apc+
(B6(AKR)-ApcMin) 		increased intestinal adenocarcinoma incidence J:10209
ApcMin/Apc+
((AKR/J x C57BL/6J-ApcMin)F1) 		increased intestinal adenocarcinoma incidence J:21369
ApcMin/Apc+
Ccdc80tm1.1Ftk/Ccdc80tm1.1Ftk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * C57BL/6J * C57BL/6N) 		increased colon adenocarcinoma incidence J:216704
ApcMin/Apc+
Esr1tm1.1Mma/Esr1+
(involves: 129S2/SvPas * C57BL/6J) 		increased carcinoma incidence J:118600
ApcMin/Apc+
Hdac2Gt(W035F03)Joe/Hdac2Gt(W035F03)Joe
(involves: 129S2/SvPas * C57BL/6J) 		increased small intestine adenocarcinoma incidence J:152134
ApcMin/Apc+
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * AKR/J * C57BL/6 * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:90337
ApcMin/Apc+
Spata18tm1.2Hifa/Spata18+
(involves: C57BL/6J) 		increased colon adenocarcinoma incidence J:254117
increased intestinal adenocarcinoma incidence J:254117
increased small intestine adenocarcinoma incidence J:254117
ApcMin/Apc+
Spata18tm1.2Hifa/Spata18tm1.2Hifa
(involves: C57BL/6J) 		increased colon adenocarcinoma incidence J:254117
increased intestinal adenocarcinoma incidence J:254117
increased small intestine adenocarcinoma incidence J:254117
ApcMin/Apc+
Tcf7tm1Cle/Tcf7tm1Cle
(involves: 129P2/OlaHsd * C57BL/6J) 		increased mammary adenoacanthoma incidence J:57721
ApcMin/Apc+
Tgfbr1tm1Bopa/Tgfbr1+
(involves: 129S1/SvImJ * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:143706
ApcMin/Apc+
Tgfbr1tm1Bopa/Tgfbr1+
(B6.Cg-Tgfbr1tm1Bopa ApcMin) 		increased intestinal adenocarcinoma incidence J:143706
ApcMin/Apc+
Thbs1tm1Hyn/Thbs1tm1Hyn
(involves: C57BL/6J) 		increased carcinoma incidence J:79641
ApcMin/Apc+
Trp53tm1Mlh/Trp53tm1Mlh
(involves: 129P2/OlaHsd * C57BL/6 * SWR) 		increased pancreatic acinar cell carcinoma incidence J:29664
ApcMin/Apctm1Tno
Ctnnb1tm4.1Wbm/Ctnnb1+
(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:156864
Apctm1.1Rsmi/Apc+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased large intestine adenocarcinoma incidence J:159883
increased small intestine adenocarcinoma incidence J:159883
Apctm1Cip/Apc+
(involves: 129P2/OlaHsd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:94108
increased mammary adenocarcinoma incidence J:94108
Apctm1Cip/Apc+
H19tm1Lda/H19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA) 		increased intestinal adenocarcinoma incidence J:138826
Apctm1Hsa/Apc+
(involves: 129P2/OlaHsd * C57BL/6) 		increased mammary adenocarcinoma incidence J:61978
Apctm1Mmt/Apc+
Smad4tm1Mmt/Smad4+
(involves: 129S2/SvPas * C57BL/6) 		increased intestinal adenocarcinoma incidence J:46242
increased pancreatic ductal adenocarcinoma incidence J:46242
Apctm1Rak/Apc+
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:20443
increased intestinal adenocarcinoma incidence J:20443
Apctm1Rak/Apc+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:65142
Apctm1Rak/Apc+
Cdh1tm1Cbm/Cdh1+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:65142
Apctm1Rak/Apc+
Dcctm1.1Mehl/Dcctm1.1Mehl
(involves: 129P2/OlaHsd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:181517
Apctm1Rak/Apc+
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased adenocarcinoma incidence J:53451
increased carcinoma incidence J:53451
Apctm1Rak/Apc+
Smad4E6sad/Smad4+
(B6.129P2-Apctm1Rak +/+ Smad4E6sad) 		increased intestinal adenocarcinoma incidence J:107273
Apctm1Rsmi/Apc+
Tg(Fabp1-cre)1Jig/0
(involves: 129P2/OlaHsd * FVB/N) 		increased intestinal adenocarcinoma incidence J:159883
increased large intestine adenocarcinoma incidence J:159883
increased small intestine adenocarcinoma incidence J:159883
Apctm1Tno/Apc+
(involves: 129 * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:156864
Apctm1Tno/Apc+
Brf1tm1Arte/Brf1tm1Arte
Tg(Cyp1a1-cre)1Dwi/0
(involves: C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:285667
Apctm1Tno/Apc+
Ptentm2Mak/Ptentm2Mak
Tg(Cyp1a1-cre/ERT)1Dwi/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA) 		increased intestinal adenocarcinoma incidence J:143082
Apctm1Tno/Apc+
Tg(CDX2-cre)101Erf/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:126018
Apctm1Tno/Apc+
Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased small intestine adenocarcinoma incidence J:126018
Apctm1Tno/Apctm1Tno
(involves: 129 * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:156864
Apctm1Tno/Apctm1Tno
Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased ovarian carcinoma incidence J:120955
Apctm1Tno/Apctm1Tno
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA/2) 		increased prostate gland adenocarcinoma incidence J:120308
Apctm2.1Cip/Apc+
Krastm4Tyj/Kras+
Tg(Fabp1-cre)1Jig/0
(involves: 129P2/OlaHsd * 129S4/SvJae * FVB) 		increased intestinal adenocarcinoma incidence J:132357
Apctm2.1Cip/Apc+
Tg(Fabp1-cre)1Jig/0
(involves: 129P2/OlaHsd * FVB/N) 		increased intestinal adenocarcinoma incidence J:132357
Apctm2.1Cip/Apctm2.1Cip
(involves: 129P2/OlaHsd * C57BL/6N) 		increased hepatocellular carcinoma incidence J:94721
Apctm2Rak/Apctm2Rak
(involves: 129/Sv * C57BL/6J * SJL) 		increased carcinoma incidence J:156532
Apctm2Rak/Apctm2Rak
Krastm4Tyj/Kras+
(involves: 129 * 129S4/SvJae * C57BL/6J * SJL) 		increased adenocarcinoma incidence J:156532
increased carcinoma incidence J:156532
Apctm2Rfo/Apc+
(B6.129P2-Apctm2Rfo) 		increased mammary adenocarcinoma incidence J:151494
Apctm2Rfo/Apc+
((C57BL/6J x 129P2/OlaHsd)F1) 		increased mammary adenocarcinoma incidence J:204440, J:151494
Apctm2Rfo/Apc+
(129P2/OlaHsd-Apctm2Rfo) 		increased mammary adenocarcinoma incidence J:151494
Apctm2Rfo/Apc+
Smad4E6sad/Smad4+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased mammary adenocarcinoma incidence J:151494
Apex1tm1Ecf/Apex1+
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6)) 		increased carcinoma incidence J:70397
increased sarcoma incidence J:70397
Artm1Verh/Y
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:172730
Arid1atm1.1Mag/Arid1atm1.1Mag
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * CD-1) 		increased ovarian carcinoma incidence J:219794
Arid4atm1Alb/Arid4atm1Alb
(involves: 129S7/SvEvBrd) 		increased sarcoma incidence J:141004
Arid4atm1Alb/Arid4atm1Alb
Arid4btm1Alb/Arid4b+
(involves: 129S7/SvEvBrd) 		increased sarcoma incidence J:141004
Asxl1tm1.1Mjxu/Asxl1+
(involves: 129 * C57BL/6) 		increased malignant tumor incidence J:208085
increased sarcoma incidence J:208085
Atad5Gt(RRF055)Byg/Atad5+
(involves: 129P2/OlaHsd) 		increased hemangiosarcoma incidence J:176672
increased liver adenocarcinoma incidence J:176672
increased lung adenocarcinoma incidence J:176672
increased lung carcinoma incidence J:176672
increased sarcoma incidence J:176672
increased spindle cell carcinoma incidence J:176672
Atmtm1Awb/Atmtm1Awb
(A.129S6-Atmtm1Awb) 		increased hepatocellular carcinoma incidence J:208539
Atmtm1Mfl/Atm+
(involves: 129T2/SvEms * C57BL/6J) 		increased sarcoma incidence J:78527
Atp2a2tm1Ges/Atp2a2+
(involves: 129X1/SvJ * Black Swiss) 		increased squamous cell carcinoma incidence J:69754
Atp2c1tm1Ges/Atp2c1+
(involves: 129X1/SvJ * Black Swiss) 		increased squamous cell carcinoma incidence J:124662
Atp11cambr/Y
(C57BL/6-Atp11cambr) 		increased hepatocellular carcinoma incidence J:171924
Atrxtm1Rjg/Y
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * CD-1) 		increased osteosarcoma incidence J:329449
Atrxtm1Rjg/Atrxtm1Rjg
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * CD-1) 		increased osteosarcoma incidence J:329449
AurkaGt(XQ0149)Wtsi/Aurka+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lung carcinoma incidence J:143099
increased squamous cell carcinoma incidence J:143099
Aurkbtm1.2Mama/Aurkb+
(involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL) 		increased adenocarcinoma incidence J:173575
increased liver adenocarcinoma incidence J:173575
B2mtm1Unc/B2mtm1Unc
Il2tm1Hor/Il2tm1Hor
(involves: 129 * C57BL/6) 		increased intestinal adenocarcinoma incidence J:51450
B3gnt6tm1Lx/B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J) 		increased adenocarcinoma incidence J:123826
increased carcinoma incidence J:123826
B3gnt6tm1Lx/B3gnt6tm1Lx
C1galt1tm1.1Rpmc/C1galt1tm1.1Rpmc
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2) 		increased duodenum adenocarcinoma incidence J:239765
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Krastm4Tyj/Kras+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		increased adenocarcinoma incidence J:125101
Bap1em1Test/Bap1+
(involves: FVB) 		increased lung carcinoma incidence J:231692
increased mammary adenocarcinoma incidence J:231692
increased squamous cell carcinoma incidence J:213725
Bap1em2Test/Bap1+
(involves: FVB) 		increased lung carcinoma incidence J:231692
increased mammary adenocarcinoma incidence J:231692
increased pancreatic islet cell carcinoma incidence J:231692
Bap1em3Test/Bap1+
(involves: FVB) 		increased lung carcinoma incidence J:231692
increased mammary adenocarcinoma incidence J:231692
Bard1tm1Thl/Bard1tm2Thl
Waptm1(cre)Arge/0
(involves: 129S1/Sv * C57BL/6J) 		increased mammary adenocarcinoma incidence J:134977
Bard1tm2Thl/Bard1tm2Thl
Brca1tm1Thl/Brca1tm1Thl
Waptm1(cre)Arge/0
(involves: 129/Sv * 129S1/Sv * C57BL/6J) 		increased mammary adenocarcinoma incidence J:134977
Bard1tm2Thl/Bard1tm2Thl
Waptm1(cre)Arge/0
(involves: 129/Sv * 129S1/Sv * C57BL/6J) 		increased mammary adenocarcinoma incidence J:134977
Becn1tm1Blev/Becn1+
(involves: 129X1/SvJ * C57BL/6J) 		increased hepatocellular carcinoma incidence J:86953
increased histiocytic sarcoma incidence J:86953
increased lung adenocarcinoma incidence J:86953
increased lung carcinoma incidence J:86953
increased malignant tumor incidence J:86953
Becn1tm1Htz/Becn1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:86982
increased lung adenocarcinoma incidence J:86982
Bhlha15tm2(Kras)Skz/Bhlha15+
(involves: 129S6/SvEvTac * C57BL/6) 		increased hepatocellular carcinoma incidence J:105076
increased pancreatic acinar cell carcinoma incidence J:105076
Bhlha15tm2(Kras)Skz/Bhlha15+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		increased hepatocellular carcinoma incidence J:105076
Bhmttm1.2Zei/Bhmttm1.2Zei
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:177569
Bin1tm1Gcp/Bin1tm2Gcp
Tg(MMTV-Myc)141-3Led/0
Tg(Wap-cre)11738Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL) 		increased mammary adenocarcinoma incidence J:117330
Bin3tm1Gcp/Bin3tm1Gcp
(involves: 129 * C57BL/6) 		increased lung adenocarcinoma incidence J:133313
Blmtm1Ches/Blmtm4Ches
Tg(LGB-cre)74Acl/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL) 		increased mammary adenocarcinoma incidence J:112115
Bmpr1atm2.1Bhr/Bmpr1atm2.1Bhr
Ctnnb1tm1Mmt/Ctnnb1+
Krt14tm1.1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * 129X1/SvJ) 		increased squamous cell carcinoma incidence J:199091
Braftm1.1Brd/Braf+
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn
Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL) 		increased carcinoma incidence J:199307
Braftm1.1Brd/Braf+
Tg(Vil1-cre)997Gum/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		increased carcinoma incidence J:199307
Braftm1Cpri/Braftm1Cpri
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Tyr-cre/ERT2)1Lru/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * DBA/2 * SJL) 		increased melanoma incidence J:147434
Braftm1Cpri/Braftm1Cpri
Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * FVB/NCr) 		increased thyroid carcinoma incidence J:168249
Braftm1Cpri/Braftm1Cpri
Tg(Tyr-cre/ERT2)1Lru/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased melanoma incidence J:147434
Braftm1Mmcm/Braf+
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:121715
Braftm1Mmcm/Braf+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased thyroid carcinoma incidence J:208854
Braftm1Mmcm/Braf+
Ezh2tm1.1Nesh/Ezh2+
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB) 		increased melanoma incidence J:239472
Braftm1Mmcm/Braf+
Ptentm1Mro/Ptentm1Mro
Tg(Tyr-cre/ERT2)1Lru/0
(B6.Cg-Braftm1Mmcm Tg(Tyr-cre/ERT2)1Lru Ptentm1Mro) 		increased cutaneous melanoma incidence J:188523
Braftm1Mmcm/Braf+
Ptentm1Rdp/Ptentm1Rdp
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased cutaneous melanoma incidence J:151023
Braftm1Mmcm/Braf+
Ptentm2.1Ppp/Pten+
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S1/Sv * FVB) 		increased cutaneous melanoma incidence J:151023
Braftm1Mmcm/Braf+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S1/Sv * FVB) 		increased cutaneous melanoma incidence J:151023
Braftm1Mmcm/Braf+
Tg(Tg-cre/ERT2)#Mmcm/0
(involves: 129P2/OlaHsd) 		increased thyroid carcinoma incidence J:172205
Braftm1Mmcm/Braf+
Tg(TPO-cre/ERT2)1139Tyj/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac) 		increased thyroid carcinoma incidence J:208854
Braftm1Mmcm/Braf+
Tg(TPO-cre/ERT2)1139Tyj/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac) 		increased thyroid carcinoma incidence J:208854
Braftm1Mmcm/Braf+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:121715
Braftm1Mmcm/Braf+
Trp53tm1Brn/Trp53tm3.1Tyj
Tg(TPO-cre/ERT2)1139Tyj/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac) 		increased thyroid carcinoma incidence J:208854
Braftm1Mmcm/Braf+
Trp53tm3.1Tyj/Trp53+
Tg(TPO-cre/ERT2)1139Tyj/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac) 		increased thyroid carcinoma incidence J:208854
Braftm1Mmcm/Braftm1Mmcm
Nkx3-1tm4(cre/ERT2)Mms/Nkx3-1+
Ptentm1Hwu/Pten+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:191327
Braftm1Rima/Braf+
Tg(GFP/KRAS2/ALPP)1Brn/0
Tg(Tyr-cre/ERT2)1Lru/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased melanoma incidence J:161180
Braftm1Sva/Braftm1Sva
Krastm1Bbd/Kras+
(involves: 129S1/Sv * 129X1/SvJ) 		increased lung non-small cell carcinoma incidence J:172200
Braftm1Tuv/Braftm1Tuv
Gt(ROSA)26Sortm1(sb13)Tuv/Gt(ROSA)26Sor+
Tg(Tyr-cre/ERT2)13Bos/0
TgTn(sb-T2/Onc)#Dla/0
(involves: 129S6/SvEvTac * FVB/N) 		increased melanoma incidence J:177503
Brca1tm1Aash/Brca1tm1Aash
Tg(LGB-cre)74Acl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased salivary adenocarcinoma incidence J:119996
Brca1tm1Aash/Brca1tm1Aash
Trp53tm1Brd/Trp53+
Tg(LGB-cre)74Acl/0
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 * CBA) 		increased mammary gland ductal carcinoma incidence J:119996
increased salivary adenocarcinoma incidence J:119996
Brca1tm1Arge/Brca1tm1Thl
Waptm1(cre)Arge/0
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J) 		increased mammary adenocarcinoma incidence J:134977
Brca1tm1Bhk/Brca1+
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(C.129-Cdkn2ctm1Yxi Brca1tm1Bhk) 		increased mammary adenocarcinoma incidence J:198018
Brca1tm1Brn/Brca1tm1Brn
Tg(Krt18-EGFP,-TAg121)36Ysng/0
Trp53tm1Brn/Trp53tm2Tyj
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		increased carcinoma incidence J:189304
increased ovarian carcinoma incidence J:189304
Brca1tm1Cxd/Brca1tm2Cxd
Tg(KRT5-cre)5132Jlj/0
(involves: 129S6/SvEvTac * C57BL/6) 		increased squamous cell carcinoma incidence J:85354
Brca1tm1Cxd/Brca1tm2Cxd
Tg(KRT5-cre)5132Jlj/0
Tg(KRT5-E2F1)2Dgj/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased squamous cell carcinoma incidence J:85354
Brca1tm1Cxd/Brca1tm2Cxd
Tg(KRT5-E2F1)2Dgj/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased squamous cell carcinoma incidence J:85354
Brca1tm1Cxd/Brca1tm2Cxd
Tg(MMTV-cre)4Mam/0
(involves: 129S6/SvEvTac * Black Swiss * FVB) 		increased mammary adenocarcinoma incidence J:54533
Brca1tm1Thl/Brca1tm1Thl
Waptm1(cre)Arge/0
(involves: 129S1/Sv * C57BL/6J) 		increased mammary adenocarcinoma incidence J:134977
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53tm1Brd/Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		increased carcinoma incidence J:122899
Brca1tm2Cxd/Brca1+
Tg(KRT5-E2F1)2Dgj/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased squamous cell carcinoma incidence J:85354
Brca1tm2Mak/Brca1tm2Mak
Chek2tm1Mak/Chek2tm1Mak
Tg(Wap-cre)11738Mam/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL) 		increased mammary adenocarcinoma incidence J:90512
Brca1tm2Mak/Brca1tm2Mak
Trp53tm1Brd/Trp53+
Tg(Wap-cre)11738Mam/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL) 		increased mammary adenocarcinoma incidence J:90512
Brca1tm4Cxd/Brca1tm4Cxd
(involves: 129S6/SvEvTac * NIH Black Swiss) 		increased mammary gland ductal carcinoma incidence J:112308
Brca2tm1Arge/Brca2tm2Arge
Waptm1(cre)Arge/Wap+
(involves: 129S/SvEv * C57BL/6) 		increased mammary adenocarcinoma incidence J:70564
Brca2tm1Brn/Brca2+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:73028
Brca2tm1Brn/Brca2tm1Brn
Ptch1tm1Mps/Ptch1+
Trp53tm1Tyj/Trp53+
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
Brca2tm1Brn/Brca2tm1Brn
Ptch1tm1Mps/Ptch1+
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53+
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:73028
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:73028
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Tyj/Trp53+
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
Brca2tm1Brn/Brca2tm1Cam
Krastm4Tyj/Kras+
Trp53tm3Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic acinar cell carcinoma incidence J:166678
increased pancreatic ductal adenocarcinoma incidence J:166678
Brca2tm1Cam/Brca2+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:166678
Brca2tm1Cam/Brca2+
Krastm4Tyj/Kras+
Trp53tm3Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:166678
Brca2tm1Cam/Brca2tm1Brn
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:166678
Brca2tm1Cam/Brca2tm1Brn
Tg(Pdx1-cre)6Tuv/0
Trp53tm3Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N) 		increased malignant tumor incidence J:166678
increased sarcoma incidence J:166678
Brca2tm1Hst/Brca2tm1Hst
(involves: 129S7/SvEvBrd * C57BL/6) 		increased carcinoma incidence J:82434
Brca2tm1Kamc/Brca2tm1Kamc
Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) 		increased osteosarcoma incidence J:109193
Brca2tm1Mak/Brca2tm2Mak
Trp53tm1Brd/Trp53tm1Brd
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA) 		increased malignant tumor incidence J:79697
increased osteosarcoma incidence J:79697
Brca2tm2Arge/Brca2tm2Arge
Waptm1(cre)Arge/Waptm1(cre)Arge
(involves: 129S1/Sv * C57BL/6) 		increased mammary adenocarcinoma incidence J:70564
Brf1tm1Arte/Brf1tm1Arte
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S7/SvEvBrd * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:285667
Brip1Gt(RRI409)Byg/Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd) 		increased adenocarcinoma incidence J:227115
Btg3tm1Tya/Btg3tm1Tya
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lung carcinoma incidence J:149382
Bub1tm1.1Jvd/Bub1tm2Jvd
(involves: 129/Sv * C57BL/6) 		increased sarcoma incidence J:135093
Bub1tm2Jvd/Bub1tm2Jvd
(involves: 129/Sv * C57BL/6) 		increased hepatocellular carcinoma incidence J:135093
increased sarcoma incidence J:135093
Bub1bGt(neo-btk)1Dai/Bub1b+
(involves: 129S4/SvJae) 		increased intestinal adenocarcinoma incidence J:88094
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6) 		increased adenocarcinoma incidence J:201641
increased fibrosarcoma incidence J:201641
increased hemangiosarcoma incidence J:201641
increased hepatocellular carcinoma incidence J:201641
increased lung adenocarcinoma incidence J:201641
increased rectum adenocarcinoma incidence J:201641
increased sarcoma incidence J:201641
Cables1tm1Lrz/Cables1tm1Lrz
(involves: 129S1/Sv) 		increased endometrial carcinoma incidence J:87478
Calcatm1.1(cre/ERT2)Ptch/Calca+
Trp53tm1Brn/Trp53tm1Brn
Rb1tm2Brn/Rb1tm2Brn
(involves: 129 * 129P2/OlaHsd * FVB/N) 		increased lung small cell carcinoma incidence J:190366
Calcatm1.1(cre/ERT2)Ptch/Calca+
Trp53tm1Brn/Trp53tm1Brn
Rb1tm2Brn/Rb1tm2Brn
Ptentm1Hwu/Ptentm1Hwu
(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * BALB/c * FVB/N) 		increased lung small cell carcinoma incidence J:190366
Cbx7tm1Afus/Cbx7+
(involves: C57BL/6J) 		increased hepatocellular carcinoma incidence J:184383
Cbx7tm1Afus/Cbx7tm1Afus
(involves: C57BL/6J) 		increased carcinoma incidence J:184383
increased hepatocellular carcinoma incidence J:184383
increased lung carcinoma incidence J:184383
Ccdc80tm1.1Ftk/Ccdc80tm1.1Ftk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6N) 		increased hepatocellular carcinoma incidence J:216704
Ccdc80tm1Ppal/Ccdc80tm1Ppal
(Not Specified) 		increased ovarian carcinoma incidence J:217742
Ccn6tm1.1Cgkl/Ccn6tm1.1Cgkl
Tg(MMTV-cre)1Mam/0
(FVB/N-Ccn6tm1.1Cgkl Tg(MMTV-cre)1Mam) 		increased mammary adenocarcinoma incidence J:241259
Ccn6tm1.1Cgkl/Ccn6tm1.1Cgkl
Tg(MMTV-cre)1Mam/0
Tg(MMTV-PyVT)634Mul/0
(FVB/N-Ccn6tm1.1Cgkl Tg(MMTV-cre)1Mam Tg(MMTV-PyVT)634Mul) 		increased mammary adenocarcinoma incidence J:241259
Ccnd1tm4Pisc/Ccnd1tm4Pisc
Tg(MMTV-Erbb2)NK1Mul/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:156591
Ccndbp1tm1Riet/Ccndbp1tm1Riet
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:121623
Cd19tm1(cre)Cgn/Cd19+
Inpp5dtm1Rav/Inpp5dtm1Rav
Ptentm1Hwu/Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased malignant tumor incidence J:166155
Cdh1tm1Jjon/Cdh1+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:116152
increased squamous cell carcinoma incidence J:116152
Cdh1tm1Jjon/Cdh1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Wap-cre)51Nki/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:171765
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53+
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:116152
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:116152
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)7Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:212549
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
(involves: 129 * C57BL/6 * FVB/N) 		increased duodenum adenocarcinoma incidence J:212549
increased gastric adenocarcinoma incidence J:212549
increased squamous cell carcinoma incidence J:212549
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Vil1-cre)20Syr/0
(involves: 129 * C57BL/6 * DBA/2) 		increased intestinal adenocarcinoma incidence J:212549
Cdh1tm2Kem/Cdh1tm2Kem
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
(involves: 129 * C57BL/6 * FVB/N) 		increased gastric adenocarcinoma incidence J:212549
Cdk4tm1.1Bbd/Cdk4+
Krastm1Bbd/Kras+
Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		increased hemangiosarcoma incidence J:86101
increased sarcoma incidence J:86101
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd
Tg(Mt1-Hgf)#Lmb/0
(B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb) 		increased cutaneous melanoma incidence J:111992
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd
Tg(Tyr-NRAS*Q61K)1Bee/0
(FVB.Cg-Cdk4tm1.1Bbd Tg(Tyr-NRAS*Q61K)1Bee) 		increased cutaneous melanoma incidence J:222847
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
Krastm1Bbd/Krastm2Bbd
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		increased adenocarcinoma incidence J:161780
Cdk5rap2an/Cdk5rap2an
Tyrp1B-lt/Tyrp1B-lt
(WBB6F1) 		increased histiocytic sarcoma incidence J:102334
Cdk6tm1Bbd/Cdk6tm1Bbd
Krastm1Bbd/Kras+
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		increased lung non-small cell carcinoma incidence J:161780
Cdkn1atm1(HBsAg)Xya/Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		increased hepatocellular carcinoma incidence J:88078
Cdkn1atm1(HBsAg)Xya/Cdkn1atm1(HBsAg)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		increased hepatocellular carcinoma incidence J:88078
Cdkn1atm1Led/Cdkn1atm1Led
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Tg(Upk2-cre)6Xrw/0
(involves: 129S6/SvEvTac * 129X1/SvJ * FVB/N) 		increased urinary bladder carcinoma incidence J:234236
Cdkn1atm1Tyj/Cdkn1a+
(involves: 129S1/SvImJ * 129S2/SvPas * C57BL/6J) 		increased malignant tumor incidence J:83967
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased carcinoma incidence J:70894
increased hemangiosarcoma incidence J:70894
increased histiocytic sarcoma incidence J:70894
increased lung carcinoma incidence J:70894
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129/Sv * 129S2/SvPas * C57BL/6) 		increased squamous cell carcinoma incidence J:72780
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S1/SvImJ * 129S2/SvPas * C57BL/6J) 		increased malignant tumor incidence J:83967
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * 129S2/SvPas * C57BL/6 * C57BL/6J * SJL) 		increased squamous cell carcinoma incidence J:72780
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Csnk1a1tm1.1Ybn/Csnk1a1tm1.1Ybn
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129 * C57BL/6 * CD-1 * DBA/2) 		increased carcinoma incidence J:204886
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		increased hepatocellular carcinoma incidence J:138701
increased renal carcinoma incidence J:138701
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Ptentm1Hwu/Ptentm1Hwu
Tg(Fabp1-cre)1Jig/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N) 		increased urinary bladder carcinoma incidence J:106662
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Tg(MMTV-vHaras)SH1Led/0
(involves: 129S2/SvPas * C57BL/6J * CD-1 * FVB/N) 		increased mammary adenocarcinoma incidence J:66183
increased salivary adenocarcinoma incidence J:66183
Cdkn1atm2(HBx)Xya/Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		increased hepatocellular carcinoma incidence J:88078
Cdkn1atm2(HBx)Xya/Cdkn1atm2(HBx)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		increased hepatocellular carcinoma incidence J:88078
Cdkn1btm1Ako/Cdkn1b+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(TPO-cre)1Shk/0
(129S1.Cg-Cdkn1btm1Ako Tg(TPO-cre)1Shk Ptentm2.1Ppp) 		increased thyroid carcinoma incidence J:165293
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv) 		increased lung adenocarcinoma incidence J:120835
Cdkn1btm1Ako/Cdkn1btm1Ako
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(involves: 129/Sv * 129S1/Sv * C57BL/6 * DBA/2) 		increased carcinoma incidence J:50053
Cdkn1btm1Jro/Cdkn1btm1Jro
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N) 		increased osteosarcoma incidence J:318035
Cdkn1btm1Mlf/Cdkn1b+
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased hemangiosarcoma incidence J:205254
increased medulloblastoma incidence J:205254
increased rhabdomyosarcoma incidence J:205254
Cdkn1btm1Mlf/Cdkn1b+
Tg(TG-TPR/NTRK1)#Rstn/0
(involves: 129S4/SvJaeSor * C3H * C57BL/6 * C57BL/6J) 		increased thyroid carcinoma incidence J:210015
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased hemangiosarcoma incidence J:205254
increased medulloblastoma incidence J:205254
increased rhabdomyosarcoma incidence J:205254
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Tg(TG-TPR/NTRK1)#Rstn/0
(involves: 129S4/SvJaeSor * C3H * C57BL/6 * C57BL/6J) 		increased thyroid carcinoma incidence J:210015
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Trp53tm1Brd/Trp53tm1Brd
(involves: C3H * C57BL/6J * NIH) 		increased sarcoma incidence J:87536
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J) 		increased sarcoma incidence J:87536
Cdkn2atm1(GFP)Cjs/Cdkn2atm1(GFP)Cjs
(involves: 129S1/Sv * C57BL/6) 		increased hemangiosarcoma incidence J:87339
increased histiocytic sarcoma incidence J:87339
increased sarcoma incidence J:87339
Cdkn2atm1.1Brn/Cdkn2a+
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased rhabdomyosarcoma incidence J:132943
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased rhabdomyosarcoma incidence J:132943
Cdkn2atm1.1Gsu/Cdkn2atm1.1Gsu
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		increased adenocarcinoma incidence J:198619
Cdkn2atm1Cjs/Cdkn2a+
(involves: 129X1/SvJ * C57BL/6 * NIH/OlaHsd) 		increased carcinoma incidence J:93298
Cdkn2atm1Cjs/Cdkn2a+
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129X1/SvJ * FVB) 		increased rhabdomyosarcoma incidence J:237183
Cdkn2atm1Cjs/Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6) 		increased carcinoma incidence J:44427
increased fibrosarcoma incidence J:44427
Cdkn2atm1Cjs/Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6 * NIH/OlaHsd) 		increased carcinoma incidence J:93298
increased squamous cell carcinoma incidence J:93298
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Pax7tm1Pgr/Pax7+
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129S2/SvPas * 129X1/SvJ * FVB) 		increased rhabdomyosarcoma incidence J:237183
increased sarcoma incidence J:237183
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Pax7tm1Pgr/Pax7tm1Pgr
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129S2/SvPas * 129X1/SvJ * FVB) 		increased rhabdomyosarcoma incidence J:237183
increased sarcoma incidence J:237183
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Sclt1Tg(CAG-sb10)1Dla/0
TgTn(sb-T2/Onc)68Dla/0
(involves: 129X1/SvJ * FVB/N) 		increased lung adenocarcinoma incidence J:99991
increased osteosarcoma incidence J:99991
increased sarcoma incidence J:99991
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Sclt1Tg(CAG-sb10)1Dla/0
TgTn(sb-T2/Onc)76Dla/0
(involves: 129X1/SvJ * FVB/N) 		increased lung adenocarcinoma incidence J:99991
increased osteosarcoma incidence J:99991
increased sarcoma incidence J:99991
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Tacstd2tm1Lsm/Tacstd2tm1Lsm
(involves: 129X1/SvJ * C57BL/6) 		increased carcinoma incidence J:182647
increased skin squamous cell carcinoma incidence J:182647
increased spindle cell carcinoma incidence J:182647
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129X1/SvJ * FVB) 		increased rhabdomyosarcoma incidence J:237183
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 * NIH/OlaHsd) 		increased carcinoma incidence J:93298
Cdkn2atm1Nesh/Cdkn2atm1Nesh
(involves: 129S6/SvEvTac * FVB/N) 		increased lung carcinoma incidence J:88365
increased osteosarcoma incidence J:88365
increased sarcoma incidence J:88365
Cdkn2atm1Nesh/Cdkn2atm1Nesh
X/Tg(Tyr-HRAS)60Lc
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J * FVB) 		increased melanoma incidence J:85075
Cdkn2atm1Rdp/Cdkn2a+
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased neurofibrosarcoma incidence J:131914
Cdkn2atm1Rdp/Cdkn2a+
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		increased sarcoma incidence J:120065
Cdkn2atm1Rdp/Cdkn2a+
Tg(CAG-Bgeo,-tTA,-EGFP)2A11Kuw/0
Tg(Pdx1-cre)6Tuv/0
Tg(tetO-MYC)36Bop/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL) 		increased pancreatic ductal adenocarcinoma incidence J:197052
Cdkn2atm1Rdp/Cdkn2a+
X/Tg(Tyr-HRAS)60Lc
(involves: 129/Sv * C57BL/6J * CBA/J * FVB/N * SJL) 		increased intraocular melanoma incidence J:140820
Cdkn2atm1Rdp/Cdkn2a+
Tg(Tyr-NRAS*Q61K)1Bee/?
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL) 		increased cutaneous melanoma incidence J:98545
Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6 * SJL) 		increased cutaneous melanoma incidence J:98545
increased fibrosarcoma incidence J:53805
increased hemangiosarcoma incidence J:53805
increased sarcoma incidence J:53805
Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6J * FVB/N * SJL) 		increased sarcoma incidence J:88365
Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL) 		increased squamous cell carcinoma incidence J:72780
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Col1a1tm1(CAG-EGFR)Char/Col1a1tm1(CAG-EGFR)Char
Ptentm1Hwu/Ptentm1Hwu
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * SJL) 		increased glioblastoma incidence J:146494
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Col1a1tm1(CAG-EGFR)Char/Col1a1tm2(CAG-EGFR*)Char
Ptentm1Hwu/Ptentm1Hwu
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * SJL) 		increased glioblastoma incidence J:146494
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Col1a1tm2(CAG-EGFR*)Char/Col1a1tm2(CAG-EGFR*)Char
Ptentm1Hwu/Ptentm1Hwu
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * SJL) 		increased glioblastoma incidence J:146494
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Ptentm1Rps/Ptentm1Rps
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129/Sv * C57BL/6J * FVB * SJL) 		increased melanoma incidence J:155731
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Pdgfratm12Sor/Pdgfra+
(involves: 129 * C57BL/6J * SJL) 		increased fibrosarcoma incidence J:146617
increased sarcoma incidence J:146617
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Ptentm1Rdp/Ptentm1Rdp
Tg(tetO-BRAF*V600E)29Lc/0
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129/Sv * C57BL/6J * FVB * SJL) 		increased melanoma incidence J:221902
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Krastm4Tyj/Kras+
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * FVB/N * SJL) 		increased lung adenocarcinoma incidence J:124682
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased neurofibrosarcoma incidence J:131914
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Ptentm1Rps/Ptentm1Rps
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129/Sv * 129S1/Sv * C57BL/6J * FVB/N * SJL) 		increased melanoma incidence J:155731
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		increased sarcoma incidence J:120065
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Mt1-Hgf)19Lmb/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL) 		increased melanoma incidence J:79704
increased rhabdomyosarcoma incidence J:79704
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-Kras2)12Hev/0
(involves: 129 * C57BL/6J * FVB/N * SJL) 		increased lung adenocarcinoma incidence J:166963, J:73468
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(tetO-BRAF*V600E)29Lc/0
Tg(Tyr-rtTA)37Lc/0
(involves: 129/Sv * C57BL/6J * SJL) 		increased prostate gland adenocarcinoma incidence J:144358
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(tetO-Nras*Q61K)#Lc/0
Tg(Tyr-rtTA)37Lc/0
(FVB.Cg-Cdkn2atm1Rdp Tg(tetO-Nras*Q61K)#Lc Tg(Tyr-rtTA)37Lc) 		increased cutaneous melanoma incidence J:238049
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Tyr-BRAF*V600E)470Fgh/0
(involves: 129/Sv * C57BL/6J * CBA * SJL) 		increased melanoma incidence J:151455
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Tyr-BRAF*V600E)476Fgh/0
(involves: 129/Sv * C57BL/6J * CBA * SJL) 		increased melanoma incidence J:151455
Cdkn2atm1Rdp/Cdkn2atm1Rdp
X/Tg(Tyr-HRAS)60Lc
(involves: 129/Sv * C57BL/6J * CBA/J * SJL) 		increased melanoma incidence J:164588
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Tyr-NRAS*Q61K)1Bee/?
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL) 		increased cutaneous melanoma incidence J:98545
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Tyr-NRAS*Q61K)1Bee/0
(involves: 129/Sv * C57BL/6J * DBA/2 * SJL) 		increased cutaneous melanoma incidence J:193443
Cdkn2atm2.1Brn/Cdkn2atm2.1Brn
(involves: 129P2/OlaHsd * FVB/N) 		increased carcinoma incidence J:71393
increased melanoma incidence J:71393
increased sarcoma incidence J:71393
Cdkn2atm2.1Nesh/Cdkn2a+
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB) 		increased melanoma incidence J:164588
increased spindle cell carcinoma incidence J:164588
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Ezh2tm1.1Nesh/Ezh2+
Nrastm1.1Nesh/Nras+
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129 * 129S4/SvJae * 129P2/OlaHsd * C57BL/6 * FVB) 		increased melanoma incidence J:239472
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Krastm4Tyj/Kras+
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		increased melanoma incidence J:164588
increased spindle cell carcinoma incidence J:164588
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Krastm4Tyj/Kras+
Tg(Tyr-cre/ERT2)13Bos/0
(B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Cdkn2atm2.1Nesh Krastm4Tyj) 		increased cutaneous melanoma incidence J:220627
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB) 		increased melanoma incidence J:164588
increased spindle cell carcinoma incidence J:164588
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Nrastm1.1Nesh/Nras+
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129 * 129S4/SvJae * 129P2/OlaHsd * C57BL/6 * FVB) 		increased melanoma incidence J:239472
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Nrastm1.1Nesh/Nrastm1.1Nesh
Stk11tm1.1Rdp/Stk11tm1.1Rdp
Tg(Tyr-cre/ERT2)13Bos/0
(B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nrastm1.1Nesh Cdkn2atm2.1Nesh Stk11tm1.1Rdp) 		increased cutaneous melanoma incidence J:220627
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Nrastm1.1Nesh/Nrastm1.1Nesh
Tg(Tyr-cre/ERT2)13Bos/0
(B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nrastm1.1Nesh Cdkn2atm2.1Nesh) 		increased cutaneous melanoma incidence J:220627
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Nrastm1Tyj/Nrastm1Tyj
Tg(Tyr-cre/ERT2)13Bos/0
(B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nrastm1Tyj Cdkn2atm2.1Nesh) 		increased cutaneous melanoma incidence J:220627
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Trp53tm1Brn/Trp53tm1Brn
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB) 		increased melanoma incidence J:164588
Cdkn2atm2.1Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Cdkn2atm2.1Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased osteosarcoma incidence J:88365
increased sarcoma incidence J:88365
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:124682
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) 		increased adenocarcinoma incidence J:198619
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
X/Tg(Tyr-HRAS)60Lc
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J * FVB) 		increased melanoma incidence J:85075
Cdkn2atm2Brn/Cdkn2atm2Brn
Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd) 		increased rhabdomyosarcoma incidence J:132943
Cdkn2atm2Brn/Cdkn2atm2Brn
Tg(Tyr-cre/ERT,-Hras1*,-Trap1a)10BJvde/0
(involves: C57BL/6 * FVB/N) 		increased cutaneous melanoma incidence J:107175
increased neurofibrosarcoma incidence J:107175
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Smad4tm1Rdp/Smad4tm1Rdp
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Smad4tm1Rdp/Smad4tm1Rdp
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:195492
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased sarcoma incidence J:125101
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Smad4tm1Rdp/Smad4tm1Rdp
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Smad4tm1Rdp/Smad4tm1Rdp
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased malignant tumor incidence J:87196
increased pancreatic ductal adenocarcinoma incidence J:116130, J:108298, J:87196
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:187012
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Myf6tm1(cre)Mrc/Myf6+
Pax3tm1Mrc/Pax3tm1Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased rhabdomyosarcoma incidence J:93444
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Nf1tm1Par/Nf1tm1Par
(involves: 129S1/Sv * 129X1/SvJ) 		increased neurofibrosarcoma incidence J:234760
increased rhabdomyosarcoma incidence J:234760
increased sarcoma incidence J:234760
Cdkn2btm1Bbd/Cdkn2btm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased adenocarcinoma incidence J:63299
increased sarcoma incidence J:63299
Cdkn2btm1Bbd/Cdkn2btm1Bbd
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased sarcoma incidence J:63299
Cdkn2ctm1Bbd/Cdkn2c+
Trp53tm1Tyj/Trp53+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:102702
Cdkn2ctm1Bbd/Cdkn2c+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:102702
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased hemangiosarcoma incidence J:63299
increased renal carcinoma incidence J:63299
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ) 		increased medulloblastoma incidence J:102702
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased medulloblastoma incidence J:205254
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
Trp53tm1Brn/Trp53tm1Tyj
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:102702
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:102702
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(B6.129-Cdkn2ctm1Yxi) 		increased lung adenocarcinoma incidence J:120835
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
Men1tm1.1Ctre/Men1+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6) 		increased adenocarcinoma incidence J:120835
increased lung adenocarcinoma incidence J:120835
Cebpatm1Gonz/Cebpatm1Gonz
Tg(KRT5-cre)5132Jlj/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2J) 		increased squamous cell carcinoma incidence J:123139
Cers2Gt(S16-4B1)Sor/Cers2Gt(S16-4B1)Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		increased hepatocellular carcinoma incidence J:156841
Chek1tm1Sje/Chek1+
Tg(Wnt1)1Hev/0
(Not Specified) 		increased mammary adenocarcinoma incidence J:62919
Chek1tm2.1Sje/Chek1+
Trp53tm1Brn/Trp53+
Tg(MMTV-cre)#Mam/0
(involves: 129P2/OlaHsd * FVB) 		increased mammary adenocarcinoma incidence J:162126
Chuktm1Yhu/Chuktm1Yhu
Tg(Krt1-15-cre/PGR*)22Cot/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased carcinoma incidence J:141162
Chuktm2Yhu/Chuktm2Yhu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased skin squamous cell carcinoma incidence J:197037
Chuktm2Yhu/Chuktm2Yhu
Tg(Lor-CHUK)8Yhu/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased lung squamous cell carcinoma incidence J:197037
Chuktm2Yhu/Chuktm2Yhu
Tg(Lor-CHUK)8Yhu/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased squamous cell carcinoma incidence J:197037
Col1a1tm1(CAG-EGFR*T790M*C797S*L858R)Mje/Col1a1+
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		increased lung adenocarcinoma incidence J:235747
Col1a1tm1(tetO-EML4/ALK)Kkw/Col1a1+
Tg(Scgb1a1-rtTA)1Jaw/0
(involves: 129 * C57BL/6) 		increased lung carcinoma incidence J:166724
Col1a1tm1(tetO-EWSR1/ATF1)Yasu/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		increased sarcoma incidence J:194505
Col1a1tm1(tetO-EWSR1/ATF1)Yasu/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Tg(CAG-cat,-lacZ)11Miya/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J * DBA/2) 		increased sarcoma incidence J:194505
Col1a1tm1(tetO-EWSR1/ATF1)Yasu/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(EYFP)Cos
Tg(Mpz-cre)94Imeg/0
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6) 		increased sarcoma incidence J:194505
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		increased hepatocellular carcinoma incidence J:217463
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
Trp53tm1Gev/Trp53+
(B6.Cg-Trp53tm1Gev Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		increased hepatocellular carcinoma incidence J:217463
Col1a1tm1(tetO-URI1)Ndj/Col1a1tm1(tetO-URI1)Ndj
Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		increased hepatocellular carcinoma incidence J:217463
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(KRT14-cre)1Amc/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA) 		increased skin squamous cell carcinoma incidence J:171057
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:222916
Col1a1tm4(CAG-FGFR2_iIIIb*K660N)Kkw/Col1a1+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6) 		increased lung adenocarcinoma incidence J:214230
Cop1Gt(XR0653)1.1Wtsi/Cop1Gt(XR0653)1.1Wtsi
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased histiocytic sarcoma incidence J:178271
Cop1tm2.1Vmd/Cop1+
Tg(Pbsn-cre)4Prb/0
(B6N.CgCop1tm2.1Vmd Ptentm1Hwu Tg(Pbsn-cre)4Prb) 		increased prostate gland adenocarcinoma incidence J:172653
Coro1ctm1c(KOMP)Wtsi/Coro1ctm1c(KOMP)Wtsi
Ptentm2Mak/Ptentm2Mak
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre/Esr1*,-lacZ)ASbk/0
(involves: 129P2/OlaHsd * C57BL/6N * FVB/NJ) 		increased glioblastoma incidence J:290447
Crebbptm1Dli/Crebbp+
(involves: 129S6/SvEvTac * C57BL/6) 		increased histiocytic sarcoma incidence J:60630
Csf2tm1Dran/Csf2tm1Dran
Ifngtm1Ts/Ifngtm1Ts
Il3tm1Glli/Il3tm1Glli
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		increased carcinoma incidence J:83086
increased ovarian carcinoma incidence J:83086
Csnk1a1tm1.1Ybn/Csnk1a1+
Tg(Vil1-cre/ERT2)23Syr/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129 * C57BL/6 * CD-1 * DBA/2) 		increased carcinoma incidence J:204886
Csnk1a1tm1.1Ybn/Csnk1a1tm1.1Ybn
Tg(Vil1-cre/ERT2)23Syr/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129 * C57BL/6 * CD-1 * DBA/2) 		increased carcinoma incidence J:204886
Ctnnb1tm1.2Wvv/Ctnnb1+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:185942
Ctnnb1tm1Mmt/Ctnnb1+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Prom1tm1(cre/ERT2)Gilb/Prom1+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		increased intestinal adenocarcinoma incidence J:144215
Ctnnb1tm1Mmt/Ctnnb1+
Igs2tm1(CAG-Met)Zsu/Igs2+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:284956
Ctnnb1tm1Mmt/Ctnnb1+
Pik3catm1Gilb/Pik3ca+
Trp53tm1Brn/Trp53+
Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA) 		increased medulloblastoma incidence J:186709
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
Tg(Upk2-cre)6Xrw/0
(involves: 129S4/SvJae * 129X1/SvJ * FVB/N) 		increased urinary bladder carcinoma incidence J:164579
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Msx2-rtTA)885Lma/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * 129X1/SvJ * C57BL/6) 		increased urinary bladder carcinoma incidence J:202618
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased hepatoblastoma incidence J:112659
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Pbsn-cre)4Prb/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:143034, J:284956
Ctnnb1tm1Mmt/Ctnnb1+
Trp53tm1Brn/Trp53+
Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA) 		increased medulloblastoma incidence J:186709
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Krastm4Tyj/Kras+
Tg(Upk2-cre)6Xrw/0
(involves: 129S4/SvJae * 129X1/SvJ * FVB/N) 		increased urinary bladder carcinoma incidence J:234236
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Ptentm1Hwu/Ptentm1Hwu
Tg(Upk2-cre)6Xrw/0
(involves: 129S4/SvJae * 129X1/SvJ * FVB/N) 		increased urinary bladder carcinoma incidence J:164579
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased hepatoblastoma incidence J:112659
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Tg(Upk2-cre)6Xrw/0
Tg(Upk2-HRAS*Q61L)5Xrw/0
(involves: 129X1/SvJ * FVB/N) 		increased urinary bladder carcinoma incidence J:234236
Cul9tm1.2Yxi/Cul9+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased sarcoma incidence J:170976
Cul9tm1.2Yxi/Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased sarcoma incidence J:170976
Cxcr6tm1Lex/Cxcr6+
(involves: 129S/SvEvBrd * C57BL/6J) 		increased medulloblastoma incidence J:120952
Cxcr6tm1Lex/Cxcr6tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J) 		increased medulloblastoma incidence J:120952
Cytiptm1Tes/Cytiptm1Tes
(involves: 129S1/Sv * FVB/N) 		increased sarcoma incidence J:110320
Dcctm1.1Mehl/Dcctm1.1Mehl
(Not Specified) 		increased intestinal adenocarcinoma incidence J:181517
Dcctm1Nki/Dcctm1Nki
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/?
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:181090
increased spindle cell carcinoma incidence J:181090
Dclre1atm1Rleg/Dclre1a+
(involves: 129S7/SvEvBrd) 		increased histiocytic sarcoma incidence J:102381
Dclre1atm1Rleg/Dclre1a+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		increased sarcoma incidence J:102381
Dclre1atm1Rleg/Dclre1atm1Rleg
(involves: 129S7/SvEvBrd) 		increased histiocytic sarcoma incidence J:102381
increased sarcoma incidence J:102381
Dcntm1Ioz/Dcntm1Ioz
Trp53tm1Brd/Trp53tm1Brd
(involves: 129/Sv * Black Swiss * C57BL/6) 		increased hemangiosarcoma incidence J:53511
Ddb2tm1Vri/Ddb2+
(involves: 129P2/Ola * SKH1) 		increased squamous cell carcinoma incidence J:103406
Ddb2tm1Vri/Ddb2tm1Vri
(involves: 129P2/Ola * SKH1) 		increased squamous cell carcinoma incidence J:103406
Ddit3tm1.1Irt/Ddit3tm1.1Irt
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(Mup3-Plau)350-2Eps/?
(involves: C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:233146
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac) 		increased hemangiosarcoma incidence J:158126
increased osteosarcoma incidence J:158126
increased sarcoma incidence J:158126
Del(4Cdkn2a-Cdkn2b)1Brn/+
(involves: 129P2/OlaHsd) 		increased sarcoma incidence J:125189
Del(4Cdkn2a-Cdkn2b)2Brn/+
(involves: 129P2/OlaHsd * FVB/N) 		increased intestinal adenocarcinoma incidence J:125189
increased melanoma incidence J:125189
increased sarcoma incidence J:125189
Del(4D4Mit190-D4Mit51)2Aam/+
(involves: 129S7/SvEvBrd) 		increased squamous cell carcinoma incidence J:121726
Del(15Krt7-Krt18)1Tmm/+
Igs11tm1Tmm/Igs11+
Krt1ctm1Tmm/Krt1c+
Tg(ACTB-KRAS*G12V,-luc)#Lche/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:199528
DgkdGt(RRT600)Byg/Dgkd+
(involves: 129P2/OlaHsd * C57BL/6) 		increased sarcoma incidence J:126380
Dicer1tm1Mmk/Dicer1tm1Mmk
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1) 		increased myeloid sarcoma incidence J:158901
Dicer1tm1Snj/Dicer1tm1Snj
Trp53tm1Brn/Trp53+
Tg(KRT5-cre/PGR)1Der/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6N * FVB/N * ICR) 		increased basal cell carcinoma incidence J:216813
Dicer1tm1Snj/Dicer1tm1Snj
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT5-cre/PGR)1Der/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6N * FVB/N * ICR) 		increased skin squamous cell carcinoma incidence J:216813
Dicer1tm1Tara/Dicer1tm1Tara
Ptentm1Hwu/Ptentm1Hwu
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd) 		increased carcinoma incidence J:182161
increased ovarian carcinoma incidence J:182161
Dicer1tm1Tara/Dicer1tm1Tara
Ptentm1Hwu/Ptentm1Hwu
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd) 		increased carcinoma incidence J:222579
increased ovarian carcinoma incidence J:222579
Dkc1tm1Ppp/Y
(involves: 129S1/Sv) 		increased fibrosarcoma incidence J:81054
increased lung carcinoma incidence J:81054
increased malignant tumor incidence J:81054
increased mammary adenocarcinoma incidence J:81054
increased renal carcinoma incidence J:81054
Dlg2tm1a(EUCOMM)Wtsi/Dlg2tm1a(EUCOMM)Wtsi
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Col1a1-cre)1Kry/0
(involves: 129 * 129P2/OlaHsd * C57BL/6N * FVB/N) 		increased osteosarcoma incidence J:269943
Dmtf1tm1Cjs/Dmtf1+
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased cholangiocarcinoma incidence J:126002
increased lung adenocarcinoma incidence J:126002
increased osteosarcoma incidence J:126002
Dmtf1tm1Cjs/Dmtf1+
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:126002
Dmtf1tm1Cjs/Dmtf1tm1Cjs
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:126002
Dmtf1tm1Cjs/Dmtf1tm1Cjs
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:126002
Dna2tm1.1Lzhg/Dna2+
(involves: 129S1/Sv) 		increased lung adenocarcinoma incidence J:198831
Dnai7Gt(VICTR21)709Lex/Dnai7+
(involves: 129S5/SvEvBrd) 		increased lung adenocarcinoma incidence J:111629
Dnai7Gt(VICTR21)709Lex/Dnai7Gt(VICTR21)709Lex
(involves: 129S5/SvEvBrd) 		increased lung adenocarcinoma incidence J:111629
Dnmt1tm1Jae/Dnmt1+
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:75745
Dnmt1tm1Pwl/Dnmt1+
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:75745
Dock1tm2.1Jfco/Dock1+
Tg(MMTV-Erbb2*,-cre)1Mul/0
(involves: C57BL/6 * FVB/NJ) 		increased mammary adenocarcinoma incidence J:196659
Dock1tm2.1Jfco/Dock1tm2.1Jfco
Tg(MMTV-Erbb2*,-cre)1Mul/0
(involves: C57BL/6 * FVB/NJ) 		increased mammary adenocarcinoma incidence J:196659
Dok1tm1Ppp/Dok1tm1Ppp
(129S1/Sv-Dok1tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
Dok1tm1Ppp/Dok1tm1Ppp
Dok2tm1Ppp/Dok2tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok2tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
Dok1tm1Ppp/Dok1tm1Ppp
Dok2tm1Ppp/Dok2tm1Ppp
Dok3tm1Ppp/Dok3tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok2tm1Ppp Dok3tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
Dok1tm1Ppp/Dok1tm1Ppp
Dok3tm1Ppp/Dok3tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok3tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
(B6.129-Dok1tm1Yyam Dok2tm1Yyam) 		increased sarcoma incidence J:95335
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
Dok3tm1Brs/Dok3tm1Brs
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased histiocytic sarcoma incidence J:163407
Dok2tm1Ppp/Dok2tm1Ppp
(129S1/Sv-Dok2tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
Dok3tm1Ppp/Dok3tm1Ppp
(129S1/Sv-Dok3tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:33099
increased lung adenocarcinoma incidence J:33099
increased lung non-small cell carcinoma incidence J:33099
Eaf2tm1Zhow/Eaf2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lung adenocarcinoma incidence J:145228
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J) 		increased hepatocellular carcinoma incidence J:145228
increased lung adenocarcinoma incidence J:145228
Ednrbtm1Ywa/Ednrb+
Tg(Mt1-RET)304Ina/0
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6) 		increased melanoma incidence J:155735
Eef1a1tm1(Kras*)Arge/Eef1a1+
Waptm1(cre)Arge/Wap+
(involves: 129S1/Sv) 		increased mammary adenocarcinoma incidence J:146290
Eef1e1Gt(OST377244)Lex/Eef1e1+
(involves: 129S5/SvEvBrd * C57BL/6) 		increased malignant tumor incidence J:96923
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo) 		increased colon adenocarcinoma incidence J:184388
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased hepatocellular carcinoma incidence J:163795
Ergtm1.1Sho/Ergtm1.1Sho
Ptentm1Hwu/Ptentm1Hwu
Tmprss2tm3Sho/Tmprss2tm3Sho
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:212219
Errfi1tm1Jwj/Errfi1tm1Jwj
Pgrtm2(cre)Lyd/Pgr+
(involves: 129S1/Sv * 129X1/SvJ) 		increased endometrial carcinoma incidence J:150007
Errfi1tm1Jwj/Errfi1tm1Jwj
Pgrtm2(cre)Lyd/Pgr+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased endometrial carcinoma incidence J:162027
Errfi1tm1Kln/Errfi1tm1Kln
(involves: 129P2/OlaHsd * C57BL/6N) 		increased carcinoma incidence J:109556
Espl1Gt(XL058)Byg/Espl1+
Trp53tm1Tyj/Trp53+
(B6.129-Trp53tm1Tyj Espl1Gt(XL058)Byg) 		increased carcinoma incidence J:174926
Espl1Gt(XL058)Byg/Espl1+
Trp53tm1Tyj/Trp53tm1Tyj
(B6.129-Trp53tm1Tyj Espl1Gt(XL058)Byg) 		increased carcinoma incidence J:174926
Esr1tm1Ksk/Esr1tm1Ksk
Tg(Wnt1)1Hev/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:54215
Exo1tm2Wed/Exo1tm2Wed
(involves: 129 * C57BL/6) 		increased sarcoma incidence J:198719
Exo1tm3.1Wed/Exo1tm3.1Wed
(involves: 129 * C57BL/6) 		increased sarcoma incidence J:198719
Exo1tm3.1Wed/Exo1tm3.1Wed
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased sarcoma incidence J:198719
F2rtm1Pago/F2rtm1Pago
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-F2rtm1Pago Tg(MMTV-PyVT)634Mul) 		increased mammary adenocarcinoma incidence J:138924
F2rl1tm1Bpd/F2rl1tm1Bpd
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-F2rl1tm1Bpd Tg(MMTV-PyVT)634Mul) 		increased mammary adenocarcinoma incidence J:138924
F3tm1(F3)Lasn/F3tm1(F3)Lasn
(involves: 129S/SvEvBrd * C57BL/6) 		increased lung carcinoma incidence J:133293
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased hepatocellular carcinoma incidence J:138701
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL) 		increased hepatocellular carcinoma incidence J:27735
Fancd2Gt(OST57859)Lex/Fancd2Gt(OST57859)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased carcinoma incidence J:146616
Fancd2tm1Hou/Fancd2tm1Hou
(129S4/SvJae-Fancd2tm1Hou) 		increased carcinoma incidence J:84892
Fancd2tm1Hou/Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J) 		increased carcinoma incidence J:84892
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6) 		increased histiocytic sarcoma incidence J:153501
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6) 		increased histiocytic sarcoma incidence J:153501
Fbxo4tm1.1Jadi/Fbxo4+
(Not Specified) 		increased hepatocellular carcinoma incidence J:178645
increased histiocytic sarcoma incidence J:178645
increased myeloid sarcoma incidence J:178645
Fbxo4tm1.1Jadi/Fbxo4tm1.1Jadi
(Not Specified) 		increased hepatocellular carcinoma incidence J:178645
increased histiocytic sarcoma incidence J:178645
increased myeloid sarcoma incidence J:178645
Fbxw7tm1Iken/Fbxw7tm1Iken
Krastm4Tyj/Kras+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N * DBA) 		increased cholangiocarcinoma incidence J:258194
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch) 		increased hemangiosarcoma incidence J:244082
increased hepatocellular carcinoma incidence J:244082
increased lung carcinoma incidence J:244082
increased myeloid sarcoma incidence J:244082
increased sarcoma incidence J:244082
Fen1tm1Rak/Fen1+
Apctm1Rak/Apc+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * SJL/J) 		increased malignant tumor incidence J:77962
Fen1tm2Klng/Fen1tm2Klng
(involves: 129X1/SvJ * C57BL/6) 		increased sarcoma incidence J:138901
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified) 		increased lung adenocarcinoma incidence J:231218
Fgfr4tm1Axul/Fgfr4+
Tg(WapTgfa)215Bri/0
(B6.Cg-Fgfr4tm1Axul Tg(WapTgfa)215Bri) 		increased mammary adenocarcinoma incidence J:156750
Fgfr4tm1Axul/Fgfr4tm1Axul
Tg(WapTgfa)215Bri/0
(B6.Cg-Fgfr4tm1Axul Tg(WapTgfa)215Bri) 		increased mammary adenocarcinoma incidence J:156750
Fgfr4tm1Axul/Fgfr4tm1Axul
Tg(WapTgfa)215Bri/0
(FVB.Cg-Fgfr4tm1Axul Tg(WapTgfa)215Bri) 		increased mammary adenocarcinoma incidence J:156750
Fhittm1Tko/Fhittm1Tko
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:93269
Flcntm1Btt/Flcntm1Btt
Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJaeSor * C57BL/6 * ICR) 		increased renal carcinoma incidence J:143922
Flt3tm2.1Dosm/Flt3+
(B6.129(C)-Flt3tm2.1Dosm) 		increased hemangiosarcoma incidence J:205200
increased histiocytic sarcoma incidence J:205200
Fn1tm1Bwg/Fn1tm1Bwg
Tg(RIP1-Tag)2Dh/0
(involves: 129S4/SvJae * BALB/c * C57BL/6J) 		increased carcinoma incidence J:93027
Fn1tm1Ksek/Fn1tm1Ksek
Tg(RIP1-Tag)2Dh/0
(involves: 129S4/SvJae * C57BL/6J) 		increased carcinoma incidence J:93027
Fntbtm1.1Mbrg/Fntbtm1.2Mbrg
Krastm4Tyj/Kras+
Pggt1btm1Mbrg/Pggt1btm1.1Mbrg
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/cJ * C57BL/6 * FVB/N) 		increased lung carcinoma incidence J:158937
Fntbtm1Bbd/Fntbtm1Bbd
Krastm1Bbd/Kras+
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL) 		increased lung adenocarcinoma incidence J:98944
Fostm1Wag/Fostm1Wag
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased rhabdomyosarcoma incidence J:89283
Fostm1Wag/Fostm1Wag
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased rhabdomyosarcoma incidence J:89283
Foxa1tm1Khk/Foxa1tm1Khk
Foxa2tm1Khk/Foxa2tm1Khk
Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased hepatocellular carcinoma incidence J:181296
Foxm1tm1Rhc/Foxm1tm1Rhc
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:89472
Foxn1nu-str/Foxn1nu-str
(AKR/J-Foxn1nu-str/J) 		increased sarcoma incidence J:30715
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo3tm1Rdp/Foxo3tm1Rdp
Foxo4tm1Rdp/Foxo4tm1Rdp
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased hemangiosarcoma incidence J:118179
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo3tm1Rdp/Foxo3tm1Rdp
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased hemangiosarcoma incidence J:118179
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo4tm1Rdp/Foxo4tm1Rdp
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased hemangiosarcoma incidence J:118179
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased hemangiosarcoma incidence J:118179
Fshrtm1Saco/Fshrtm1Saco
(involves: 129) 		increased ovarian carcinoma incidence J:70933
Fzr1tm1.1Mama/Fzr1+
(involves: BALB/cJ * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:137456
Gadd45atm1Ajf/Gadd45atm1Ajf
Xpctm1Ecf/Xpctm1Ecf
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129X1/SvJ * C57BL/6)) 		increased lung adenocarcinoma incidence J:101421
Gfertm1.1Crg/Gfertm1.1Crg
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:227242
Gli1tm3(cre/ERT2)Alj/Gli1+
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
(involves: 129S6/SvEvTac * 129X1/SvJ) 		increased medulloblastoma incidence J:139574
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:24434
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd) 		increased intestinal adenocarcinoma incidence J:24434
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:146081
Gon4ljusty/Gon4ljusty
(C3HeB/FeJ-Gon4ljusty) 		increased salivary adenocarcinoma incidence J:197352
Gpr37l1tm1.2Gtva/Gpr37l1tm1.2Gtva
Ptch1tm1Zim/Ptch1+
(STOCK Gpr37l1tm1.2Gtva Ptch1tm1Zim/Cnrm) 		increased medulloblastoma incidence J:272049
Gprc5atm1Rlo/Gprc5atm1Rlo
(involves: 129 * C57BL/6) 		increased lung adenocarcinoma incidence J:127821
Gpx7tm1Whle/Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6) 		increased lung adenocarcinoma incidence J:193993
increased mammary adenocarcinoma incidence J:193993
increased sarcoma incidence J:193993
Grb2tm1Paw/Grb2+
Ptentm1Mak/Pten+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased endometrial carcinoma incidence J:93530
Grb2tm1Paw/Grb2+
Tg(MMTV-PyVT)634Mul/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased mammary adenocarcinoma incidence J:51424
Grhl3tm1Jane/Grhl3+
Ptentm1Mak/Pten+
(involves: 129P2/OlaHsd * 129S1/Sv) 		increased skin squamous cell carcinoma incidence J:178952
Grhl3tm1Jane/Grhl3tm3.1Jane
Tg(KRT14-cre)8Brn/0
(involves: 129S1/Sv * C57BL/6 * FVB/N) 		increased skin squamous cell carcinoma incidence J:178952
Grm1Tg(p18A4.B)1352Szc/0
(Not Specified) 		increased cutaneous melanoma incidence J:83183, J:32786
Gt(ROSA)26Sortm1(CAG-AR)Zsu/Gt(ROSA)26Sor+
Tg(Osr1-cre)4Mrt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased malignant tumor incidence J:234601
increased prostate gland adenocarcinoma incidence J:234601
Gt(ROSA)26Sortm1(CAG-AR)Zsu/Gt(ROSA)26Sortm1(CAG-AR)Zsu
Tg(Osr1-cre)4Mrt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased prostate gland adenocarcinoma incidence J:234601
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+
Ptentm1Mro/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:184533
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)) 		increased carcinoma incidence J:187257
increased medulloblastoma incidence J:187257
Gt(ROSA)26Sortm1(CAG-MYCN,-luc)Jhsc/Gt(ROSA)26Sor+
Tg(Dbh-icre)1Gsc/0
(involves: 129S6/SvEvTac * C57BL/6) 		increased neuroblastoma incidence J:222527
Gt(ROSA)26Sortm1(CAG-PIK3CA*H1047R,-EGFP)Balj/Gt(ROSA)26Sor+
Tg(MMTV-cre)7Mul/0
(involves: BALB/c * FVB/N) 		increased mammary adenocarcinoma incidence J:173655
Gt(ROSA)26Sortm1(CAG-PIK3CA*H1047R,-EGFP)Balj/Gt(ROSA)26Sor+
Tg(Wap-cre)1Gsc/0
(involves: BALB/c * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:173655
Gt(ROSA)26Sortm1(CAG-Sox2,-EGFP)Blh/Gt(ROSA)26Sor+
Tg(Sftpc-cre)1Blh/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:161806
Gt(ROSA)26Sortm1(CAG-Sox2,-EGFP)Blh/Gt(ROSA)26Sortm1(CAG-Sox2,-EGFP)Blh
Scgb1a1tm1(cre/ERT)Blh/Scgb1a1+
(involves: 129S6/SvEv * C57BL/6) 		increased lung adenocarcinoma incidence J:161806
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Pdgfratm12Sor/Pdgfra+
(involves: 129 * C57BL/6) 		increased sarcoma incidence J:146617
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129 * 129S4/SvJae * BALB/c * C57BL/6) 		increased skin squamous cell carcinoma incidence J:130367
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sortm3(SS18/EGFP)Mrc
(involves: 129 * 129S1/Sv * 129X1/SvJ) 		increased sarcoma incidence J:147728
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased sarcoma incidence J:217462
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:280854
Gt(ROSA)26Sortm1(GNAQ*)Cvrk/Gt(ROSA)26Sor+
Tg(Mitf-cre)7114Gsb/0
(C3FeJ.Cg-Gt(ROSA)26Sortm1(GNAQ*)Cvkr Tg(Mitf-cre)7114Gsb/Cvrk) 		increased intraocular melanoma incidence J:225597
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)) 		increased histiocytic sarcoma incidence J:172031
increased sarcoma incidence J:172031
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)) 		increased histiocytic sarcoma incidence J:172031
increased sarcoma incidence J:172031
Gt(ROSA)26Sortm1(JAG1)Xin/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)20Fwan/?
(involves: 129S4/SvJae * C57BL/6 * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:238768
Gt(ROSA)26Sortm1(MAML1)Wsp/Gt(ROSA)26Sor+
Tg(Tagln-cre)1Jjl/0
(involves: CD-1 * FVB/N) 		increased squamous cell carcinoma incidence J:112093
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/NJ) 		increased liposarcoma incidence J:237232
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ) 		increased liposarcoma incidence J:237232
Gt(ROSA)26Sortm1(pb)Peli/Gt(ROSA)26Sor+
TgTn(pb-sb-ATP1)S1Brd/0
(involves: 129S7/SvEvBrd * FVB) 		increased carcinoma incidence J:166063
increased sarcoma incidence J:166063
Gt(ROSA)26Sortm1(pb)Peli/Gt(ROSA)26Sor+
TgTn(pb-sb-ATP1)S2Brd/0
(involves: 129S7/SvEvBrd * FVB) 		increased carcinoma incidence J:166063
increased sarcoma incidence J:166063
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Tg(MMTV-cre)#Tfln/0
(involves: 129S6/SvEvTac) 		increased mammary adenocarcinoma incidence J:170898
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Tg(MMTV-cre)#Tfln/0
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased mammary adenocarcinoma incidence J:170898
Gt(ROSA)26Sortm1(RAC1*)Jkis/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:187582
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(tetO-Kras2)12Hev/0
Trp53tm1Tyj/Trp53+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:184378
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(tetO-Kras*G12D)#Rdp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:186194
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(tetO-Kras*G12D)#Rdp/0
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:186194
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(tetO-Kras*G12D)#Rdp/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:186194
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
Hprt1tm1(sb-Onco-Array)Peli/Y
(involves: 129S7/SvEvBrd) 		increased hemangiosarcoma incidence J:166283
increased lung adenocarcinoma incidence J:166283
increased medulloblastoma incidence J:166283
increased rhabdomyosarcoma incidence J:166283
increased skin squamous cell carcinoma incidence J:166283
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
Hprt1tm1(sb-Onco-Array)Peli/Hprt1+
(involves: 129S7/SvEvBrd) 		increased hemangiosarcoma incidence J:166283
increased lung adenocarcinoma incidence J:166283
increased medulloblastoma incidence J:166283
increased rhabdomyosarcoma incidence J:166283
increased skin squamous cell carcinoma incidence J:166283
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6057Njen/0
(involves: C3H * C57BL/6) 		increased medulloblastoma incidence J:102234
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
(involves: C3H * C57BL/6) 		increased medulloblastoma incidence J:102234
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc3)12740Njen/0
(involves: C3H * C57BL/6J) 		increased basal cell carcinoma incidence J:153656
increased blastoma incidence J:153656
increased carcinoma incidence J:153656
increased hemangiosarcoma incidence J:153656
increased hepatocellular carcinoma incidence J:153656
increased lung carcinoma incidence J:153656
increased melanoma incidence J:153656
increased sarcoma incidence J:153656
increased skin squamous cell carcinoma incidence J:153656
increased squamous cell carcinoma incidence J:153656
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/?
Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129X1/SvJ * C57BL/6 * CBA) 		increased basal cell carcinoma incidence J:114992
increased medulloblastoma incidence J:114992
increased rhabdomyosarcoma incidence J:114992
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sor+
Hk2tm1.1Uku/Hk2+
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N) 		increased medulloblastoma incidence J:210113
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sor+
Hk2tm1.1Uku/Hk2tm1.1Uku
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N) 		increased medulloblastoma incidence J:210113
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
Olig2tm2(TVA,cre)Rth/Olig2+
(involves: 129 * 129X1/SvJ) 		increased medulloblastoma incidence J:139574
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
Tg(Atoh1-cre/Esr1*)14Fsh/0
(involves: 129X1/SvJ * FVB/N) 		increased medulloblastoma incidence J:139574
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
Tg(GFAP-cre)25Mes/0
(involves: 129X1/SvJ * FVB/N) 		increased medulloblastoma incidence J:139574
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
Tg(Krt1-5-cre/ERT)1Ipc/0
(involves: 129X1/SvJ * C57BL/6 * SJL) 		increased basal cell carcinoma incidence J:158915
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
Tlx3tm1(cre)Qima/Tlx3+
(involves: 129X1/SvJ) 		increased medulloblastoma incidence J:139574
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm2(EGFP/cre)Alj
Pgbd5tm1.1Aken/Pgbd5tm1.1Aken
(involves: 129 * C57BL/6J * C57BL/6NTac * SW) 		increased medulloblastoma incidence J:346387
Gt(ROSA)26Sortm1(SPOP*F133V)Mrbn/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:239660
Gt(ROSA)26Sortm1(SPOP*F133V)Mrbn/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:239660
Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key/Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:200002
Gt(ROSA)26Sortm1(Tva)Dsa/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J) 		increased pancreatic ductal adenocarcinoma incidence J:140423
Gt(ROSA)26Sortm1(Tva)Dsa/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S6/SvEvTac * C57BL/6J) 		increased pancreatic ductal adenocarcinoma incidence J:140423
Gt(ROSA)26Sortm1.1(rtTA2S*M2)Whsu/Gt(ROSA)26Sor+
Ncstntm1.1Akli/Ncstntm1.1Akli
Tg(tetO-cre)1Jaw/0
(involves: 129 * 129S6/SvEvTac * C57BL/6) 		increased urinary bladder carcinoma incidence J:227748
Gt(ROSA)26Sortm2(CAG-Lin28b,-luc)Jhsc/Gt(ROSA)26Sor+
Tg(Dbh-icre)1Gsc/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6) 		increased neuroblastoma incidence J:241988
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
Tg(RasE)290Biat/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:226601
increased pancreatic ductal adenocarcinoma incidence J:226601
Gt(ROSA)26Sortm2(myc*T58A)Rcse/Gt(ROSA)26Sortm2(myc*T58A)Rcse
Tg(Wap-cre)11738Mam/0
(involves: 129 * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:169403
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S6/SvEvTac) 		increased carcinoma incidence J:197054
increased pancreatic ductal adenocarcinoma incidence J:197054
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
TgTn(sb-T2/Onc)68Dla/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased hepatocellular carcinoma incidence J:147264
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Tg(Vil1-cre)20Syr/0
TgTn(sb-T2/Onc)68Dla/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased small intestine adenocarcinoma incidence J:146887
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Tg(Vil1-cre)20Syr/0
TgTn(sb-T2/Onc)76Dla/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased small intestine adenocarcinoma incidence J:146887
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Trp53tm3Tyj/Trp53+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
TgTn(sb-T2/Onc)68Dla/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		increased hepatocellular carcinoma incidence J:147264
Gt(ROSA)26Sortm2(SS18)Mrc/Gt(ROSA)26Sortm2(SS18)Mrc
Myf5tm1(cre)Mrc/Myf5tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased sarcoma incidence J:120967
Gt(ROSA)26Sortm2Thl/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Trp53tm1Thl/Trp53tm1Thl
Tyrc-Brd/Tyrc-Brd
(involves: 129/Sv * 129S4/SvJae * C57BL/6) 		increased glioblastoma incidence J:172585
Gt(ROSA)26Sortm2Thl/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Tyrc-Brd/Tyrc-Brd
(involves: 129/Sv * 129S4/SvJae * C57BL/6) 		increased glioblastoma incidence J:172585
Gt(ROSA)26Sortm3(SS18/EGFP)Mrc/Gt(ROSA)26Sortm3(SS18/EGFP)Mrc
Myf5tm1(cre)Mrc/Myf5tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased sarcoma incidence J:120967
Gt(ROSA)26Sortm4(CAG-hsb5)Nki/Gt(ROSA)26Sor+
Npm1tm1Gsva/Npm1+
TgTn(pb-sb-GrOnc)#aGsva/0
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased hemangiosarcoma incidence J:172071
Gt(ROSA)26Sortm5(ASPSCR1/TFE3)Mrc/Gt(ROSA)26Sortm1(cre/ERT)Nat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased sarcoma incidence J:217462
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Hmga2tm1.1Mmw/Hmga2+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm2Tyj/Trp53+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:245611
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Prdm1tm1Clme/Prdm1tm1Clme
Tg(Pdx1-cre)6Tuv/0
Trp53tm2Tyj/Trp53+
(involves: 129 * C57BL/6NCrl * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:245611
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm2Tyj/Trp53+
(involves: 129 * C57BL/6NCrl * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:245611
Gtf2ird1Tg(Alb1-Myc)166.8Sst/0
Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		increased hepatocellular carcinoma incidence J:4527
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+
(involves: C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:34434, J:101128
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+
Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:101128
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+
Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		increased hepatocellular carcinoma incidence J:34434
H2axtm1Fwa/H2ax+
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased sarcoma incidence J:84879
H2axtm1Fwa/H2axtm1Fwa
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased colon adenocarcinoma incidence J:84879
increased sarcoma incidence J:84879
Hat1tm1.1Mrpa/Hat1+
(B6.Cg-Hat1tm1.1Mrpa) 		increased histiocytic sarcoma incidence J:296531
Hcktm1Ern/Hcktm1Ern
(involves: 129S1/Sv * C57BL/6) 		increased lung adenocarcinoma incidence J:111432
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6) 		increased carcinoma incidence J:81448
increased hepatocellular carcinoma incidence J:81448
increased lung adenocarcinoma incidence J:81448
increased malignant tumor incidence J:81448
increased pancreatic islet cell carcinoma incidence J:81448
increased sarcoma incidence J:81448
increased squamous cell carcinoma incidence J:81448
Hip1tm4Tsr/Hip1+
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:151974
Hmgn1tm1Mbus/Hmgn1tm1Mbus
(involves: 129X1/SvJ) 		increased malignant tumor incidence J:100773
Hprt1tm1(CAG-BRF1)Gu/Hprt1+
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:285667
Hprt1tm1(CUX1)Anep/Hprt1+
(FVB.129P2-Hprt1tm1(CUX1)Anep) 		increased mammary adenocarcinoma incidence J:152682
Hprt1tm1(Pbsn*-cre/ERT2)Jir/Y
Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:144357
Hprt1tm2(CUX1)Anep/Hprt1+
(FVB.129P2-Hprt1tm2(CUX1)Anep) 		increased mammary adenocarcinoma incidence J:152682
Hrhr/Hrhr
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd) 		increased skin squamous cell carcinoma incidence J:79734
Hrhr/Hrhr
Msh2tm1Htr/Msh2tm1Htr
Xpatm1Tnka/Xpatm1Tnka
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased skin squamous cell carcinoma incidence J:79734
Hrhr/Hrhr
Tg(KRT14-Birc5)19Gros/0
(involves: C3H * C57BL/6 * SKH1) 		increased squamous cell carcinoma incidence J:95011
Hrastm1Jaf/Hras+
Tg(CAG-cre)13Miya/0
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6) 		increased hemangiosarcoma incidence J:148393
Hrastm2Xbr/Hrastm2Xbr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:137729
Hspa5tm1Alee/Hspa5+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/?
(involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:142106
Htatip2tm1Hx/Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased carcinoma incidence J:87066
increased hemangiosarcoma incidence J:87066
increased hepatocellular carcinoma incidence J:87066
increased malignant tumor incidence J:87066
increased neuroblastoma incidence J:87066
increased urinary bladder transitional cell carcinoma incidence J:87066
Htatip2tm1Hx/Htatip2tm1Hx
(involves: 129P2/OlaHsd * C57BL/6J) 		increased carcinoma incidence J:87066
increased duodenum adenocarcinoma incidence J:87066
increased hepatocellular carcinoma incidence J:87066
increased malignant tumor incidence J:87066
increased sarcoma incidence J:87066
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts) 		increased sarcoma incidence J:77491
Ifngtm1Ts/Ifngtm1Ts
(C.129S7-Ifngtm1Ts) 		increased lung adenocarcinoma incidence J:77491
Igs2tm1(CAG-Met)Zsu/Igs2+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2 * FVB/N) 		increased carcinoma incidence J:268934
increased prostate gland adenocarcinoma incidence J:268934
Ikbkgtm1.1Chtr/Y
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL) 		increased hepatocellular carcinoma incidence J:151485
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL) 		increased hepatocellular carcinoma incidence J:151485
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0
(involves: FVB/N) 		increased hepatocellular carcinoma incidence J:160521
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		increased hepatocellular carcinoma incidence J:118336
Il6tm1Kopf/Il6+
Ncoa5tm1Hxia/Ncoa5+
(involves: 129S2/SvPas * C57BL/6) 		increased hepatocellular carcinoma incidence J:207622
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:68476
increased large intestine adenocarcinoma incidence J:35020
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J) 		increased colon adenocarcinoma incidence J:149347
Il10tm1Cgn/Il10tm1Cgn
Tg(MUC1)79.24Gend/0
(B6.Cg-Il10tm1Cgn Tg(MUC1)79.24Gend) 		increased colon adenocarcinoma incidence J:149347
Il12rb2tm1Jm/Il12rb2tm1Jm
(B6;129S1-Il12rb2tm1Jm/J) 		increased lung carcinoma incidence J:106805
Immp2lTg(HLA-A/H2-D)2Enge/0
Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6 * CBA/Ca) 		increased melanoma incidence J:130879
Ing2tm1.1Ccha/Ing2tm1.1Ccha
(involves: 129 * C57BL/6J * FVB/N) 		increased histiocytic sarcoma incidence J:167311
increased sarcoma incidence J:167311
Ino80tm1.1Schg/Ino80+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6J) 		increased sarcoma incidence J:221224
Iqgap1tm1Aber/Iqgap1tm1Aber
Iqgap2tm1Vs/Iqgap2tm1Vs
(involves: 129S4/SvJae) 		increased hepatocellular carcinoma incidence J:132670
Iqgap2tm1Vs/Iqgap2tm1Vs
(either: 129S4/SvJae-Iqgap2tm1Vs or B6.129S4-Iqgap2tm1Vs) 		increased hepatocellular carcinoma incidence J:132670
Iqgap2tm1Vs/Iqgap2tm1Vs
(involves: 129S4/SvJae) 		increased hepatocellular carcinoma incidence J:205882
Irf1tm1Mak/Irf1tm1Mak
Tg(HRAS)2Jic/?
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		increased hemangiosarcoma incidence J:55418
Irf1tm1Mak/Irf1tm1Mak
Trp53tm1Sia/Trp53tm1Sia
(involves: 129S2/SvPas * C57BL/6 * CBA) 		increased hemangiosarcoma incidence J:55418
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL) 		increased intestinal adenocarcinoma incidence J:125508
KitW-v/Kit+
Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6) 		increased melanoma incidence J:88074
KitW-v/KitW-v
Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6) 		increased melanoma incidence J:88074
KitlSl-d/KitlSl-d
Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6 * DBA/2) 		increased melanoma incidence J:88074
Kmt2atm1(AFF1)Ksy/Kmt2a+
(involves: 129S1/Sv * C57BL/6 * FVB) 		increased malignant tumor incidence J:110241
Krastm1.1Khai/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:276349
Krastm1Bbd/Kras+
(involves: 129S1/Sv * 129X1/SvJ) 		increased lung non-small cell carcinoma incidence J:172200
Krastm1Bbd/Kras+
Map2k1tm1Chrn/Map2k1tm1Chrn
(involves: 129S1/Sv * 129X1/SvJ) 		increased lung non-small cell carcinoma incidence J:172200
Krastm1Bbd/Kras+
Map2k2tm1Chrn/Map2k2tm1Chrn
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL) 		increased lung non-small cell carcinoma incidence J:172200
Krastm1Bbd/Kras+
Mapk1tm1.1Hed/Mapk1tm1.1Hed
(involves: 129S1/Sv * 129X1/SvJ) 		increased lung non-small cell carcinoma incidence J:172200
Krastm1Bbd/Kras+
Mapk3tm1Gpg/Mapk3tm1Gpg
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ) 		increased lung non-small cell carcinoma incidence J:172200
Krastm1Bbd/Kras+
Mapk14tm1Nbr/Mapk14tm2Nbr
Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL) 		increased lung adenocarcinoma incidence J:122397
Krastm1Bbd/Kras+
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		increased lung non-small cell carcinoma incidence J:161780
Krastm1Bbd/Kras+
Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		increased lung adenocarcinoma incidence J:86101
increased sarcoma incidence J:86101
Krastm1Bbd/Kras+
Tg(CMV-cre/ERT)1Ipc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased lung adenocarcinoma incidence J:86101
Krastm1Bbd/Kras+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:143034
Krastm1Bbd/Kras+
Trp53tm1Brd/Trp53+
Tg(Cela1-tTA)#Eps/?
Tg(tetO-cre)3Jig/?
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:119988
Krastm1Bbd/Krastm1Bbd
Tg(Cela1-tTA)#Eps/?
Tg(tetO-cre)3Jig/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:119988
Krastm1Bbd/Krastm2Bbd
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		increased lung non-small cell carcinoma incidence J:161780
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:68981
Krastm2Tyj/Kras+
(involves: 129S2/SvPas) 		increased carcinoma incidence J:129627
increased fibrosarcoma incidence J:129627
increased hemangiosarcoma incidence J:129627
increased lung adenocarcinoma incidence J:136369
increased sarcoma incidence J:129627
increased squamous cell carcinoma incidence J:129627
Krastm2Tyj/Kras+
Trp53tm1Glo/Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		increased fibrosarcoma incidence J:129627
increased hemangiosarcoma incidence J:129627
increased squamous cell carcinoma incidence J:129627
Krastm2Tyj/Kras+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased fibrosarcoma incidence J:68981
increased hemangiosarcoma incidence J:68981
Krastm2Tyj/Kras+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased fibrosarcoma incidence J:68981
increased hemangiosarcoma incidence J:68981
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:68981
Krastm3Tyj/Kras+
Tg(CAG-Mir21,-EGFP)#Eno/0
(involves: 129S4/SvJae * C3H * C57BL/6) 		increased lung non-small cell carcinoma incidence J:164198
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:207982
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:147590
increased lung carcinoma incidence J:158937
Krastm4Tyj/Kras+
(B6.129S4-Krastm4Tyj) 		increased lung adenocarcinoma incidence J:177379
Krastm4Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:124682
Krastm4Tyj/Kras+
Gt(ROSA)26Sortm1(sb13)Tuv/Gt(ROSA)26Sor+
Tg(Pdx1-cre)6Tuv/0
TgTn(sb-T2/Onc)#Dla/0
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:186717
Krastm4Tyj/Kras+
Map2k7tm1.1Twad/Map2k7tm1.2Twad
(B6.Cg-Krastm4Tyj Map2k7tm1.1Twad/Map2k7tm1.2Twad) 		increased lung adenocarcinoma incidence J:170904
Krastm4Tyj/Kras+
Map2k7tm1.1Twad/Map2k7tm1.2Twad
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:170904
Krastm4Tyj/Kras+
Myod1tm1.1(cre/ERT,TVA)Gcg/Myod1+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased sarcoma incidence J:205518
Krastm4Tyj/Kras+
Pax7tm2.1(cre/ERT2)Fan/Pax7+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129/Sv * 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		increased sarcoma incidence J:205518
Krastm4Tyj/Kras+
Pdpk1tm1Mlw/Pdpk1tm1Mlw
Tg(Cela1-cre/ERT)1Dam/0
(involves: 129S4/SvJae) 		increased lung non-small cell carcinoma incidence J:197054
Krastm4Tyj/Kras+
Pggt1btm1Mbrg/Pggt1b+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		increased lung adenocarcinoma incidence J:122107
Krastm4Tyj/Kras+
Ptentm1Hwu/Pten+
Tg(Gfap-cre)77.6Mvs/0
(involves: 129S4/SvJae * BALB/c * C57BL/6NHsd) 		increased neurofibrosarcoma incidence J:154673
Krastm4Tyj/Kras+
Ptentm1Hwu/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:184935
Krastm4Tyj/Kras+
Ptentm1Hwu/Pten+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		increased pancreatic ductal adenocarcinoma incidence J:164210
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * C57BL/6J) 		increased endometrial carcinoma incidence J:96296
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Scgb1a1tm1.1(cre)Fjd/Scgb1a1+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased lung adenocarcinoma incidence J:131721
increased lung carcinoma incidence J:131721
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:184935
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:164210
Krastm4Tyj/Kras+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(TPO-cre)1Shk/0
(129.Cg-Krastm4Tyj Tg(Tpo-cre)1Shk Ptentm2.1Ppp) 		increased thyroid carcinoma incidence J:147732
Krastm4Tyj/Kras+
Ptentm2Mak/Pten+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased cholangiocarcinoma incidence J:254370
increased hepatocellular carcinoma incidence J:254370
Krastm4Tyj/Kras+
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased cholangiocarcinoma incidence J:254370
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased pancreatic ductal adenocarcinoma incidence J:116130, J:87973
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(B6.Cg-Krastm4Tyj Ptf1atm1.1(cre)Cvw) 		increased pancreatic ductal adenocarcinoma incidence J:138959
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(MUC1)79.24Gend/0
(B6.Cg-Krastm4Tyj Ptf1atm1.1(cre)Cvw Tg(MUC1)79.24Gend) 		increased pancreatic ductal adenocarcinoma incidence J:138959
Krastm4Tyj/Kras+
Raf1tm2Bacc/Raf1tm2Bacc
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased pancreatic ductal adenocarcinoma incidence J:197054
Krastm4Tyj/Kras+
Rb1tm3Tyj/Rb1tm3Tyj
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:147590
Krastm4Tyj/Kras+
Rbl2tm2Tyj/Rbl2tm2Tyj
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:147590
Krastm4Tyj/Kras+
Rnf7Gt(XE423)Byg/Rnf7+
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased lung adenocarcinoma incidence J:207982
Krastm4Tyj/Kras+
Scgb1a1tm1(cre/ERT)Blh/Scgb1a1+
Trp53tm5Tyj/Trp53+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6) 		increased adenocarcinoma incidence J:182218
Krastm4Tyj/Kras+
Scribtm1.1Phum/Scrib+
Tg(Pbsn-cre)20Fwan/0
(involves: 129S4/SvJae * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:178461
Krastm4Tyj/Kras+
Scribtm1.1Phum/Scribtm1.1Phum
Tg(Pbsn-cre)20Fwan/0
(involves: 129S4/SvJae * FVB/NCrl) 		increased carcinoma incidence J:178461
increased prostate gland adenocarcinoma incidence J:178461
Krastm4Tyj/Kras+
Sftpctm1(cre/ERT2)Blh/Sftpc+
Trp53tm5Tyj/Trp53+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6) 		increased adenocarcinoma incidence J:182218
Krastm4Tyj/Kras+
Sftpctm1.1(cre/ERT2)Ptch/Sftpc+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB) 		increased lung adenocarcinoma incidence J:195738
Krastm4Tyj/Kras+
Smad4tm1Rdp/Smad4tm1Rdp
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Krastm4Tyj/Kras+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Tg(Krt1-15-cre/PGR*)22Cot/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL/J) 		increased skin squamous cell carcinoma incidence J:203922
Krastm4Tyj/Kras+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		increased cholangiocarcinoma incidence J:184949
Krastm4Tyj/Kras+
Stk11tm1.1Rdp/Stk11tm1.1Rdp
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:124682
increased lung large cell carcinoma incidence J:124682
increased lung squamous cell carcinoma incidence J:124682
Krastm4Tyj/Kras+
Stk11tm1.1Rdp/Stk11tm1.2Rdp
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:124682
increased lung large cell carcinoma incidence J:124682
increased lung squamous cell carcinoma incidence J:124682
Krastm4Tyj/Kras+
Tg(CAG-Bgeo,-tsA58T)T26Ichi/0
Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:214846
Krastm4Tyj/Kras+
Tg(Cela1-cre/ERT)1Dam/0
(involves: 129S4/SvJae) 		increased lung non-small cell carcinoma incidence J:197054
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/?
(involves: 129S4/SvJae * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:87973
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm1Gev/Trp53tm1Gev
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:220300
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:276349
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm3Tyj/Trp53+
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:166678
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:116130, J:164210
Krastm4Tyj/Kras+
Tg(Scgb1a1-cre)1Kkw/?
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:107260
Krastm4Tyj/Kras+
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129S4/SvJae * FVB) 		increased melanoma incidence J:164588
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased pancreatic ductal adenocarcinoma incidence J:116129
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
(B6.129-Krastm4Tyj Tgfbr2tm1.2Hlm) 		increased lung adenocarcinoma incidence J:177379
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased pancreatic ductal adenocarcinoma incidence J:116129
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased cholangiocarcinoma incidence J:184949
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(KRT5-cre/PGR)1Der/?
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * FVB * ICR) 		increased carcinoma incidence J:124222
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased adenocarcinoma incidence J:103407
increased lung adenocarcinoma incidence J:195492, J:154041, J:103407
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased sarcoma incidence J:155389, J:125101
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:124682
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Krt19tm1(cre/ERT)Ggu/Krt19+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac) 		increased carcinoma incidence J:172048
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased cholangiocarcinoma incidence J:184949
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT5-cre/PGR)1Der/?
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * FVB * ICR) 		increased squamous cell carcinoma incidence J:124222
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre/ERT)20Efu/0
(involves: 129P2/OlaHsd * 129S4/SvJae * CD-1) 		increased skin squamous cell carcinoma incidence J:172048
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S4/SvJae * FVB) 		increased melanoma incidence J:164588
increased spindle cell carcinoma incidence J:164588
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm2Tyj
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased adenocarcinoma incidence J:103407
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm2Tyj
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased pancreatic ductal adenocarcinoma incidence J:197054
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm3Glo
Tg(KRT5-cre/PGR)1Der/?
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * FVB * ICR) 		increased carcinoma incidence J:124222
increased spindle cell carcinoma incidence J:124222
Krastm4Tyj/Kras+
Trp53tm1Lejo/Trp53tm1Lejo
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:187012
increased lung non-small cell carcinoma incidence J:187012
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:191425
increased lung non-small cell carcinoma incidence J:191425
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:98936
increased teratocarcinoma incidence J:98936
Krastm4Tyj/Kras+
Trp53tm3Glo/Trp53+
Tg(KRT5-cre/PGR)1Der/?
(involves: 129/Sv * C57BL/6 * FVB * ICR) 		increased carcinoma incidence J:124222
Krastm4Tyj/Krastm4Tyj
Yap1tm1.1Dupa/Yap1tm1.1Dupa
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:162628
Krastm5Tyj/Kras+
Pdx1tm1.1(flpo)Most/Pdx1+
Trp53tm1.1Dgk/Trp53+
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * Black Swiss * C57BL/6) 		increased pancreatic ductal adenocarcinoma incidence J:248550
Krastm5Tyj/Kras+
Pdx1tm1.1(flpo)Most/Pdx1+
Trp53tm1.1Dgk/Trp53tm1.1Dgk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * Black Swiss * C57BL/6) 		increased pancreatic ductal adenocarcinoma incidence J:248550
Krastm5Tyj/Kras+
Trp53tm1.1Dgk/Trp53tm1.1Dgk
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:180576
increased sarcoma incidence J:180576
Krastm5Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sortm1(cre/ERT2)Tyj
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased sarcoma incidence J:172206
Krt14tm1.1(cre)Wbm/Krt14+
Tg(KRT14-Snai1)1Efu/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * CD-1) 		increased basal cell carcinoma incidence J:229072
increased skin squamous cell carcinoma incidence J:229072
Krt18tm1Tmm/Krt18tm1Tmm
(involves: 129P2/OlaHsd) 		increased hepatocellular carcinoma incidence J:309021
Lats1tm1Tx/Lats1tm1Tx
(involves: 129S2/SvPas * C57BL/6J) 		increased sarcoma incidence J:52536
Lect2tm1Ymg/Lect2tm1Ymg
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Lect2tm1Ymg Tg(Pklr-Myc)73Ak) 		increased hepatocellular carcinoma incidence J:184496
increased malignant tumor incidence J:184496
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * CD-1) 		increased hepatocellular carcinoma incidence J:221030
Lig1tm3Dwm/Lig1tm3Dwm
(involves: 129P2/OlaHsd * C57BL/6) 		increased adenocarcinoma incidence J:77902
Lig4tm1Icrf/Lig4tm1Icrf
Trp53tm1Tyj/Trp53tm1Tyj
(either: (involves: 129P2/OlaHsd * 129S2/SvPas) or (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)) 		increased medulloblastoma incidence J:111068
Lig4tm1Pmc/Lig4tm1Pmc
Trp53tm1Tyj/Trp53+
Xrcc2tm2Pmc/Xrcc2tm2Pmc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
Lig4tm1Pmc/Lig4tm1Pmc
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
Lig4tm1Pmc/Lig4tm1Pmc
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc2tm2Pmc/Xrcc2tm2Pmc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		increased colon adenocarcinoma incidence J:157574
increased medulloblastoma incidence J:157574
Lmo7tm1Miyo/Lmo7+
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:150612
Lmo7tm1Miyo/Lmo7+
(involves: 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:150612
Lmo7tm1Miyo/Lmo7tm1Miyo
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:150612
Lmo7tm1Miyo/Lmo7tm1Miyo
(involves: 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:150612
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL) 		increased histiocytic sarcoma incidence J:307289
increased lung carcinoma incidence J:307289
increased sarcoma incidence J:307289
Ltbp4Gt(U3Cre)1Vmel/Ltbp4Gt(U3Cre)1Vmel
(B6.129S2-Ltbp4Gt(U3Cre)1Vmel) 		increased large intestine adenocarcinoma incidence J:78819
Ly6atm2(RUNX1)Grau/Ly6a+
(involves: 129X1/SvJ * C57BL/6J) 		increased squamous cell carcinoma incidence J:93408
Lzts1tm1Cro/Lzts1+
(involves: 129 * C57BL/6J) 		increased carcinoma incidence J:119989
increased gastric adenocarcinoma incidence J:119989
increased hepatocellular carcinoma incidence J:119989
Lzts1tm1Cro/Lzts1tm1Cro
(involves: 129 * C57BL/6J) 		increased carcinoma incidence J:119989
increased gastric adenocarcinoma incidence J:119989
increased hepatocellular carcinoma incidence J:119989
increased lung adenocarcinoma incidence J:119989
increased sarcoma incidence J:119989
Mad1l1tm1.1Ktj/Mad1l1+
(involves: BALB/c * C57BL/6J) 		increased carcinoma incidence J:117337
increased hemangiosarcoma incidence J:117337
increased hepatocellular carcinoma incidence J:117337
increased lung adenocarcinoma incidence J:117337
increased osteosarcoma incidence J:117337
increased rhabdomyosarcoma incidence J:117337
increased sarcoma incidence J:117337
Mad2l1tm1Sorg/Mad2l1+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:67456
Map2k7tm1.1Twad/Map2k7tm1.2Twad
Tg(MMTV-cre)4Mam/0
Tg(MMTV-Erbb2)1Pv/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA * FVB/N) 		increased mammary adenocarcinoma incidence J:170904
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		increased hepatocellular carcinoma incidence J:160521
Mapk14tm1Nbr/Mapk14tm2Nbr
Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL) 		increased lung adenocarcinoma incidence J:122397
Mc1re/Mc1re
Xpctm1Brd/Xpctm1Brd
Tg(KRT14-Kitl)1Takk/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		increased squamous cell carcinoma incidence J:112959
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J) 		increased hepatocellular carcinoma incidence J:177386
Mcctm1.1Maija/Mcctm1.1Maija
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL) 		increased large intestine adenocarcinoma incidence J:294342
Mcm4chaos3/Mcm4chaos3
(C3.B6-Mcm4chaos3) 		increased hepatocellular carcinoma incidence J:117494
increased lung adenocarcinoma incidence J:117494
increased mammary adenocarcinoma incidence J:117494
Mcm9Gt(AW0655)Wtsi/Mcm9Gt(AW0655)Wtsi
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		increased hepatocellular carcinoma incidence J:177420
Mcm9Gt(AW0655)Wtsi/Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		increased hepatocellular carcinoma incidence J:177420
Mcm9Gt(XG743)Byg/Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		increased hepatocellular carcinoma incidence J:177420
Mdm2tm3.1Glo/Mdm2tm3.1Glo
(B6.129S6-Mdm2tm3.1Glo) 		increased mammary adenocarcinoma incidence J:164201
Mdm2tm3.1Glo/Mdm2tm3.1Glo
Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo) 		increased adenocarcinoma incidence J:164201
increased carcinoma incidence J:164201
increased fibrosarcoma incidence J:164201
increased hemangiosarcoma incidence J:164201
increased histiocytic sarcoma incidence J:164201
increased leiomyosarcoma incidence J:164201
increased liver adenocarcinoma incidence J:164201
increased mammary adenocarcinoma incidence J:164201
increased osteosarcoma incidence J:164201
increased sarcoma incidence J:164201
increased squamous cell carcinoma incidence J:164201
Mdm2tm4.1Glo/Mdm2tm4.1Glo
(B6.129S6-Mdm2tm4.1Glo) 		increased sarcoma incidence J:164201
Mdm2tm4.1Glo/Mdm2tm4.1Glo
Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm4.1Glo Trp53tm3.1Glo) 		increased adenocarcinoma incidence J:164201
increased carcinoma incidence J:164201
increased fibrosarcoma incidence J:164201
increased histiocytic sarcoma incidence J:164201
increased liver adenocarcinoma incidence J:164201
increased osteosarcoma incidence J:164201
increased sarcoma incidence J:164201
increased squamous cell carcinoma incidence J:164201
Men1tm1.1Ctre/Men1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased lung adenocarcinoma incidence J:120835
Men1tm1.1Ctre/Men1+
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J * FVB/N) 		increased thyroid C-cell carcinoma incidence J:133299
Men1tm1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N)) 		increased carcinoma incidence J:67128
increased lung adenocarcinoma incidence J:67128
Men1tm1Zqw/Men1+
(involves: 129/Sv * 129P2/OlaHsd) 		increased pancreatic islet cell carcinoma incidence J:85302
increased thyroid carcinoma incidence J:85302
Mettm1Gvw/Met+
(involves: 129 * C57BL/6J) 		increased carcinoma incidence J:94722
increased histiocytic sarcoma incidence J:94722
increased squamous cell carcinoma incidence J:94722
Mettm2Gvw/Met+
(involves: 129 * C57BL/6J) 		increased hemangiosarcoma incidence J:94722
increased histiocytic sarcoma incidence J:94722
Mettm3Gvw/Mettm3Gvw
(involves: 129 * C57BL/6J) 		increased hemangiosarcoma incidence J:94722
Mettm4Gvw/Met+
(involves: 129 * C57BL/6J) 		increased sarcoma incidence J:94722
Mettm4Gvw/Met+
(involves: 129 * C57BL/6J * FVB/N) 		increased hemangiosarcoma incidence J:151890
increased mammary adenocarcinoma incidence J:151890
increased sarcoma incidence J:151890
increased squamous cell carcinoma incidence J:151890
Mfge8tm1Mcu/Mfge8tm1Mcu
Tg(RIP1-Tag)2Dh/?
(involves: 129X1/SvJ * C57BL/6J * C57BL/6NCr * DBA/2J) 		increased carcinoma incidence J:123138
Miftm1Gfr/Miftm1Gfr
(C57BL/6-Miftm1Gfr) 		increased fibrosarcoma incidence J:84791
Mir34atm1.2Arte/Mir34a+
Tg(Neurod2-Smo*A1)199Jols/0
(involves: C57BL/6 * C57BL/6N) 		increased medulloblastoma incidence J:221990
Mir34atm1.2Arte/Mir34atm1.2Arte
Tg(Neurod2-Smo*A1)199Jols/0
(involves: C57BL/6 * C57BL/6N) 		increased medulloblastoma incidence J:221990
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:190066
Mir122tm1.1Kgh/Mir122+
(involves: 129S1/Sv * 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:190067
Mir122tm1.1Kgh/Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:190067
Mir122tm1.2Kgh/Mir122+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:190067
Mir122tm1.2Kgh/Mir122tm1.2Kgh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:190067
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6) 		increased myeloid sarcoma incidence J:173230
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(ARR2/Pbsn-MYC)7Key/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL/J) 		increased prostate gland adenocarcinoma incidence J:223213
Mldhrtm1Zhgn/Mldhrtm1Zhgn
Tg(GFAP-cre)25Mes/0
(involves: FVB/N) 		increased glioblastoma incidence J:303725
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:75745
Mlh1tm1Rak/Mlh1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased adenocarcinoma incidence J:53451
increased carcinoma incidence J:53451
increased lung carcinoma incidence J:53451
increased squamous cell carcinoma incidence J:53451
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased carcinoma incidence J:53451
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd) 		increased small intestine adenocarcinoma incidence J:133352
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:153684
Mlh1tm1Wed/Mlh1tm1Wed
(involves: 129/Sv * C57BL/6J * SJL) 		increased basal cell carcinoma incidence J:133352
Mmp8tm1Otin/Mmp8tm1Otin
(involves: 129X1/SvJ * C57BL/6J) 		increased fibrosarcoma incidence J:86393
Mmp9tm1Tvu/Mmp9tm1Tvu
Tg(KRT14-HPV16)wt1Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * FVB/N) 		increased skin squamous cell carcinoma incidence J:65699
Mmp11tm1Mrio/Mmp11tm1Mrio
Tg(MMTV-vHaras)SH1Led/Tg(MMTV-vHaras)SH1Led
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6J * CD-1 * FVB) 		increased carcinoma incidence J:86074
Mnttm1Awb/Mnttm1.1Awb
Tg(MMTV-cre)4Mam/?
(involves: 129S6/SvEvTac * FVB/N) 		increased mammary adenocarcinoma incidence J:110115
Mnttm1Phu/Mnttm1Phu
Tg(MMTV-cre)4Mam/?
(involves: FVB) 		increased mammary adenocarcinoma incidence J:85481
Mob1atm1.1Asuz/Mob1atm1.1Asuz
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Mob1bGt(CC0690)Wtsi Mob1atm1.1Asuz Speer6-ps1Tg(Alb-cre)21Mgn) 		increased cholangiocarcinoma incidence J:228499
increased hepatocellular carcinoma incidence J:228499
Mob1atm1.2Asuz/Mob1a+
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased fibrosarcoma incidence J:193981
increased osteosarcoma incidence J:193981
Mob1atm1.2Asuz/Mob1atm1.2Asuz
Mob1bGt(CC0690)Wtsi/Mob1b+
(involves: 129P2/OlaHsd * C57BL/6) 		increased fibrosarcoma incidence J:193981
increased osteosarcoma incidence J:193981
Msh2tm1Htr/Msh2+
(involves: 129P2/OlaHsd) 		increased hemangiosarcoma incidence J:45433
increased osteosarcoma incidence J:45433
Msh2tm1Mak/Msh2+
Mutyhtm1Jhmi/Mutyhtm1Jhmi
Ogg1tm1Tld/Ogg1tm1Tld
(involves: 129 * C57BL/6J) 		increased lung adenocarcinoma incidence J:89742
Msh2tm1Rak/Msh2tm2.1Rak
Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * DBA/2 * SJL) 		increased intestinal adenocarcinoma incidence J:161577
Msh2tm1Wed/Msh2tm1Wed
(involves: C57BL/6) 		increased intestinal adenocarcinoma incidence J:86278
Msh2tm1Wed/Msh2tm1Wed
(involves: 129 * C57BL/6 * SJL) 		increased intestinal adenocarcinoma incidence J:88092
Msh2tm1Whl/Msh2tm1Whl
(involves: 129P2/OlaHsd * C57BL/6J) 		increased squamous cell carcinoma incidence J:79016
Msh2tm1Whl/Msh2tm1Whl
Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased thyroid C-cell carcinoma incidence J:79016
Msh2tm2.1Rak/Msh2tm2.1Rak
Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL) 		increased small intestine adenocarcinoma incidence J:161577
Msh2tm2.1Rak/Msh2tm3.1Rak
Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL) 		increased intestinal adenocarcinoma incidence J:161577
Msh3tm1Rak/Msh3tm1Rak
(involves: 129/Sv * C57BL/6J * SJL) 		increased intestinal adenocarcinoma incidence J:60604
Msh3tm1Rak/Msh3tm1Rak
Msh6tm1Rak/Msh6tm1Rak
(involves: 129/Sv * C57BL/6J * SJL) 		increased intestinal adenocarcinoma incidence J:60604
Msh6tm1Wed/Msh6tm1Wed
(involves: 129/Sv * C57BL/6J * SJL) 		increased basal cell carcinoma incidence J:92555
Msmbtm1Xuan/Msmbtm1Xuan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * CD-1)) 		increased prostate gland adenocarcinoma incidence J:96884
Mtv2a/Mtv2a
(DDD.GR-Mtv2a) 		increased mammary adenocarcinoma incidence J:109201
Muc2tm1Avel/Muc2tm1Avel
(involves: 129P2/OlaHsd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:75047
Mus81tm1Raz/Mus81+
(involves: 129P2/OlaHsd) 		increased carcinoma incidence J:91570
Mus81tm1Raz/Mus81tm1Raz
(involves: 129P2/OlaHsd) 		increased carcinoma incidence J:91570
Myf6tm1(cre)Mrc/Myf6+
Pax3tm1Mrc/Pax3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased rhabdomyosarcoma incidence J:93444
Myf6tm1(cre)Mrc/Myf6+
Pax3tm1Mrc/Pax3tm1Mrc
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased rhabdomyosarcoma incidence J:93444
Myf6tm1(cre)Mrc/Myf6+
Pax3tm1Mrc/Pax3tm1Mrc
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased rhabdomyosarcoma incidence J:93444
Mzf1tm1Ppp/Mzf1tm1Ppp
(involves: 129) 		increased hepatocellular carcinoma incidence J:70407
Nabp2tm1.1Kkha/Nabp2tm1.1Kkha
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac) 		increased hepatocellular carcinoma incidence J:195140
Nbnem3Jpt/Nbnem3Jpt
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased hemangiosarcoma incidence J:251434
increased histiocytic sarcoma incidence J:251434
increased leiomyosarcoma incidence J:251434
increased rhabdomyosarcoma incidence J:251434
increased squamous cell carcinoma incidence J:251434
Nbnem4Jpt/Nbnem4Jpt
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased hemangiosarcoma incidence J:251434
increased histiocytic sarcoma incidence J:251434
increased leiomyosarcoma incidence J:251434
increased rhabdomyosarcoma incidence J:251434
increased squamous cell carcinoma incidence J:251434
Nbntm1Zqw/Nbn+
(involves: 129S2/SvPas * C57BL/6) 		increased liver adenocarcinoma incidence J:86563
increased lung adenocarcinoma incidence J:86563
increased mammary adenocarcinoma incidence J:86563
Nbntm2Zqw/Nbntm2Zqw
Trp53tm1Brd/Trp53tm1Brd
Tg(Nes-cre)1Wme/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA) 		increased sarcoma incidence J:98316
Ncoa3tm1Jxu/Ncoa3+
Tg(MMTV-vHaras)SH1Led/0
(involves: 129S6/SvEvTac * C57BL/6J * CD-1) 		increased mammary adenocarcinoma incidence J:88789
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:207622
Ncoa5tm1Hxia/Ncoa5+
(C.129(B6)-Ncoa5tm1Hxia) 		increased hepatocellular carcinoma incidence J:207622
Ncstntm1.1Akli/Ncstntm1.1Akli
Tg(Upk2-cre,-EGFP)#Akli/0
(involves: 129) 		increased urinary bladder carcinoma incidence J:227748
Ndrg2tm1Kmori/Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased hepatocellular carcinoma incidence J:210264
increased lung carcinoma incidence J:210264
Ndrg2tm1Kmori/Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased hepatocellular carcinoma incidence J:210264
increased lung carcinoma incidence J:210264
Nf1tm1Fcr/Nf1+
Trp53tm1Brd/Trp53+
(B6.129-Trp53tm1Brd Nf1tm1Fcr) 		increased malignant tumor incidence J:95933
increased sarcoma incidence J:95933
Nf1tm1Fcr/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		increased carcinoma incidence J:58877
increased leiomyosarcoma incidence J:58877
increased malignant triton tumor incidence J:58877
increased neuroblastoma incidence J:58877
increased neurofibrosarcoma incidence J:58877
increased rhabdomyosarcoma incidence J:58877
increased sarcoma incidence J:58877
Nf1tm1Tyj/?
Nstr1C57BL/6J/Nstr1C57BL/6J
Trp53tm1Tyj/?
(involves: 129S2/SvPas * A/J * C57BL/6J) 		increased neurofibrosarcoma incidence J:105038
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * C57BL/6) 		increased fibrosarcoma incidence J:18542
increased lung adenocarcinoma incidence J:18542
increased neurofibrosarcoma incidence J:18542
Nf1tm1Tyj/Nf1+
Suz12Gt(Betageo)1Khe/Suz12+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased hepatocellular carcinoma incidence J:217077
increased histiocytic sarcoma incidence J:217077
increased neurofibrosarcoma incidence J:217077
Nf1tm1Tyj/Nf1+
Suz12Gt(Betageo)1Khe/Suz12+
Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased hemangiosarcoma incidence J:217077
increased histiocytic sarcoma incidence J:217077
increased neurofibrosarcoma incidence J:217077
Nf1tm1Tyj/Nf1+
Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:41126
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129/Sv * C57BL/6) 		increased neurofibrosarcoma incidence J:58876
increased sarcoma incidence J:58876
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas) 		increased neurofibrosarcoma incidence J:131914
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
(B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +) 		increased glioblastoma incidence J:64364
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
((C3H/HeJ x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1) 		increased glioblastoma incidence J:64364
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
((CAST/EiJ x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1) 		increased glioblastoma incidence J:64364
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
((SJL/J x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1) 		increased glioblastoma incidence J:64364
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:217077
increased neuroblastoma incidence J:217077
increased neurofibrosarcoma incidence J:217077
increased sarcoma incidence J:228258
Nf2tm1Gth/Nf2+
(involves: 129P2/OlaHsd * FVB/N) 		increased lung adenocarcinoma incidence J:63264
increased neurofibrosarcoma incidence J:63264
increased osteosarcoma incidence J:63264
increased renal carcinoma incidence J:63264
increased sarcoma incidence J:63264
Nf2tm1Gth/Nf2tm2Gth
Tg(Mpz-cre)#Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased neurofibrosarcoma incidence J:63264
increased odontosarcoma incidence J:63264
Nf2tm1Tyj/Nf2+
(either: (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) or (involves: 129S2/SvPas * C57BL/6J)) 		increased carcinoma incidence J:47282
increased fibrosarcoma incidence J:47282
increased lung adenocarcinoma incidence J:47282
increased malignant tumor incidence J:47282
increased osteosarcoma incidence J:47282
increased sarcoma incidence J:47282
Nf2tm2.1Gth/Nf2+
(involves: 129P2/OlaHsd * FVB/N) 		increased fibrosarcoma incidence J:63264
increased lung adenocarcinoma incidence J:63264
increased osteosarcoma incidence J:63264
Nf2tm2Gth/Nf2+
Tg(Mpz-cre)#Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased lung adenocarcinoma incidence J:63264
Nf2tm2Gth/Nf2+
Trp53tm1Brd/Trp53+
Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		increased neurofibrosarcoma incidence J:92413
increased osteosarcoma incidence J:92413
Nf2tm2Gth/Nf2tm2Gth
Ptgdstm1.1(cre)Gvn/Ptgds+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * FVB/N) 		increased osteosarcoma incidence J:173718
Nf2tm2Gth/Nf2tm2Gth
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:162628
Nf2tm2Gth/Nf2tm2Gth
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased extremity angiosarcoma incidence J:92413
increased lung adenocarcinoma incidence J:92413
increased neurofibrosarcoma incidence J:92413
increased renal carcinoma incidence J:92413
Nf2tm2Gth/Nf2tm2Gth
Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased lung adenocarcinoma incidence J:63264
increased neurofibrosarcoma incidence J:63264
increased osteosarcoma incidence J:63264
increased renal carcinoma incidence J:63264
increased sarcoma incidence J:63264
Nf2tm2Gth/Nf2tm2Gth
Tg(Mpz-cre)#Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased neurofibrosarcoma incidence J:63264
increased odontosarcoma incidence J:63264
increased osteosarcoma incidence J:63264
increased renal carcinoma incidence J:63264
Nf2tm2Gth/Nf2tm2Gth
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased renal carcinoma incidence J:150071
Nf2tm2Gth/Nf2tm2Gth
Tg(Postn-cre)1Sjc/0
(involves: 129P2/OlaHsd * FVB/NTac) 		increased neurofibrosarcoma incidence J:216420
Nf2tm2Gth/Nf2tm2Gth
Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased renal carcinoma incidence J:150071
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brd/Trp53+
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		increased leiomyosarcoma incidence J:92413
increased neurofibrosarcoma incidence J:92413
increased sarcoma incidence J:92413
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brd/Trp53+
Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		increased neurofibrosarcoma incidence J:92413
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brd/Trp53tm1Brd
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		increased extremity angiosarcoma incidence J:92413
increased neurofibrosarcoma incidence J:92413
increased osteosarcoma incidence J:92413
increased rhabdomyosarcoma incidence J:92413
increased sarcoma incidence J:92413
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased rhabdomyosarcoma incidence J:132943
Nfe2tm1.1Hlpa/?
(involves: 129 * C57BL/6) 		increased myeloid sarcoma incidence J:275444
Nfe2l1tm1Jefc/Nfe2l1tm1Ywk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J) 		increased hepatocellular carcinoma incidence J:97188
Nhej1tm1Fwa/Nhej1tm1Fwa
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129) 		increased medulloblastoma incidence J:138774
Nkx2-9tm1Jlck/Nkx2-9tm1Jlck
(involves: 129/Sv * C57BL/6 * SJL) 		increased squamous cell carcinoma incidence J:115581
Nkx3-1tm4(cre/ERT2)Mms/Nkx3-1+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:153425
Nmitm1.1Geno/Nmitm1.1Geno
Tg(KRT14-cre)1Amc/0
Tg(MMTVneu)202Mul/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N) 		increased mammary adenocarcinoma incidence J:261035
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr
Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lung squamous cell carcinoma incidence J:234268
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6N) 		increased hepatocellular carcinoma incidence J:121075
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6) 		increased hepatocellular carcinoma incidence J:118204
Nrastm1Tyj/Nrastm1Tyj
Tg(Tyr-cre)1Lru/0
(involves: C57BL/6 * DBA/2) 		increased melanoma incidence J:198244
Nrbp1tm1.1Dja/Nrbp1tm1.1Dja
Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J) 		increased lung carcinoma incidence J:184685
Nrbp1tm1.1Dja/Nrbp1tm1.2Dja
Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J) 		increased lung carcinoma incidence J:184685
Nsmce2Gt(AA0032)Wtsi/Nsmce2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased histiocytic sarcoma incidence J:227197
Nudt1tm1Tts/Nudt1tm1Tts
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:71836
Ogg1tm1Yun/Ogg1tm1Yun
(involves: 129S/SvEv * C57BL/6J) 		increased lung carcinoma incidence J:82287
Ossc1C3H/HeJ/?
Ossc2102/El/?
(involves: 102/El * C3H/HeJ) 		increased sarcoma incidence J:75213
Ossc3BALB/c/Ossc3CBA/Ca
(involves: BALB/c * CBA/Ca) 		increased osteosarcoma incidence J:107725
Otulinem1Gvl/Otulintm1c(EUCOMM)Hmgu
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA/2) 		increased squamous cell carcinoma incidence J:312394
Otulintm1c(EUCOMM)Hmgu/Otulintm1c(EUCOMM)Hmgu
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * DBA/2) 		increased skin squamous cell carcinoma incidence J:312394
Paqr3tm1Ychn/Paqr3tm1Ychn
(involves: 129 * C57BL/6J) 		increased carcinoma incidence J:139058
Parms1BALB/cByJ/Parms1C57BL/6NCrl
Ptch1tm1Zim/Ptch1+
(involves: 129/Sv * BALB/cByJ * C57BL/6NCrl) 		increased rhabdomyosarcoma incidence J:93364
Parms1C57BL/6NCrl/Parms1C57BL/6NCrl
Ptch1tm1Zim/Ptch1+
(involves: 129/Sv * BALB/cByJ * C57BL/6NCrl) 		increased rhabdomyosarcoma incidence J:93364
Pcbp4Gt(D136D11)Wrst/Pcbp4+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:231514
Pcbp4Gt(D136D11)Wrst/Pcbp4Gt(D136D11)Wrst
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:231514
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(B6;129-Pcsk2tm1Dfs/J) 		increased pancreatic ductal adenocarcinoma incidence J:236905
Perptm2Att/Perptm2Att
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S4/SvJae) 		increased skin squamous cell carcinoma incidence J:167545
Pgbd5tm1.1Aken/Pgbd5tm1.2Aken
Ptch1tm1Bjw/Ptch1tm1Bjw
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * C57BL/6J * C57BL/6NTac * FVB/N * SW) 		increased medulloblastoma incidence J:346387
Pgrtm2(cre)Lyd/Pgr+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		increased endometrial carcinoma incidence J:139053
Pgrtm2(cre)Lyd/Pgr+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased endometrial carcinoma incidence J:162027, J:218222
Pgrtm2(cre)Lyd/Pgr+
Ptentm1Hwu/Ptentm1Hwu
Trp53tm1Brn/Trp53tm1Brn
(involves: 129 * C57BL/6) 		increased endometrial carcinoma incidence J:139053
Pik3catm1.1Waph/Pik3ca+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S1/Sv * 129S4/SvJae * BALB/c * C57BL/6) 		increased adenocarcinoma incidence J:184382
Pik3catm1.1Waph/Pik3ca+
Tg(MMTV-cre)#Mam/0
(involves: 129S1/Sv * C57BL/6 * FVB) 		increased mammary adenoacanthoma incidence J:187299
increased osteosarcoma incidence J:187299
increased sarcoma incidence J:187299
Pinx1tm1.1Kplu/Pinx1+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased carcinoma incidence J:171997
increased hemangiosarcoma incidence J:171997
increased histiocytic sarcoma incidence J:171997
increased sarcoma incidence J:171997
Pinx1tm1.1Kplu/Pinx1+
Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased carcinoma incidence J:171997
increased hepatocellular carcinoma incidence J:171997
increased lung carcinoma incidence J:171997
Pinx1tm1.1Kplu/Pinx1+
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased carcinoma incidence J:171997
increased hepatocellular carcinoma incidence J:171997
increased lung carcinoma incidence J:171997
Plautm1Mlg/Plautm1Mlg
Tg(RIP1-Tag)2Dh/0
(involves: C57BL/6) 		increased carcinoma incidence J:65019
Plgtm1Jld/Plgtm1Jld
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * Black Swiss * FVB/N) 		increased mammary adenocarcinoma incidence J:48285
Plk1Gt(RRR358)Byg/Plk1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lung carcinoma incidence J:142593
increased sarcoma incidence J:142593
increased squamous cell carcinoma incidence J:142593
Plk3tm1Dai/Plk3tm1Dai
(involves: 129S4/SvJae * C57BL/6) 		increased leiomyosarcoma incidence J:136425
increased lung adenocarcinoma incidence J:136425
Pmltm1Ppp/Pml+
Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		increased carcinoma incidence J:317504
increased osteosarcoma incidence J:317504
increased sarcoma incidence J:317504
Pmltm1Ppp/Pmltm1Ppp
Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		increased carcinoma incidence J:317504
increased osteosarcoma incidence J:317504
increased sarcoma incidence J:317504
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr) 		increased adenocarcinoma incidence J:162378
increased sarcoma incidence J:162378
Pms2tm1Lisk/Pms2tm1Lisk
(involves: 129S2/SvPas * C57BL/6) 		increased sarcoma incidence J:27389
Pms2tm1Lisk/Pms2tm1Lisk
(involves: 129S2/SvPas) 		increased carcinoma incidence J:125218
increased sarcoma incidence J:125218
Pms2tm1Lisk/Pms2tm1Lisk
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * 129S2/SvPas * C57BL/6 * C57BL/6J * SJL) 		increased carcinoma incidence J:125218
increased sarcoma incidence J:125218
Pold1tm1.1Bdp/Pold1tm1.1Bdp
(B6.129-Pold1tm1.1Bdp) 		increased intestinal adenocarcinoma incidence J:153684
Pold1tm1Bdp/Pold1tm1Bdp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:100685
increased sarcoma incidence J:100685
increased squamous cell carcinoma incidence J:100685
Poletm1.1Bdp/Poletm1.1Bdp
(B6.129-Poletm1.1Bdp) 		increased colon adenocarcinoma incidence J:153684
increased histiocytic sarcoma incidence J:153684
increased intestinal adenocarcinoma incidence J:153684
increased small intestine adenocarcinoma incidence J:153684
Polhtm1.1Rak/Polhtm1.1Rak
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased squamous cell carcinoma incidence J:105034
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N) 		increased intestinal adenocarcinoma incidence J:90217
Ppp2r1atm1.2Wltr/Ppp2r1atm2.1Wltr
(FVB.129-Ppp2r1atm1.2Wltr/Ppp2r1atm2.1Wltr) 		increased lung adenocarcinoma incidence J:175748
Prdm2tm1Shg/Prdm2+
(involves: 129S2/SvPas * C57BL/6) 		increased hemangiosarcoma incidence J:71406
increased lung adenocarcinoma incidence J:71406
Prdm2tm1Shg/Prdm2tm1Shg
(involves: 129S2/SvPas * C57BL/6) 		increased hemangiosarcoma incidence J:71406
increased lung adenocarcinoma incidence J:71406
Prdx1tm1Rave/Prdx1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased fibrosarcoma incidence J:84677
increased hemangiosarcoma incidence J:84677
increased hepatocellular carcinoma incidence J:84677
increased histiocytic sarcoma incidence J:84677
increased lung adenocarcinoma incidence J:84677
increased malignant tumor incidence J:84677
increased mammary adenocarcinoma incidence J:84677
increased osteosarcoma incidence J:84677
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6) 		increased carcinoma incidence J:84677
increased fibrosarcoma incidence J:84677
increased hemangiosarcoma incidence J:84677
increased hepatocellular carcinoma incidence J:84677
increased histiocytic sarcoma incidence J:84677
increased lung adenocarcinoma incidence J:84677
increased mammary adenocarcinoma incidence J:84677
increased sarcoma incidence J:84677
Prf1tm1Sdz/Prf1tm1Sdz
(C.B6-Prf1tm1Sdz) 		increased lung adenocarcinoma incidence J:77491
increased sarcoma incidence J:77491
Prkacatm1Gsm/Prkaca+
Prkar1atm1.1Lsk/Prkar1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased osteosarcoma incidence J:160299
Prkar1atm1.1Lsk/Prkar1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased osteosarcoma incidence J:160299
Prkar1atm1.2Lsk/Prkar1a+
Rb1tm2Brn/Rb1+
Tg(Col1a1-cre)1Kry/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129 * 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * FVB/N) 		increased osteosarcoma incidence J:234128
Prkar1atm1.2Lsk/Prkar1a+
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Col1a1-cre)1Kry/0
(involves: 129 * 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * FVB/N) 		increased osteosarcoma incidence J:234128
Prkar1atm1.2Lsk/Prkar1a+
Tg(Bglap2-TAg)1Rkho/0
Tg(Col1a1-cre)1Kry/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased osteosarcoma incidence J:165282
Prkar1atm1.2Lsk/Prkar1a+
Tg(Col1a1-cre)1Kry/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * FVB/N) 		increased osteosarcoma incidence J:234128
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk
Ptentm1.1Mwst/Ptentm1.1Mwst
Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr) 		increased thyroid carcinoma incidence J:225245
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk
Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr) 		increased thyroid carcinoma incidence J:225245, J:241066
Prkar1atm1Gsm/Prkar1a+
(involves: 129X1/SvJ) 		increased fibrosarcoma incidence J:93393
increased hemangiosarcoma incidence J:93393
increased hepatocellular carcinoma incidence J:93393
increased sarcoma incidence J:93393
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129/Sv * 129P2/OlaHsd) 		increased thyroid carcinoma incidence J:101609
Prmt1tm1c(EUCOMM)Wtsi/Prmt1+
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CD-1) 		increased osteosarcoma incidence J:245660
Pscatm1Witt/Psca+
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
Pscatm1Witt/Pscatm1Witt
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
Psmb9tm1Stl/Psmb9tm1Stl
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:73945
increased leiomyosarcoma incidence J:73945
Psmb9tm1Stl/Psmb9tm1Stl
Trp53tm1Brd/Trp53tm1Brd
(involves: 129P2/OlaHsd * C57BL/6) 		increased sarcoma incidence J:67509
Ptch1tm1.1Hahn/Ptch1+
(involves: 129 * BALB/c * C57BL/6 * FVB/N) 		increased medulloblastoma incidence J:149148
increased rhabdomyosarcoma incidence J:149148
Ptch1tm1Bjw/Ptch1tm1Bjw
Tg(Atoh1-cre)1Bfri/0
(involves: 129T2/SvEms * C57BL/6 * CBA) 		increased medulloblastoma incidence J:139573
Ptch1tm1Bjw/Ptch1tm1Bjw
Tg(Atoh1-cre/Esr1*)14Fsh/0
(involves: 129T2/SvEms * FVB/N) 		increased medulloblastoma incidence J:139573
Ptch1tm1Bjw/Ptch1tm1Bjw
Tg(GFAP-cre)25Mes/0
(involves: 129T2/SvEms * FVB/N) 		increased medulloblastoma incidence J:139573
Ptch1tm1Bjw/Ptch1tm1Bjw
Tg(KRT14-cre)8Brn/0
(involves: 129T2/SvEms * FVB/N) 		increased basal cell carcinoma incidence J:231264
Ptch1tm1Cklr/Ptch1+
Pax7tm1(cre)Mrc/Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased medulloblastoma incidence J:159972
Ptch1tm1Cklr/Ptch1+
Trp53tm1Brn/?
Pax7tm1(cre)Mrc/Pax7+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased medulloblastoma incidence J:159972
Ptch1tm1Hahn/Ptch1tm1Hahn
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased basal cell carcinoma incidence J:149148
Ptch1tm1Hahn/Ptch1tm1Hahn
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		increased basal cell carcinoma incidence J:158915
Ptch1tm1Hahn/Ptch1tm1Hahn
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		increased basal cell carcinoma incidence J:149148
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased hemangiosarcoma incidence J:205254
increased medulloblastoma incidence J:205254
increased rhabdomyosarcoma incidence J:205254
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased medulloblastoma incidence J:42441
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ) 		increased medulloblastoma incidence J:144811, J:114992, J:102702
increased rhabdomyosarcoma incidence J:114992
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J) 		increased basal cell carcinoma incidence J:58328
Ptch1tm1Mps/Ptch1+
Ptch2tm1Pmc/Ptch2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased basal cell carcinoma incidence J:112118
increased rhabdomyosarcoma incidence J:112118
Ptch1tm1Mps/Ptch1+
Ptch2tm1Pmc/Ptch2tm1Pmc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased basal cell carcinoma incidence J:112118
increased medulloblastoma incidence J:112118
increased rhabdomyosarcoma incidence J:112118
Ptch1tm1Mps/Ptch1+
Tg(Atoh1-GFP)1Jejo/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased medulloblastoma incidence J:144811
Ptch1tm1Mps/Ptch1+
Tg(Atoh1-sb11)1Mtay/0
TgTn(sb-T2/Onc3)12740Njen/0
(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6J * ICR) 		increased medulloblastoma incidence J:181542
Ptch1tm1Mps/Ptch1+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129 * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:125534
increased rhabdomyosarcoma incidence J:125534
Ptch1tm1Yy/Ptch1+
Trp53tm1Brd/Trp53+
Tg(BGLAP-cre)1Clem/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/NJ) 		increased osteosarcoma incidence J:214349
Ptch1tm1Zim/Ptch1+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1)) 		increased medulloblastoma incidence J:47421
increased rhabdomyosarcoma incidence J:47421
Ptch1tm1Zim/Ptch1+
(involves: 129 * CD-1) 		increased medulloblastoma incidence J:79666, J:165388
Ptentm1.1Hwu/Pten+
(involves: 129S4/SvJae * BALB/c) 		increased mammary adenocarcinoma incidence J:110567
Ptentm1.1Mwst/Ptentm1.1Mwst
Tg(MMTVneu)202Mul/0
Tg(S100a4-cre)1Gle/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:153747
Ptentm1.2Mwst/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased mammary adenoacanthoma incidence J:158751
increased uterus carcinoma incidence J:158751
Ptentm1Hwu/Pten+
Tg(ARR2/Pbsn-FGF8)3Prb/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:106650
Ptentm1Hwu/Pten+
Tg(KRT14-cre)#Smr/0
(involves: 129S4/SvJae * C57BL/6J * SJL/J) 		increased mammary adenocarcinoma incidence J:138927
Ptentm1Hwu/Pten+
Tmprss2tm2.1(ETV1)Sho/Tmprss2tm2.1(ETV1)Sho
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:212219
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae) 		increased prostate gland adenocarcinoma incidence J:144810
Ptentm1Hwu/Ptentm1Hwu
Cop1tm2.1Vmd/Cop1tm2.1Vmd
Tg(Pbsn-cre)4Prb/0
(B6N.CgCop1tm2.1Vmd Ptentm1Hwu Tg(Pbsn-cre)4Prb) 		increased prostate gland adenocarcinoma incidence J:172653
Ptentm1Hwu/Ptentm1Hwu
Ptpn1tm1Bpk/Ptpn1tm1Bpk
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:231906
Ptentm1Hwu/Ptentm1Hwu
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) 		increased cholangiocarcinoma incidence J:111718
Ptentm1Hwu/Ptentm1Hwu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		increased cholangiocarcinoma incidence J:218587
increased hepatocellular carcinoma incidence J:218587
Ptentm1Hwu/Ptentm1Hwu
Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJae * FVB/N) 		increased cholangiocarcinoma incidence J:111718
increased hepatocellular carcinoma incidence J:111718
Ptentm1Hwu/Ptentm1Hwu
Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/0
Tg(TPO-cre)1Shk/0
(involves: 129S4/SvJae * FVB/NCr * FVB/NJ) 		increased thyroid carcinoma incidence J:177181
Ptentm1Hwu/Ptentm1Hwu
Tg(CAG-MYC,-GFP*)#Rugg/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA/2) 		increased prostate gland adenocarcinoma incidence J:261540
Ptentm1Hwu/Ptentm1Hwu
Tg(Fabp1-cre)1Jig/0
(involves: 129S4/SvJae * FVB/N) 		increased carcinoma incidence J:106662
increased colon adenocarcinoma incidence J:106662
increased renal carcinoma incidence J:106662
increased squamous cell carcinoma incidence J:106662
increased urinary bladder carcinoma incidence J:106662
Ptentm1Hwu/Ptentm1Hwu
Tg(KRT14-cre)#Smr/0
(involves: 129S4/SvJae * C57BL/6J * SJL/J) 		increased mammary adenocarcinoma incidence J:138927
Ptentm1Hwu/Ptentm1Hwu
Tg(MMTV-cre)#Tfln/0
(involves: 129S4/SvJae) 		increased mammary adenocarcinoma incidence J:78415
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:142106
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased carcinoma incidence J:268934
increased prostate gland adenocarcinoma incidence J:268934, J:184935, J:212219
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:93902, J:124208
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)20Fwan/?
(involves: 129S4/SvJae * C57BL/6 * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:238768
Ptentm1Hwu/Ptentm1Hwu
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased malignant tumor incidence J:102226
increased pancreatic ductal adenocarcinoma incidence J:102226
Ptentm1Hwu/Ptentm1Hwu
Tg(Pdx1-cre)89.1Dam/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * CBA) 		increased pancreatic acinar cell carcinoma incidence J:102226
increased pancreatic ductal adenocarcinoma incidence J:102226
Ptentm1Hwu/Ptentm1Hwu
Tg(Pgc-cre,-secNluc)#Hcz/0
(involves: 129S4/SvJae) 		increased mammary adenocarcinoma incidence J:338079
Ptentm1Hwu/Ptentm1Hwu
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
Tg(KRT14-cre/ERT)20Efu/0
(involves: 129 * 129S4/SvJae * C57BL/6 * CD-1 * FVB/N) 		increased squamous cell carcinoma incidence J:209026, J:194652
Ptentm1Hwu/Ptentm1Hwu
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB) 		increased carcinoma incidence J:146760
increased urinary bladder carcinoma incidence J:146760
Ptentm1Hwu/Ptentm1Hwu
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd) 		increased ovarian carcinoma incidence J:222579
Ptentm1Mak/Pten+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased carcinoma incidence J:50437
increased endometrial carcinoma incidence J:63478
increased mammary adenocarcinoma incidence J:63478
Ptentm1Mak/Pten+
(B6.129P2-Ptentm1Mak) 		increased endometrial carcinoma incidence J:93530
Ptentm1Mro/Pten+
Tg(KLK3-cre)D4Trp/0
(involves: 129P2/OlaHsd * FVB) 		increased prostate gland adenocarcinoma incidence J:99524
Ptentm1Mro/Ptentm1Mro
Tg(KRT14-cre)8Brn/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * DBA/2J * FVB/N) 		increased carcinoma incidence J:144831
Ptentm1Ppp/Pten+
(involves: 129S1/Sv * C57BL/6J) 		increased malignant tumor incidence J:49532
Ptentm1Ppp/Pten+
Tg(Pbsn-TAg)15Tvd/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:103408
Ptentm1Rdp/Pten+
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased glioblastoma incidence J:140704
Ptentm1Rdp/Ptentm1Rdp
Smad4tm1Rdp/Smad4tm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm1Rdp/Tert+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm3Rdp/Terttm3Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rps/Pten+
(involves: 129S1/Sv * C57BL/6J) 		increased thyroid carcinoma incidence J:53065
Ptentm1Rps/Pten+
Tg(Wnt1)1Hev/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL) 		increased adenocarcinoma incidence J:67497
increased mammary adenocarcinoma incidence J:67497
increased mammary gland ductal carcinoma incidence J:67497
increased salivary adenocarcinoma incidence J:67497
Ptentm2.1Gle/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased mammary adenoacanthoma incidence J:158751
Ptentm2.1Ppp/Pten+
Tg(Cnp-EGFR)10Nrat/0
Tg(Dhh-cre)1Mejr/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL) 		increased neurofibrosarcoma incidence J:195067
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Cnp-EGFR)10Nrat/0
Tg(Dhh-cre)1Mejr/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL) 		increased neurofibrosarcoma incidence J:195067
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Dhh-cre)1Mejr/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL) 		increased neurofibrosarcoma incidence J:195067
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:163589, J:100683
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(TPO-cre)1Shk/0
(129S1.Cg-Ptentm2.1Ppp Tg(TPO-cre)1Shk) 		increased thyroid carcinoma incidence J:165293
Ptentm2.1Ppp/Ptentm2.1Ppp
Trp53tm1Brn/Trp53tm1Brn
Tg(TPO-cre)1Shk/0
(129.Cg-Tg(TPO-cre)1Shk Trp53tm1Brn Ptentm2.1Ppp) 		increased thyroid carcinoma incidence J:211100
Ptentm2.1Ppp/Ptentm2.1Ppp
Trp53tm1Thl/Trp53tm1Thl
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased carcinoma incidence J:100683
Ptentm2Mak/Ptentm2Mak
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Tg(KRT5-cre)1Xya/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased carcinoma incidence J:101602
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:138099
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA) 		increased hepatocellular carcinoma incidence J:90905
Ptentm2Mak/Ptentm2Mak
Stk11tm1Keis/Stk11tm1Keis
Tg(Cyp1a1-cre/ERT)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA) 		increased urinary bladder carcinoma incidence J:169565
Ptentm2Mak/Ptentm2Mak
Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:143082
Ptentm2Mak/Ptentm2Mak
Tg(Fabp1-cre)1Jig/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased urinary bladder transitional cell carcinoma incidence J:113388
Ptentm2Mak/Ptentm2Mak
Tg(GFAP-cre/Esr1*,-lacZ)ASbk/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * FVB/NJ) 		increased glioblastoma incidence J:290447
Ptentm2Mak/Ptentm2Mak
Tg(KLK3-cre)13Saa/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:214242
Ptentm2Mak/Ptentm2Mak
Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:224955
increased spindle cell carcinoma incidence J:224955
Ptentm2Mak/Ptentm2Mak
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased lung adenocarcinoma incidence J:127405
increased lung squamous cell carcinoma incidence J:127405
Ptentm2Mak/Ptentm2Mak
Tg(Wap-cre)11738Mam/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		increased mammary adenocarcinoma incidence J:224955
increased spindle cell carcinoma incidence J:224955
Ptentm2Mak/Ptentm2Mak
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:224955
increased spindle cell carcinoma incidence J:224955
Ptentm2Mak/Ptentm2Mak
Trp53tm1Brn/Trp53tm1Brn
Tg(Nes-cre/ERT2,-ALPP)1Sbk/0
(involves: 129P2/OlaHsd) 		increased medulloblastoma incidence J:237990
Ptentm2Mak/Ptentm2Mak
Trp53tm1Brn/Trp53tm1Brn
Tg(Wap-cre)11738Mam/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		increased mammary adenocarcinoma incidence J:224955
increased spindle cell carcinoma incidence J:224955
Ptprz1tm1Schl/Ptprz1+
Trp53tm1Tyj/Trp53+
(involves: 129 * 129S2/SvPas * C57BL/6J) 		increased osteosarcoma incidence J:243104
Ptprz1tm1Schl/Ptprz1tm1Schl
(involves: 129) 		increased osteosarcoma incidence J:243104
Ptprz1tm1Schl/Ptprz1tm1Schl
Trp53tm1Tyj/Trp53+
(involves: 129 * 129S2/SvPas * C57BL/6J) 		increased osteosarcoma incidence J:243104
Rab25tm1Jrgo/Rab25tm1Jrgo
Smad3tm1Par/Smad3+
(129-Rab25tm1Jrgo Smad3tm1Par) 		increased colon adenocarcinoma incidence J:158733
Rad50tm4.1Jpt/Rad50+
(involves: 129/Sv * C57BL/6) 		increased hepatoblastoma incidence J:209141
Rag1tm1Mom/Rag1tm1Mom
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL) 		increased hemangiosarcoma incidence J:141515
increased hepatocellular carcinoma incidence J:141515
increased medulloblastoma incidence J:141515
increased sarcoma incidence J:141515
Rag1tm1Mom/Rag1tm1Mom
Trp53tm1Brd/Trp53tm1Brd
Xrcc5tm1Dbr/Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL) 		increased medulloblastoma incidence J:141515
increased sarcoma incidence J:141515
Rag2tm1Fwa/Rag2tm1Fwa
Stat1tm1Rds/Stat1tm1Rds
(involves: 129S/SvEv * 129S6/SvEvTac) 		increased mammary adenocarcinoma incidence J:216040
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Cd4-NPM/ALK)N1Ingh/0
Tg(TcraTcrb)1100Mjb/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster) 		increased hepatocellular carcinoma incidence J:235890
increased sarcoma incidence J:235890
Ranbp2tm1Jvd/Ranbp2tm1.1Jvd
(involves: 129/Sv * C57BL/6) 		increased hepatocellular carcinoma incidence J:137482
increased lung carcinoma incidence J:137482
increased sarcoma incidence J:137482
Ranbp2tm1Jvd/Ranbp2tm1Jvd
(involves: 129/Sv * C57BL/6) 		increased hepatocellular carcinoma incidence J:137482
increased lung carcinoma incidence J:137482
increased sarcoma incidence J:137482
Raph1tm1.2Fbg/Raph1tm1.2Fbg
(involves: 129S4/SvJae * C57BL/6) 		increased carcinoma incidence J:238262
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd
Tg(MMTVneu)202Mul/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl * FVB/N) 		increased mammary adenocarcinoma incidence J:202603
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl) 		increased hepatocellular carcinoma incidence J:202603
Rassf1tm1.2Brd/Rassf1tm1.2Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:101369
Rassf1tm1Gpp/Rassf1tm1Gpp
(involves: 129S1/SvImJ) 		increased hepatocellular carcinoma incidence J:231761
Rassf1tm1Gpp/Rassf1tm1Gpp
Sav1tm1.1Gpp/Sav1+
(involves: 129S1/Sv * 129S1/SvImJ) 		increased hepatoblastoma incidence J:231761
increased hepatocellular carcinoma incidence J:231761
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		increased hepatocellular carcinoma incidence J:168749
increased lung adenocarcinoma incidence J:168749
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw
Trp53tm1Tyj/Trp53tm1Tyj
(129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw) 		increased intestinal adenocarcinoma incidence J:102483
Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased thyroid C-cell carcinoma incidence J:79016
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6J) 		increased thyroid C-cell carcinoma incidence J:133299
Rb1tm1Tyj/Rb1+
Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:41126
Rb1tm1Tyj/Rb1+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased leiomyosarcoma incidence J:19542
increased pancreatic islet cell carcinoma incidence J:19542
increased sarcoma incidence J:19542
Rb1tm1Tyj/Rb1tm2Brn
Rbl1tm1Tyj/Rbl1+
Tg(Chx10-EGFP/cre,-ALPP)2Clc/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		increased retinoblastoma incidence J:120315
Rb1tm1Tyj/Rb1tm2Brn
Rbl1tm1Tyj/Rbl1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Chx10-EGFP/cre,-ALPP)2Clc/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		increased retinoblastoma incidence J:120315
Rb1tm1Tyj/Rb1tm2Brn
Rbl1tm1Tyj/Rbl1tm1Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Chx10-EGFP/cre,-ALPP)2Clc/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		increased retinoblastoma incidence J:120315
Rb1tm1Tyj/Rb1tm2Brn
Rbl1tm1Tyj/Rbl1tm1Tyj
Trp53tm1Brn/Trp53tm1Tyj
Tg(Chx10-EGFP/cre,-ALPP)2Clc/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		increased retinoblastoma incidence J:120315
Rb1tm2Brn/Rb1+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:86077
increased lung small cell carcinoma incidence J:86077
Rb1tm2Brn/Rb1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Col1a1-cre)1Kry/0
(involves: 129 * 129P2/OlaHsd * FVB/N) 		increased osteosarcoma incidence J:234128
Rb1tm2Brn/Rb1tm2Brn
Rbl1tm1Tyj/Rbl1tm1Tyj
Rbl2tm2Tyj/Rbl2tm2Tyj
(involves: 129 * 129S2/SvPas * 129S4/SvJae) 		increased urinary bladder carcinoma incidence J:217195
Rb1tm2Brn/Rb1tm2Brn
Tg(Gfap-cre)2Brn/0
(involves: 129 * FVB/N) 		increased carcinoma incidence J:187257
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brd/Trp53tm1Brd
Tg(Gfap-cre)2Brn/0
(involves: 129 * 129S7/SvEvBrd * FVB/N) 		increased medulloblastoma incidence J:61961
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:86077, J:157319
increased lung small cell carcinoma incidence J:86077, J:157319
increased thyroid carcinoma incidence J:86077, J:157319
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd) 		increased lung carcinoma incidence J:86077
increased lung small cell carcinoma incidence J:86077, J:157319
increased ovarian carcinoma incidence J:84345
increased thyroid carcinoma incidence J:86077, J:157319
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(BGLAP-cre)1Clem/0
(involves: 129 * 129P2/OlaHsd * FVB/NJ) 		increased osteosarcoma incidence J:326989
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Col1a1-cre)1Kry/0
(involves: 129 * 129P2/OlaHsd * FVB/N) 		increased osteosarcoma incidence J:234128
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Gfap-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased medulloblastoma incidence J:61961
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Gfap-cre)2Brn/0
(involves: 129 * 129P2/OlaHsd * FVB/N) 		increased carcinoma incidence J:187257
increased medulloblastoma incidence J:187257
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)105Ayn/0
(FVB.Cg-Trp53tm1Brn Rb1tm2Brn Tg(MMTV-cre)105Ayn) 		increased carcinoma incidence J:165292
increased squamous cell carcinoma incidence J:165292
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Ren-cre)#Kwg/0
(involves: 129 * 129P2/OlaHsd) 		increased pancreatic islet cell carcinoma incidence J:216559
increased sarcoma incidence J:216559
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Lejo/Trp53tm1Lejo
(involves: 129) 		increased lung small cell carcinoma incidence J:187012
Rb1tm3Tyj/Rb1+
Trp53tm1Brn/Trp53+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N) 		increased osteosarcoma incidence J:136693
Rb1tm3Tyj/Rb1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N) 		increased osteosarcoma incidence J:136693
Rb1tm3Tyj/Rb1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1) 		increased osteosarcoma incidence J:318885
Rb1tm3Tyj/Rb1tm3Tyj
Rbl1tm1Tyj/Rbl1tm1Tyj
Rbl2tm2.1Tyj/Rbl2tm2.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:177573
Rb1tm3Tyj/Rb1tm3Tyj
Rbl1tm1Tyj/Rbl1tm1Tyj
Tg(Pax6-cre,GFP)2Pgr/0
(involves: 129S2/SvPas * 129S4/SvJae * 129X1/SvJ * C57BL/6 * FVB/N) 		increased retinoblastoma incidence J:119919
Rb1tm3Tyj/Rb1tm3Tyj
Rbl2tm1Tyj/Rbl2tm1Tyj
Tg(Nes-cre)1Atp/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N) 		increased retinoblastoma incidence J:91406
Rb1tm3Tyj/Rb1tm3Tyj
Rbl2tm2.1Tyj/Rbl2tm2.1Tyj
Tg(Pax6-cre,GFP)2Pgr/0
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6 * FVB/N) 		increased retinoblastoma incidence J:119919
Rb1tm3Tyj/Rb1tm3Tyj
Rbl2tm2Tyj/Rbl2tm2Tyj
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased lung small cell carcinoma incidence J:160148
Rb1tm3Tyj/Rb1tm3Tyj
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Tg(tetO-RNAi:Trp53)ASlowe/0
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		increased osteosarcoma incidence J:199542
Rb1tm3Tyj/Rb1tm3Tyj
Tg(tetO-MYC)36aBop/0
Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		increased hepatocellular carcinoma incidence J:172430
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N) 		increased osteosarcoma incidence J:136693
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased lung small cell carcinoma incidence J:160148
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N) 		increased osteosarcoma incidence J:136693, J:318035
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CD-1) 		increased osteosarcoma incidence J:199542
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * CD-1) 		increased osteosarcoma incidence J:329449
Rbm38tm1.1Xch/Rbm38tm1.1Xch
(involves: C57BL/6 * FVB/N) 		increased hemangiosarcoma incidence J:216929
Rcbtb2tm1.1Xyw/Rcbtb2+
(involves: C57BL/6 * CBA) 		increased histiocytic sarcoma incidence J:282928
Rcbtb2tm1.1Xyw/Rcbtb2tm1.1Xyw
(involves: C57BL/6 * CBA) 		increased histiocytic sarcoma incidence J:282928
Recql4tm1Glu/Recql4tm1Glu
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased sarcoma incidence J:97101
Rettm2.1Cos/?
Tg(Th-MYCN)41Waw/0
(involves: 129S1/Sv * BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:261033
Rev3ltm1Rwd/Rev3ltm2.1Rwd
Tg(MMTV-cre)1Mam/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		increased carcinoma incidence J:158922
Rev3ltm1Rwd/Rev3ltm2.1Rwd
Trp53tm1Brd/Trp53+
Tg(MMTV-cre)1Mam/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased carcinoma incidence J:158922
increased osteosarcoma incidence J:158922
Rgsc682/Rgsc682+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased squamous cell carcinoma incidence J:133634
Rgsc814/Rgsc814+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased squamous cell carcinoma incidence J:133634
Rgsc1033/Rgsc1033+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased thyroid carcinoma incidence J:133634
Rgsc1049/Rgsc1049+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased squamous cell carcinoma incidence J:133634
Rgsc1050/Rgsc1050+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased renal carcinoma incidence J:133634
Rhoctm1Mak/Rhoctm1Mak
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:100482
Rint1tm1Whl/Rint1+
(Not Specified) 		increased hepatocellular carcinoma incidence J:122805
increased lung adenocarcinoma incidence J:122805
increased mammary adenocarcinoma incidence J:122805
increased skin squamous cell carcinoma incidence J:122805
Rnf8Gt(AS0574)Wtsi/Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased mammary adenocarcinoma incidence J:161240
increased sarcoma incidence J:161240
Rnf8Gt(RRR260)Byg/Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased mammary adenocarcinoma incidence J:161240
increased sarcoma incidence J:161240
Rnf20Gt(RRJ249)Byg/Rnf20+
(involves: 129P2/OlaHsd) 		increased colon adenocarcinoma incidence J:268221
increased large intestine adenocarcinoma incidence J:268221
Rnf168Gt(156B6)Cmhd/Rnf168Gt(156B6)Cmhd
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6) 		increased hemangiosarcoma incidence J:198260
increased sarcoma incidence J:198260
Rnf168Gt(405F11)Cmhd/Rnf168Gt(405F11)Cmhd
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6) 		increased hemangiosarcoma incidence J:198260
increased sarcoma incidence J:198260
Robo1tm1Phr/Robo1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased carcinoma incidence J:93666
increased lung adenocarcinoma incidence J:93666
RrsvA/WySnJ/RrsvA/WySnJ
(involves: A/WySnJ * SW) 		increased sarcoma incidence J:6009
RrsvCBA/J/RrsvCBA/J
(involves: CBA/J * SW) 		increased sarcoma incidence J:6009
Rtel1tm2.1Hdin/Rtel1tm2.1Hdin
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased medulloblastoma incidence J:202812
increased sarcoma incidence J:202812
Runx1tm3Dow/Runx1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		increased sarcoma incidence J:77129
Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs/Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs
Trp53tm1Sia/Trp53+
(involves: 129X1/SvJ * C57BL/6 * CBA) 		increased rhabdomyosarcoma incidence J:117828
Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs/Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs
Trp53tm1Sia/Trp53tm1Sia
(involves: 129X1/SvJ * C57BL/6 * CBA) 		increased rhabdomyosarcoma incidence J:117828
S100a4tm1Amba/S100a4tm1Amba
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		increased fibrosarcoma incidence J:89563
increased hepatocellular carcinoma incidence J:89563
increased lung carcinoma incidence J:89563
increased mammary adenocarcinoma incidence J:89563
Sav1tm1.1Gpp/Sav1+
(involves: 129S1/Sv) 		increased hepatocellular carcinoma incidence J:231761
Sav1tm1.1Rjo/Sav1tm1.1Rjo
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL) 		increased carcinoma incidence J:156531
increased hepatocellular carcinoma incidence J:156531
Sav1tm1Dlim/Sav1+
(involves: 129S1/Sv * 129X1/SvJ) 		increased osteosarcoma incidence J:160325
Sav1tm2.1Dlim/Sav1tm2.1Dlim
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:238319
Scribtm1.2Phum/Scrib+
(involves: FVB/N) 		increased lung adenocarcinoma incidence J:178461
increased lung non-small cell carcinoma incidence J:216266
SfnEr/Sfn+
(involves: 129/Sv * C57BL/6) 		increased squamous cell carcinoma incidence J:12025
Sirt1tm1.1Cxd/Sirt1+
Trp53tm1Brd/Trp53+
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N)) 		increased carcinoma incidence J:140089
increased sarcoma incidence J:140089
Sirt2tm1.1Cxd/Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss)) 		increased hepatocellular carcinoma incidence J:177486
Slc29a3tm1Lex/Slc29a3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased histiocytic sarcoma incidence J:179286
Slc33a1tm1.1Lpu/Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased sarcoma incidence J:211266
Sluc10B10.O20/Dem/Sluc10B10.O20/Dem
Sluc25O20/A/Sluc25O20/A
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Sluc10O20/A/Sluc10O20/A
Sluc25O20/A/Sluc25O20/A
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Sluc18B10.O20/Dem/Sluc18B10.O20/Dem
Sluc26B10.O20/Dem/Sluc26B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Sluc25O20/A/Sluc25O20/A
Sluc5B10.O20/Dem/Sluc5B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Sluc25O20/A/Sluc25O20/A
Sluc9B10.O20/Dem/Sluc9O20/A
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Sluc25O20/A/Sluc25O20/A
Sluc9O20/A/Sluc9O20/A
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Smad3tm1Cxd/Smad3tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		increased intestinal adenocarcinoma incidence J:53510
Smad3tm1Par/Smad3tm1Par
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased intestinal adenocarcinoma incidence J:49839
Smad3tm1Par/Smad3tm1Par
(129-Smad3tm1Par/J) 		increased intestinal adenocarcinoma incidence J:106572
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Tg(KRT5-cre)1Xya/0
(involves: 129S6/SvEvTac) 		increased carcinoma incidence J:101602
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)7Mul/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * FVB/N) 		increased mammary adenocarcinoma incidence J:212549
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased intestinal adenocarcinoma incidence J:212549
Smarca2tm1Mya/Smarca2tm1Mya
Smarca4tm1Mag/Smarca4+
(involves: 129S/Sv * 129S2/SvPas * C57BL/6J * CD-1) 		increased hemangiosarcoma incidence J:132091
Smarca4tm1Mag/Smarca4+
(involves: 129S/Sv * C57BL/6J * CD-1) 		increased mammary adenocarcinoma incidence J:132091
increased osteosarcoma incidence J:132091
Smarcb1tm1Gvk/Smarcb1+
(involves: 129/Sv * C57BL/6J * SJL/J) 		increased blastoma incidence J:101185
Smarcb1tm1Mya/Smarcb1+
(involves: 129S2/SvPas * C57BL/6) 		increased sarcoma incidence J:68501
Smarcb1tm1Sho/Smarcb1+
(involves: 129S6/SvEvTac * C57BL/6J * DBA/2J) 		increased malignant tumor incidence J:120820
Smarcb1tm1Sho/Smarcb1+
Tg(LPV-TAg121)2Tvd/0
(involves: 129S6/SvEvTac * C57BL/6J * DBA/2J) 		increased carcinoma incidence J:120820
increased malignant tumor incidence J:120820
Smg1Gt(AG0297)Wtsi/Smg1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lung adenocarcinoma incidence J:193626
Smurf2Gt(RRA098)Byg/Smurf2Gt(RRA098)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:189320
increased sarcoma incidence J:189320
increased small intestine adenocarcinoma incidence J:189320
Sod1m1H/Sod1m1H
(involves: C3H/HeH * C57BL/6J) 		increased hepatocellular carcinoma incidence J:219360
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased hepatocellular carcinoma incidence J:132133
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac) 		increased carcinoma incidence J:166879
increased hepatocellular carcinoma incidence J:166879
increased lung adenocarcinoma incidence J:166879
increased renal carcinoma incidence J:166879
increased sarcoma incidence J:166879
increased thyroid carcinoma incidence J:166879
Srpxtm1Hzi/Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:119999
increased sarcoma incidence J:119999
Ssbp2tm1Lana/Ssbp2tm1Lana
(involves: 129S/SvEv * C57BL/6) 		increased carcinoma incidence J:162035
increased jejunum adenocarcinoma incidence J:162035
increased malignant tumor incidence J:162035
increased sarcoma incidence J:162035
increased squamous cell carcinoma incidence J:162035
Ssic1C57BL/10J/Ssic1C57BL/10J
(involves: C57BL/10 * O20/A) 		increased small intestine adenocarcinoma incidence J:26873
Stag1Gt(P099A04)Wrst/Stag1+
(involves: 129S2/SvPas) 		increased carcinoma incidence J:184720
increased hepatocellular carcinoma incidence J:184720
increased histiocytic sarcoma incidence J:184720
Stat1tm1Dlv/Stat1tm1Dlv
(B6.129S-Stat1tm1Dlv) 		increased mammary adenocarcinoma incidence J:216040
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac) 		increased mammary adenocarcinoma incidence J:216040
Stat3tm1Dlv/Stat3tm1Dlv
Tg(Csf1r-icre)1Jwp/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		increased carcinoma incidence J:156593
Stat3tm4Vpo/Stat3tm4Vpo
Tg(MMTV-Erbb2)1Pv/0
(involves: 129P2/OlaHsd * BALB/cAn * C57BL/6 * CD-1 * DBA) 		increased mammary adenocarcinoma incidence J:157976
Stk3tm1.1Jav/Stk3+
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
Stk3tm1.1Jav/Stk3tm1.1Jav
Stk4Gt(AJ0315)Wtsi/Stk4+
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
Stk3tm1.1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
Stk3tm1.1Rjo/Stk3tm1.1Rjo
Stk4tm1.1Rjo/Stk4tm1.1Rjo
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL) 		increased hepatocellular carcinoma incidence J:156531
Stk3tm1.1Yy/Stk3tm1Yy
Stk4tm1.1Yy/Stk4tm1.1Yy
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA) 		increased carcinoma incidence J:156541
increased hepatocellular carcinoma incidence J:156541
Stk3tm1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
Stk3tm1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
Stk3tm1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * 129P2/OlaHsd * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:238319
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased histiocytic sarcoma incidence J:153945
Stk11tm1.1Mlfr/Stk11+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J) 		increased osteosarcoma incidence J:104347
increased sarcoma incidence J:104347
Stk11tm1.1Rdp/Stk11tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased endometrial carcinoma incidence J:131865
Stk11tm1.1Rdp/Stk11tm1.1Rdp
Tg(KRT14-cre)1Ipc/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL) 		increased squamous cell carcinoma incidence J:131037
Stk11tm1.1Rdp/Stk11tm1.1Rdp
Tg(Sprr2f-cre)1Dcas/0
(involves: 129S6/SvEvTac * FVB/N) 		increased endometrial carcinoma incidence J:158190
Stk11tm1.2Rdp/Stk11+
(involves: 129S6/SvEvTac * FVB/N) 		increased endometrial carcinoma incidence J:131865
Stk11tm1Mmt/Stk11+
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:76202
Stk11tm1Mmt/Stk11+
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:107275
Stk11tm1Tpm/Stk11+
(Not Specified) 		increased endometrial carcinoma incidence J:79074
increased hepatocellular carcinoma incidence J:79074
SufuGt(XB699)Byg/Sufu+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:125534
increased rhabdomyosarcoma incidence J:125534
Suz12Gt(Betageo)1Khe/Suz12+
(involves: 129P2/OlaHsd) 		increased histiocytic sarcoma incidence J:217077
T(9;17)138Ca/T(9;17)138Ca
(Not Specified) 		increased adenocarcinoma incidence J:189952
Taf4tm1Idvd/Taf4tm1Idvd
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: C57BL/6 * SJL) 		increased malignant tumor incidence J:124111
increased squamous cell carcinoma incidence J:124111
Tbx21tm1Glm/Tbx21tm1Glm
Tg(TRAMP)8247Ng/0
(involves: 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:88093
Tcf7tm1Cle/Tcf7tm1Cle
(involves: 129P2/OlaHsd) 		increased mammary adenoacanthoma incidence J:57721
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tcra-Jtm1Tgi Tg(Pklr-Myc)73Ak) 		increased hepatocellular carcinoma incidence J:184496
increased malignant tumor incidence J:184496
Terctm1Rdp/Terctm1Rdp
Wrntm1Lgu/Wrntm1Lgu
(involves: 129/Sv * BALB/c * C57BL/6 * SLJ) 		increased osteosarcoma incidence J:91715
increased sarcoma incidence J:91715
Terf1tm1.1Blas/Terf1tm1.1Blas
Tg(KRT5-cre)1Tak/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129 * C3H * C57BL/6 * SJL) 		increased skin squamous cell carcinoma incidence J:152077
Testm1Cro/Tes+
(involves: 129X1/SvJ * C57BL/6J) 		increased carcinoma incidence J:100181
Testm1Cro/Testm1Cro
(involves: 129X1/SvJ * C57BL/6J) 		increased carcinoma incidence J:100181
Tff1tm1Mrio/Tff1tm1Mrio
(involves: 129S2/SvPas * 129X1/SvJ) 		increased carcinoma incidence J:35923
Tg(Acta2-RAC1*G12V)33Pjgc/0
(involves: C57BL/6 * FVB/N) 		increased sarcoma incidence J:150015
Tg(Acta2-RAC1*G12V)33Pjgc/Tg(Acta2-RAC1*G12V)33Pjgc
(involves: C57BL/6 * FVB/N) 		increased sarcoma incidence J:150015
Tg(ACTB-Eif4e)#Ppp/?
(Not Specified) 		increased lung adenocarcinoma incidence J:89878
increased sarcoma incidence J:89878
Tg(ACTB-KRAS*G12V,-luc)#Lche/0
(involves: C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:199528
Tg(Alb1-Myc)#Sst/0
(involves: C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:34434
Tg(Alb1-Myc)#Sst/0
Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		increased hepatocellular carcinoma incidence J:34434
Tg(Alb1-Myc)#Sst/0
Tg(MtTGFA)Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		increased hepatocellular carcinoma incidence J:176432
Tg(Alb1HBV)44Bri/0
(involves: C57BL/6J * SJL/J) 		increased hepatocellular carcinoma incidence J:86165
Tg(Alb1HBV)44Bri/0
(C57BL/6J-Tg(Alb1HBV)44Bri/J) 		increased hepatocellular carcinoma incidence J:223921
Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6J * CBA/J) 		increased hepatocellular carcinoma incidence J:65354, J:101128
Tg(Alb-HBx)A112Tfts/0
(involves: C57BL/6) 		increased hepatocellular carcinoma incidence J:104728
Tg(Alb-HRAS*G12V)28Yu/0
(involves: C57BL/6J * CBA/J) 		increased hepatocellular carcinoma incidence J:107083, J:238319
Tg(Alb-PDGFC)#Jcam/0
(involves: C57BL/6) 		increased hepatocellular carcinoma incidence J:96979, J:211984
Tg(Alb-SND1)3aDsar/0
(involves: C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:242582
Tg(Alb-TAg)1Gjh/0
(C3.Cg-Tg(Alb-TAg)1Gjh) 		increased hepatocellular carcinoma incidence J:105110
Tg(Alb-TAg)#Arnd/0
(C3Fe.Cg-Tg(Alb-TAg)#Arnd) 		increased hepatocellular carcinoma incidence J:171880
Tg(AMH-Fshr*D580H)#Hht/0
(involves: FVB/N) 		increased ovarian carcinoma incidence J:160015
Tg(Amhr2-SV40TAg)1Dcco/0
((C57BL/6 x C3H)F1) 		increased ovarian carcinoma incidence J:82550
Tg(Amy1TAg)501Knw/?
(C57BL/6-Tg(Amy1TAg)501Knw) 		increased osteosarcoma incidence J:90730
Tg(ARR2/Pbsn-MYC)7Key/?
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:223213, J:85480
Tg(Atoh1-sb11)1Mtay/0
TgTn(sb-T2/Onc3)12740Njen/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C3H * C57BL/6J * ICR) 		increased medulloblastoma incidence J:181542
Tg(Atp4b-TAg)#Jig/0
(involves: FVB/N) 		increased carcinoma incidence J:89240
Tg(Bglap2-TAg)1Rkho/0
(FVB/N-Tg(Bglap2-TAg)1Rkho) 		increased osteosarcoma incidence J:165282
Tg(Bglap2-TAg)1Rkho/0
(involves: FVB/N) 		increased osteosarcoma incidence J:234128
Tg(Bglap2-TAg)1Rkho/0
Tg(Col1a1-cre)1Kry/0
Tnfrsf11atm1.1Pngr/Tnfrsf11atm1.1Pngr
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased osteosarcoma incidence J:234128
Tg(Bglap2-TAg)1Rkho/0
Tnfsf11tm1Pngr/Tnfsf11+
(involves: 129P2/OlaHsd * FVB/N) 		increased osteosarcoma incidence J:234128
Tg(C3-1-TAg)cJeg/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:52786, J:46513
increased prostate gland adenocarcinoma incidence J:52786, J:46513, J:72324
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
Tg(Dbh-icre)1Gsc/0
(involves: C57BL/6 * FVB/N) 		increased neuroblastoma incidence J:186696
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
Tg(Dbh-icre)1Gsc/0
Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J * FVB/N) 		increased neuroblastoma incidence J:186696
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
Thtm1(cre)Te/Th+
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased neuroblastoma incidence J:186696
Tg(CAG-Bgeo,-Tle1,-ALPP)1Lbe/0
Tg(CAG-cre)1Nagy/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased lung adenocarcinoma incidence J:106684
Tg(CAG-Bgeo,-tTA,-EGFP)2A11Kuw/0
Tg(Pdx1-cre)6Tuv/0
Tg(tetO-MYC)36Bop/0
(involves: 129P2/OlaHsd * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:197052
Tg(CAG-Has2)99Nita/0
Tg(MMTV-cre)4Mam/0
Tg(MMTVneu)202Mul/0
(FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTV-cre)4Mam Tg(MMTVneu)202Mul) 		increased mammary adenocarcinoma incidence J:130531, J:164205
Tg(CAG-Has2)99Nita/0
Tg(MMTVneu)202Mul/0
(FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTVneu)202Mul) 		increased mammary adenocarcinoma incidence J:130531
Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N) 		increased ovarian carcinoma incidence J:158388
Tg(CAG-Ptafr)1Tksh/0
(B6;D2-Tg(CAG-Ptafr)1Tksh/TkshRbrc) 		increased cutaneous melanoma incidence J:38639
Tg(CAG-Tle1,-ALPP)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased lung adenocarcinoma incidence J:106684
Tg(CAG-TRIM29)ADims/0
(FVB/NJ-Tg(CAG-TRIM29)ADims) 		increased urinary bladder carcinoma incidence J:226764
Tg(Cd4-NPM/ALK)N1Ingh/0
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster) 		increased hepatocellular carcinoma incidence J:235890
increased sarcoma incidence J:235890
Tg(CEACAM5-Tag)L5496Wzm/0
(involves: C57BL/6 * CBA) 		increased gastric adenocarcinoma incidence J:62581
Tg(Cebpb-tTA)5Bjd/0
Tg(tetO-MYC,-OVAL)#Gtgm/0
(B6J.Cg-Tg(Cebpb-tTA)5Bjd Tg(tetO-MYC,-OVAL)#Gtgm) 		increased hepatocellular carcinoma incidence J:186226
Tg(Cela1-luc,Cela1-TAg)#Nzh/0
(involves: FVB/N) 		increased pancreatic acinar cell carcinoma incidence J:207960
Tg(CMV-tTA)3Bjd/0
Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		increased histiocytic sarcoma incidence J:94953
increased spindle cell carcinoma incidence J:94953
Tg(Cnp-EGFR)10Nrat/0
(involves: C57BL/6 * SJL) 		increased malignant triton tumor incidence J:95933
increased rhabdomyosarcoma incidence J:95933
Tg(Dct-Birc5)21Gros/0
Tg(Mt1-Hgf)19Lmb/0
(involves: C57BL/6 * CBA * FVB/N) 		increased melanoma incidence J:122181
Tg(Dct-Grm1)ESzc/0
(involves: C57BL/6J) 		increased cutaneous melanoma incidence J:83183
Tg(Dct-Grm1)ESzc/0
(C57BL/6J-Tg(Dct-Grm1)ESzc) 		increased intraocular melanoma incidence J:230115
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
(B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw) 		increased adenocarcinoma incidence J:180282
Tg(Ela1-Myc)158Bri/0
(involves: C57BL/6 * SJL) 		increased pancreatic acinar cell carcinoma incidence J:76992
Tg(Ela1-Myc)159Bri/0
(involves: C57BL/6 * SJL) 		increased pancreatic acinar cell carcinoma incidence J:76992
Tg(Ela1-Myc)160Bri/0
(involves: C57BL/6 * SJL) 		increased pancreatic acinar cell carcinoma incidence J:76992
Tg(Ela1-TAg)18Bri/0
(involves: C57BL/6 * SJL) 		increased pancreatic acinar cell carcinoma incidence J:76995
Tg(Ela1-TAg)19Bri/0
(involves: C57BL/6 * SJL) 		increased pancreatic acinar cell carcinoma incidence J:76995
Tg(Ela1-TAg*)79Mjt/0
(involves: C57BL/6 * DBA/2) 		increased pancreatic acinar cell carcinoma incidence J:78026
Tg(Ela1-TAg*)79Mjt/0
Tg(MUC1)79.24Gend/0
(involves: C57BL/6 * DBA/2) 		increased pancreatic acinar cell carcinoma incidence J:64570
Tg(Ela1-TAg*)289Mjt/0
(involves: C57BL/6 * DBA/2) 		increased pancreatic acinar cell carcinoma incidence J:78026
Tg(Ela1-Tgfa)150Bri/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL) 		increased malignant tumor incidence J:67389
increased pancreatic ductal adenocarcinoma incidence J:67389
Tg(EmuSR-HDAC9)1468Kpet/0
(involves: C57BL/6 * CBA) 		increased histiocytic sarcoma incidence J:237420
Tg(Erbb2-Erbb2*V664E)#Led/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:62441
Tg(Fabp1-Ccnd1)4Rdb/0
(C57BL/6-Tg(Fabp1-Ccnd1)4Rdb/J) 		increased hepatocellular carcinoma incidence J:70394
Tg(Fabp4-Il22)#Ychn/0
(involves: ICR) 		increased liposarcoma incidence J:176141
Tg(Gcg-TAg)25Ddr/?
(involves: CD-1) 		increased large intestine adenocarcinoma incidence J:91490, J:101537
Tg(GFAP-tTA)67Pop/0
Tg(tetO-Ifng)184Pop/0
(B6.Cg-Tg(GFAP-tTA)67Pop Tg(tetO-Ifng)184Pop) 		increased medulloblastoma incidence J:94092
Tg(GFAP-tTA)67Pop/0
Tg(tetO-Ifng)184Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased medulloblastoma incidence J:94092
Tg(Ggt1-Hif1a*)43Log/0
(involves: C57BL/6) 		increased renal carcinoma incidence J:177381
Tg(Ggt1-tTA)#Agoc/0
Tg(tetO-MYC)36aBop/0
(involves: FVB/N) 		increased renal carcinoma incidence J:222943
Tg(H2-K-Fosl2,-EGFP)13Wag/0
(either: 129.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag or B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag) 		increased fibrosarcoma incidence J:139032
Tg(H-2K1-Lrp5/Fkbp1a,-luc*)#Dmps/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727, J:184212
Tg(H-2K1-Lrp5/Fkbp1a,-luc*)#Dmps/0
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727
increased spindle cell carcinoma incidence J:206727
Tg(HBV-HCV)21Kko/0
(C57BL/6N-Tg(HBV-HCV)21Kko) 		increased hepatocellular carcinoma incidence J:52686
Tg(HBV-HCV)49Kko/0
(C57BL/6N-Tg(HBV-HCV)49Kko) 		increased hepatocellular carcinoma incidence J:52686
Tg(HBV-HCV)Kko/0
(C57BL/6N-Tg(HBV-HCV)Kko) 		increased hepatocellular carcinoma incidence J:52686
Tg(HBVX*,-Myc)#Skp/0
(Not Specified) 		increased hepatocellular carcinoma incidence J:81098
Tg(HBVX*,-Myc)#Skp/Tg(HBVX*,-Myc)#Skp
(Not Specified) 		increased hepatocellular carcinoma incidence J:81098
Tg(HBx)3Yu/0
(involves: C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:56196
Tg(HRAS)2Jic/?
(involves: BALB/c * C57BL/6) 		increased adenocarcinoma incidence J:64968
increased lung adenocarcinoma incidence J:64968
increased sarcoma incidence J:64968
Tg(HRAS)7Mok/?
(involves: C57BL/6) 		increased adenocarcinoma incidence J:64968
increased lung adenocarcinoma incidence J:64968
increased sarcoma incidence J:64968
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased sarcoma incidence J:78177
Tg(Ins1-GAS)1Sbr/0
(involves: FVB/NTac) 		increased carcinoma incidence J:59575
Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Tg(Ins2-Akt1*)3Mbb) 		increased pancreatic islet cell carcinoma incidence J:144599
Tg(Ins2-IGF1R)1Dh/0
Tg(RIP1-Tag)2Dh/0
(involves: C3H * C57BL/6 * C57BL/6J * DBA/2J) 		increased pancreatic islet cell carcinoma incidence J:205389
Tg(Ins2-Tag*,-flpe)#Gne/0
(involves: C57BL/6J) 		increased pancreatic islet cell carcinoma incidence J:187012
Tg(Ins2-Tag*,-flpe)#Gne/0
(Not Specified) 		increased pancreatic islet cell carcinoma incidence J:188693
Tg(IRS1)1Mhep/0
Tg(SERPINA1-HBVX)1655Jtsb/0
(involves: C3H * C57BL/6 * FVB * ICR) 		increased hepatocellular carcinoma incidence J:227278
Tg(K5-Ptgs2)19Kmd/0
(involves: NMRI) 		increased squamous cell carcinoma incidence J:79071
Tg(K5-Ptgs2)667Kmd/0
(involves: NMRI) 		increased squamous cell carcinoma incidence J:79071
Tg(KRT5-Akt1*)Jmpa/0
(involves: C57BL/6 * DBA/2 * DBA/2J * FVB/N) 		increased adenocarcinoma incidence J:144831
increased carcinoma incidence J:144831
increased squamous cell carcinoma incidence J:144831
Tg(KRT5-rtTA)#Glk/0
Tg(tetO/CMV-Dek,-luc)317Siwe/0
(involves: FVB/N) 		increased squamous cell carcinoma incidence J:261249
Tg(KRT5-Terf2)PMBlas/Y
(involves: C57BL/6 * CBA) 		increased skin squamous cell carcinoma incidence J:102653
Tg(KRT5-Terf2)POBlas/0
(involves: C57BL/6 * CBA) 		increased skin squamous cell carcinoma incidence J:102653
Tg(KRT14-cre)8Brn/0
Tg(KRT5-Akt1*)Jmpa/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * DBA/2J * FVB/N) 		increased carcinoma incidence J:144831
increased squamous cell carcinoma incidence J:144831
Tg(KRT14-Fyn*)aJsey/0
(involves: C57BL/6 * CBA) 		increased skin squamous cell carcinoma incidence J:155536
Tg(KRT14-Fyn*)aJsey/0
(involves: C57BL/6 * CBA * FVB/N) 		increased skin squamous cell carcinoma incidence J:155536
Tg(KRT14-HPV8)9Vuc/0
(FVB.Cg-Tg(KRT14-HPV8)9Vuc) 		increased skin squamous cell carcinoma incidence J:96784
Tg(KRT14-HPV8)85Vuc/0
(FVB.Cg-Tg(KRT14-HPV8)85Vuc) 		increased skin squamous cell carcinoma incidence J:96784
Tg(KRT14-HPV8)#Vuc/0
(involves: C57BL/6 * DBA * FVB/N) 		increased skin squamous cell carcinoma incidence J:96784
Tg(KRT14-HPV16)wt1Dh/0
(FVB.Cg-Tg(KRT14-HPV16)wt1Dh/Nci) 		increased skin squamous cell carcinoma incidence J:65699
Tg(KRT14-HPV16)wt1Dh/0
(either: FVB.Cg-Tg(KRT14-HPV16)wt1Dh or (involves: C57BL/6 * DBA/2 * FVB/N)) 		increased skin squamous cell carcinoma incidence J:20130
increased spindle cell carcinoma incidence J:20130
Tg(KRT14-HPV16E7)2304Plam/0
(involves: FVB/N) 		increased skin squamous cell carcinoma incidence J:86018
Tg(KRT14-HPV16E7)2326Plam/0
(involves: FVB/N) 		increased skin squamous cell carcinoma incidence J:86018
Tg(KRT14-Shh)#Cobm/0
(involves: C57BL/6 * CBA) 		increased basal cell carcinoma incidence J:150375
Tg(KRT14-Snai1)1Efu/0
(involves: CD-1) 		increased basal cell carcinoma incidence J:229072
increased skin squamous cell carcinoma incidence J:229072
Tg(Krt18-EGFP,-TAg121)36Ysng/0
(involves: C57BL/6 * DBA/2) 		increased ovarian carcinoma incidence J:189304
Tg(Krt19-Ptgs2,Krt19-Ptges)8Tko/0
Tg(Krt19-Wnt1)2Maos/0
(involves: C3H * C57BL/6) 		increased gastric adenocarcinoma incidence J:116782
Tg(KRT19-TAg)7Eps/0
(involves: FVB/N) 		increased urinary bladder transitional cell carcinoma incidence J:64395
Tg(LPV-TAg121)2Tvd/0
(involves: 129S6/SvEvTac * C57BL/6J * DBA/2J) 		increased carcinoma incidence J:120820
Tg(Ly6a-BCR/ABL1)IS1AIsg/0
(involves: C57BL/6J * CBA) 		increased lung adenocarcinoma incidence J:144382
increased osteosarcoma incidence J:144382
Tg(Ly6a-BCR/ABL1)IS1BIsg/0
(involves: C57BL/6J * CBA) 		increased lung adenocarcinoma incidence J:144382
increased osteosarcoma incidence J:144382
Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased adenocarcinoma incidence J:51661
increased hemangiosarcoma incidence J:51661
increased rhabdomyosarcoma incidence J:51661
increased sarcoma incidence J:51661
Tg(Mdm2)1Snj/0
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased hemangiosarcoma incidence J:51661
increased medulloblastoma incidence J:51661
increased osteosarcoma incidence J:51661
increased squamous cell carcinoma incidence J:51661
Tg(MMTV-AURKA)#Cxd/?
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:145680
Tg(MMTV-AURKA)#Cxd/?
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * FVB/N) 		increased mammary adenocarcinoma incidence J:145680
Tg(MMTV-CCND1)1Esmp/0
(Not Specified) 		increased mammary adenoacanthoma incidence J:70571
increased mammary adenocarcinoma incidence J:70571
increased sarcoma incidence J:70571
Tg(MMTV-CCND1)1Esmp/0
Tg(MMTV-Cdc37)1Stp/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased mammary adenocarcinoma incidence J:62465
Tg(MMTV-Cdc37)1Stp/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased mammary adenoacanthoma incidence J:62465
increased mammary adenocarcinoma incidence J:62465
Tg(MMTV-Cdc37)1Stp/0
Tg(MMTV-Myc)141-3Led/0
(involves: C57BL/6 * CD-1 * DBA/2 * FVB/N) 		increased mammary adenocarcinoma incidence J:62465
increased salivary adenocarcinoma incidence J:62465
Tg(MMTV-Cdc37)2Stp/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased mammary adenoacanthoma incidence J:62465
increased sarcoma incidence J:62465
Tg(MMTV-ENPP2)20Gbm/0
(FVB/N-Tg(MMTV-ENPP2)20Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-ENPP2)21Gbm/0
(FVB/N-Tg(MMTV-ENPP2)21Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-ENPP2)#Gbm/0
(FVB/N-Tg(MMTV-ENPP2)#Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-Erbb2)1Pv/0
(involves: BALB/c * C57BL/6 * CD-1 * DBA) 		increased mammary adenocarcinoma incidence J:234420
Tg(MMTV-ERBB2)5Erick/?
(FVB/N-Tg(MMTV-ERBB2)5Erick) 		increased mammary adenocarcinoma incidence J:90202
Tg(MMTV-Erbb2)9Pjo/0
(involves: BALB/c * C3H * C57BL/6) 		increased mammary adenocarcinoma incidence J:72129
Tg(MMTV-Erbb2)10Pjo/0
(involves: BALB/c * C3H * C57BL/6) 		increased mammary adenocarcinoma incidence J:72129
Tg(MMTV-Erbb2)12Pjo/0
(involves: BALB/c * C3H * C57BL/6) 		increased mammary adenocarcinoma incidence J:72129
Tg(MMTV-Erbb2)17Pjo/0
(involves: BALB/c * C3H * C57BL/6) 		increased mammary adenocarcinoma incidence J:72129
Tg(MMTV-Erbb2)NA1Mul/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:48632
Tg(MMTV-Erbb2)NF1Mul/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:48632
Tg(MMTV-Erbb2)NF1Mul/0
(involves: CD-1 * FVB/N) 		increased mammary adenocarcinoma incidence J:48632
Tg(MMTV-Erbb2)NF1Mul/0
(FVB/N-Tg(MMTV-Erbb2)NF1Mul) 		increased mammary adenocarcinoma incidence J:48632
Tg(MMTV-Erbb2)NK1Mul/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:48632
Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Tg(MMTV-ERBB2*,-luc)6157Aami/0
(FVB-Tg(MMTV-ERBB2*,-luc)6157Aami) 		increased mammary adenocarcinoma incidence J:172352
Tg(MMTV-ERBB3)1Slg/0
(involves: FVB) 		increased lung adenocarcinoma incidence J:80974
Tg(MMTV-ERBB3)1Slg/0
Tg(MMTVneu)202Mul/0
(involves: FVB) 		increased lung adenocarcinoma incidence J:80974
Tg(MMTV-Espl1)1Pati/0
(involves: C57BL/6) 		increased mammary adenocarcinoma incidence J:216267
Tg(MMTV-KLF4)1Rup/0
Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6NTac * FVB/NJ * SJL) 		increased sarcoma incidence J:96886
Tg(MMTV-KRAS*G12V)3025Mrl/0
(involves: C57BL/6 * FVB * SJL) 		increased mammary adenocarcinoma incidence J:77272
Tg(MMTV-LPAR1)2Gbm/Tg(MMTV-LPAR1)2Gbm
(FVB/N-Tg(MMTV-LPAR1)2Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR1)7Gbm/Tg(MMTV-LPAR1)7Gbm
(FVB/N-Tg(MMTV-LPAR1)7Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR1)27Gbm/Tg(MMTV-LPAR1)27Gbm
(FVB/N-Tg(MMTV-LPAR1)27Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR1)#Gbm/Tg(MMTV-LPAR1)#Gbm
(FVB/N-Tg(MMTV-LPAR1)#Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR2)3Gbm/Tg(MMTV-LPAR2)3Gbm
(FVB/N-Tg(MMTV-LPAR2)3Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR2)6Gbm/Tg(MMTV-LPAR2)6Gbm
(FVB/N-Tg(MMTV-LPAR2)6Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR2)#Gbm/Tg(MMTV-LPAR2)#Gbm
(FVB/N-Tg(MMTV-LPAR2)#Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR3)3Gbm/Tg(MMTV-LPAR3)3Gbm
(FVB/N-Tg(MMTV-LPAR3)3Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR3)22Gbm/Tg(MMTV-LPAR3)22Gbm
(FVB/N-Tg(MMTV-LPAR3)22Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR3)#Gbm/Tg(MMTV-LPAR3)#Gbm
(FVB/N-Tg(MMTV-LPAR3)#Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-Myc)WT13Jrn/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:153233
Tg(MMTV-Myc)WT21Jrn/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:153233
Tg(MMTV-Myc*T58A)TA14Jrn/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:153233
Tg(MMTV-Myc*T58A)TA41Jrn/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:153233
Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr) 		increased leiomyosarcoma incidence J:93548
increased lung adenocarcinoma incidence J:93548
increased mammary adenocarcinoma incidence J:93548
Tg(MMTV-neu/OT-I/OT-II)CBnel/?
Tg(Trp53R172H)8512Jmr/?
(involves: C57BL/6 * FVB) 		increased mammary adenocarcinoma incidence J:122846
Tg(MMTV-Notch4)3Rnc/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:11644
increased salivary adenocarcinoma incidence J:11644
Tg(MMTV-PTGS2)#Thla/0
(involves: CD-1) 		increased adenocarcinoma incidence J:68565
increased mammary adenocarcinoma incidence J:68565
increased mammary gland ductal carcinoma incidence J:68565
Tg(MMTV-PyVT)634Mul/0
(FVB/N-Tg(MMTV-PyVT)634Mul/Nci) 		increased mammary adenocarcinoma incidence J:46460, J:51424, J:87544, J:48285
Tg(MMTV-PyVT)634Mul/0
(multiple strains) 		increased mammary adenocarcinoma incidence J:48854
Tg(MMTV-PyVT)634Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Tg(MMTV-PyVT)#Mul/0
(B6.FVB-Tg(MMTV-PyVT)#Mul) 		increased mammary adenocarcinoma incidence J:147923
Tg(MMTV-PyVT*Y250F)250-2Mul/?
(FVB/N-Tg(MMTV-PyVT*Y250F)250-2Mul) 		increased mammary adenocarcinoma incidence J:56327
Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul/?
(FVB/N-Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul) 		increased mammary adenocarcinoma incidence J:56327
Tg(MMTV-rtTA)1Lach/0
Tg(TetO-Erbb2)1Lach/0
(involves: FVB) 		increased mammary adenocarcinoma incidence J:81083
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-ERBB2)#Jjz/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:231766
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-Esr1)#Paf/0
(involves: FVB/N) 		increased mammary gland ductal carcinoma incidence J:96383
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-IGF1R)1Ramo/0
(involves: FVB) 		increased mammary adenocarcinoma incidence J:121069
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-MYC)1Lach/0
(involves: FVB) 		increased mammary adenocarcinoma incidence J:67498
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-PIK3CA*H1047R,-luc)2239Jjz/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:175839
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-PyVT,-cre)1Mul/0
(FVB/N-Tg(MMTV-rtTA)1Lach Tg(tetO-PyVT,-cre)#Mul) 		increased mammary adenocarcinoma incidence J:231983
Tg(MMTV-TGFBR2)7Hlm/?
Tg(MMTVTGFA)29Rjc/?
(involves: C57BL/6 * DBA) 		increased mammary adenocarcinoma incidence J:85799
Tg(MMTV-TGFBR2)7Hlm/Tg(MMTV-TGFBR2)7Hlm
(involves: C57BL/6 * DBA) 		increased mammary adenocarcinoma incidence J:85799
Tg(MMTV-vHaras)SH1Led/Tg(MMTV-vHaras)SH1Led
(involves: 129X1/SvJ * C57BL/6J * CD-1 * FVB) 		increased carcinoma incidence J:86074
increased mammary adenocarcinoma incidence J:86074
Tg(MMTVneu)202Mul/0
(FVB/N-Tg(MMTVneu)202Mul) 		increased mammary adenocarcinoma incidence J:56332
Tg(MMTVneu)202Mul/0
Tg(Trp53R172H)8512Jmr/0
(C.FVB-Tg(MMTVneu)202Mul Tg(Trp53R172H)8512Jmr) 		increased mammary adenocarcinoma incidence J:115041
Tg(MMTVTGFA)29Rjc/0
(involves: C57BL/6 * DBA/2) 		increased mammary adenocarcinoma incidence J:72085, J:72080, J:28453, J:71696
increased squamous cell carcinoma incidence J:72080
Tg(MMTVTGFA)254Rjc/0
(involves: C57BL/6 * DBA/2) 		increased mammary adenocarcinoma incidence J:72085
Tg(Msmb-TAg)183-2Xuan/0
(either: (involves: C57BL/6 * CBA) or (involves: C57BL/6 * CBA * CD-1)) 		increased carcinoma incidence J:96884
Tg(Msmb-TAg)183-2Xuan/0
(involves: C57BL/6 * CBA) 		increased prostate gland adenocarcinoma incidence J:80313
Tg(Msmb-TAg)186-3Xuan/0
(either: (involves: C57BL/6 * CBA) or (involves: C57BL/6 * CBA * CD-1)) 		increased carcinoma incidence J:96884
Tg(Msmb-TAg)186-3Xuan/0
(involves: C57BL/6 * CBA) 		increased carcinoma incidence J:80313
Tg(Mt1-Hgf)19Lmb/0
(involves: FVB/N) 		increased cutaneous melanoma incidence J:50947
increased melanoma incidence J:50947
Tg(Mt1-RET)304Ina/0
(B6.C-Tg(Mt1-RET)304Ina) 		increased cutaneous melanoma incidence J:50392
Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6) 		increased cutaneous melanoma incidence J:88074, J:155735
increased melanoma incidence J:155735
Tg(Mt1-Tgfa)147Bri/0
(involves: C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:56318
Tg(MtTGFA)42Lmb/Tg(MtTGFA)42Lmb
(involves: CD-1) 		increased hepatocellular carcinoma incidence J:28452
Tg(MtTGFA)100Lmb/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:72083
Tg(MtTPRMET)243Lng/0
(FVB/N-Tg(MtTPRMET)243Lng) 		increased osteosarcoma incidence J:71573
increased sarcoma incidence J:71573
Tg(MtTPRMET)773Lng/0
(FVB/N-Tg(MtTPRMET)773Lng) 		increased sarcoma incidence J:71573
Tg(Mup3-Plau)350-2Eps/?
(C57BL/6-Tg(Mup3-Plau)350-2Eps) 		increased hepatocellular carcinoma incidence J:233146
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB) 		increased hepatocellular carcinoma incidence J:187236, J:77160
Tg(Neurod2-Smo*A1)199Jols/0
(C57BL/6-Tg(Neurod2-Smo*A1)199Jols) 		increased medulloblastoma incidence J:93861
Tg(Neurod2-Smo*A1)199Jols/0
(involves: C57BL/6) 		increased medulloblastoma incidence J:221990
Tg(Neurod2-Smo*A1)199Jols/Tg(Neurod2-Smo*A1)199Jols
(C57BL/6-Tg(Neurod2-Smo*A1)199Jols) 		increased medulloblastoma incidence J:133312, J:189258
Tg(Neurod2-Smo*A2)#Jols/0
(C57BL/6-Tg(Neurod2-Smo*A2)#Jols) 		increased medulloblastoma incidence J:189258
Tg(OMP-SV40T)13Bse/0
(involves: C57BL/6 * SJL) 		increased neuroblastoma incidence J:54269
Tg(Pax6-TAg)1796Hur/0
(involves: FVB) 		increased retinoblastoma incidence J:196814
Tg(Pax8-rtTA2S*M2)1Koes/0
Tg(tetO-MYC)36aBop/0
(involves: C57BL/6 * DBA * FVB/N) 		increased renal carcinoma incidence J:140925
Tg(Pbsn-Ar*E231G)7353Ng/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:96117
Tg(Pbsn-ERG*)1Vv/0
(involves: 129S1/SvImJ * C57BL/6J * CBA) 		increased prostate gland adenocarcinoma incidence J:222916
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
(FVB-Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp) 		increased prostate gland adenocarcinoma incidence J:130340
increased sarcoma incidence J:130340
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
Tg(Pbsn-Lrp5/Fkbp1a,-luc*)#Dmps/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727
Tg(Pbsn-Hpn,-GFP)DVv/0
Tg(Pbsn-Tag)12T7fRjm/0
(involves: C57BL/6J * CBA * CD-1) 		increased prostate gland adenocarcinoma incidence J:92562
Tg(Pbsn-MYC)6Key/?
(involves: FVB) 		increased prostate gland adenocarcinoma incidence J:85480
Tg(Pbsn-MYC)#Tt/?
(involves: C57BL/6J) 		increased prostate gland adenocarcinoma incidence J:205395
Tg(Pbsn-Tag)12T7fRjm/0
(involves: CD-1) 		increased prostate gland adenocarcinoma incidence J:48623
Tg(Pbsn-Tag)12T10Rjm/0
(involves: CD-1) 		increased prostate gland adenocarcinoma incidence J:68483, J:48623
Tg(Pbsn-TAg)15Tvd/0
(involves: C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:103408
Tg(Pklr-HRAS*G12V)23Ak/0
(involves: C57BL/6 * DBA/2) 		increased hepatocellular carcinoma incidence J:44803
Tg(Pklr-Myc)73Ak/0
(involves: C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:185488
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tg(Pklr-Myc)73Ak) 		increased hepatocellular carcinoma incidence J:184496
Tg(Pklr-SV40)1Ak/0
(involves: C57BL/6 * DBA) 		increased adenocarcinoma incidence J:185488
increased hepatocellular carcinoma incidence J:185488
increased osteosarcoma incidence J:185488
Tg(RasE)290Biat/0
(involves: C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:226601
Tg(Rbp3-SV40)IT-2Jjw/?
(involves: BALB/c * C57BL/6) 		increased retinoblastoma incidence J:60231
Tg(Ren2-TAg)4Kwg/?
(involves: C3H/HeRos * C57BL/10Ros) 		increased sarcoma incidence J:36423
Tg(RIP1-Tag)2Dh/0
(involves: C57BL/6J * DBA/2J) 		increased pancreatic islet cell carcinoma incidence J:205389
Tg(rTH-Tag)20Dmc/0
(involves: C57BL/6NTac * DBA/2NTac) 		increased neuroblastoma incidence J:90323
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*delta19)11Hev/0
(involves: C57BL/6 * CBA) 		increased lung adenocarcinoma incidence J:109092
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*L858R)56Hev/0
(involves: C57BL/6 * CBA) 		increased lung adenocarcinoma incidence J:109092
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*L858R)57Hev/0
(involves: C57BL/6 * CBA) 		increased lung adenocarcinoma incidence J:109092
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*L858R)#Hev/0
(involves: 129 * C57BL/6 * CBA) 		increased lung adenocarcinoma incidence J:128700, J:213447
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*T790M)8Paow/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:128700
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*T790M*L858R)19Kkw/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:122849
increased lung carcinoma incidence J:122849
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*T790M*L858R)51Paow/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:128700
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-ERBB2*)5BKkw/0
(involves: FVB/N) 		increased lung carcinoma incidence J:143874
increased lung non-small cell carcinoma incidence J:143874
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-ERBB2*)26Kkw/0
(involves: FVB/N) 		increased lung carcinoma incidence J:143874
increased lung non-small cell carcinoma incidence J:143874
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-Kras2)12Hev/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:73468
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-Kras2)12Hev/0
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:73468
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-MYC)36Bop/0
(involves: 129 * C57BL/6) 		increased lung adenocarcinoma incidence J:169920
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-PIK3CA*H1047R)13Lca/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:142254
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-PTPN11*E76K)#Jiwu/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung non-small cell carcinoma incidence J:212505
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO/CMV-KRAS*G12C)9.1Msmi/0
(involves: FVB/N) 		increased lung adenocarcinoma incidence J:102839
Tg(SERPINA1-TAg)1812Jtsb/0
(involves: C3H * C57BL/6 * ICR) 		increased hepatocellular carcinoma incidence J:101633
Tg(SERPINC1-SV40)A1Pbr/0
(involves: C57BL/6 * DBA/2) 		increased hepatocellular carcinoma incidence J:101541
Tg(SERPINC1-SV40)A1Pbr/Tg(SERPINC1-SV40)A1Pbr
(involves: C57BL/6 * DBA/2) 		increased hepatocellular carcinoma incidence J:101541
X/Tg(SERPINC1-SV40)BPbr
(involves: C57BL/6 * DBA/2) 		increased hepatocellular carcinoma incidence J:84204, J:101541
Tg(SFTPC-CCNE1)1Edm/?
(involves: FVB/N) 		increased lung adenocarcinoma incidence J:122698
Tg(SFTPC-CCNE1*T62A*T380A)3Edm/?
(involves: FVB/N) 		increased lung adenocarcinoma incidence J:122698
Tg(SFTPC-CCNE1*T62A*T380A)4Edm/?
(involves: FVB/N) 		increased lung adenocarcinoma incidence J:122698
Tg(SFTPC-CD74/ROS1)125Tno/0
(C57BL/6J-Tg(SFTPC-CD74/ROS1)125Tno) 		increased lung adenocarcinoma incidence J:231770
increased lung non-small cell carcinoma incidence J:231770
Tg(SFTPC-EGFR*L858R)4-3Kkiu/0
(involves: C57BL/6Cr) 		increased lung adenocarcinoma incidence J:152157
increased lung carcinoma incidence J:152157
Tg(SFTPC-EML4/ALK)502-4Hima/0
(involves: C57BL/6J) 		increased lung adenocarcinoma incidence J:142679
Tg(SFTPC-env)1Yhch/0
(FVB/N-Tg(SFTPC-env)1Yhch) 		increased lung adenocarcinoma incidence J:153538, J:247986
Tg(SFTPC-EZR/ROS1)AShiba/0
(C57BL/6-Tg(SFTPC-EZR/ROS1)AShiba) 		increased lung adenocarcinoma incidence J:199415
Tg(SFTPC-KIF5B/RET)1Tkoh/0
(involves: C57BL/6J) 		increased lung adenocarcinoma incidence J:215989
Tg(SFTPC-MST1R)71Mhw/0
(involves: C3H * C57BL/6) 		increased lung adenocarcinoma incidence J:79080
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-Fgf9,-EGFP)#Dor/0
(involves: FVB) 		increased blastoma incidence J:224791
increased lung adenocarcinoma incidence J:204282
increased malignant tumor incidence J:204282
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-MYC)36Bop/0
(Not Specified) 		increased lung adenocarcinoma incidence J:169920
Tg(SFTPC-SDC4/ROS1)141Tno/0
(C57BL/6J-Tg(SFTPC-SDC4/ROS1)141Tno) 		increased lung adenocarcinoma incidence J:231770
increased lung non-small cell carcinoma incidence J:231770
Tg(Slc1a2-tTA)#Waw/0
Tg(tetO-MYCN,-luc)#Waw/0
(involves: FVB/NJ) 		increased malignant tumor incidence J:160518
increased medulloblastoma incidence J:160518
Tg(Slc1a2-tTA)#Waw/0
Tg(tetO-MYCN,-luc)#Waw/Tg(tetO-MYCN,-luc)#Waw
(involves: FVB/NJ) 		increased malignant tumor incidence J:160518
increased medulloblastoma incidence J:160518
Tg(Smgb-TAg)8Mir/Tg(Smgb-TAg)8Mir
(involves: BALB/cJ * C57BL/6J) 		increased salivary adenocarcinoma incidence J:66189
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Tg(tetO-RNAi:Trp53)ASlowe/0
(involves: C57BL/6 * CD-1) 		increased osteosarcoma incidence J:199542
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129 * 129P2/OlaHsd * C57BL/6J * CD-1 * FVB/N) 		increased osteosarcoma incidence J:136693
Tg(SV40-NRAS*G12D)1Sco/?
(Not Specified) 		increased sarcoma incidence J:125150
Tg(TagRb)1Plm/?
(involves: BALB/cJ * C57BL/6J) 		increased retinoblastoma incidence J:10320
Tg(Tal1-cre/ERT)1Jrg/0
Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae * C57BL/6) 		increased extremity angiosarcoma incidence J:231316
increased hemangiosarcoma incidence J:231316
Tg(tetO-BCR/ABL1)2Dgt/0
Tg(Tal1-tTA)19Dgt/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased sarcoma incidence J:96511
Tg(tetO-BRAF*V600E)26Jaf/0
Tg(TG-rtTA)30Jaf/0
(involves: FVB/N) 		increased thyroid carcinoma incidence J:184420
Tg(tetO-MET)23Rwng/0
Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		increased hepatocellular carcinoma incidence J:69731
Tg(tetO-MYC)36aBop/0
Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		increased hepatoblastoma incidence J:93899
increased hepatocellular carcinoma incidence J:172430, J:186226, J:190067, J:93899
Tg(tetO-TAg)2-5Hiwa/0
(involves: C57BL/6) 		increased neuroblastoma incidence J:156984, J:175962
Tg(tetO-TAg,CMV-rtTA)123Yihu/0
(involves: FVB/N) 		increased medulloblastoma incidence J:141623
Tg(TetOp-Polb/tTA)2Sbl/0
(B6.Cg-Tg(TetOp-Polb/tTA)2Sbl) 		increased osteosarcoma incidence J:152481
Tg(Tff3-Tmem207)1Tamo/0
(C57BL/6-Tg(Tff3-Tmem207)1Tamo) 		increased carcinoma incidence J:217436
Tg(TG-BRAF*V600E)2Jaf/0
(FVB/N-Tg(TG-BRAF*V600E)2Jaf) 		increased thyroid carcinoma incidence J:98550
Tg(TG-BRAF*V600E)3Jaf/0
(FVB/N-Tg(TG-BRAF*V600E)3Jaf) 		increased thyroid carcinoma incidence J:98550
Tg(TG-NRAS*Q61K)#Msnt/0
(Not Specified) 		increased thyroid carcinoma incidence J:210016
Tg(TG-RET/CCDC6)1Cled/0
(involves: FVB/N) 		increased thyroid carcinoma incidence J:55883, J:93679
Tg(TG-RET/CCDC6)42Cled/0
(involves: FVB/N) 		increased thyroid carcinoma incidence J:55883, J:93679
Tg(TG-RET/NCOA4)3209Rstn/0
(involves: C57BL/6) 		increased thyroid carcinoma incidence J:51366
Tg(TG-SV40)#Cled/0
(involves: C57BL/6J * DBA/2J) 		increased thyroid carcinoma incidence J:209788
Tg(TG-TPR/NTRK1)5215Rstn/0
(involves: C3H * C57BL/6) 		increased thyroid carcinoma incidence J:67120
Tg(TG-TPR/NTRK1)#Rstn/0
(involves: 129S4/SvJaeSor * C3H * C57BL/6 * C57BL/6J) 		increased thyroid carcinoma incidence J:210015
Tg(Th-ALK*F1174L)2Loch/0
Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6J * CBA) 		increased neuroblastoma incidence J:191012
Tg(Th-MYCN)41Waw/0
(involves: BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:41126
Tg(Th-MYCN)41Waw/0
(involves: BALB/c * C57BL/6J * FVB/N) 		increased neuroblastoma incidence J:41126
Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:172448
Tg(Th-MYCN)41Waw/0
Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6J * FVB/N) 		increased neuroblastoma incidence J:41126
Tg(Th-MYCN)41Waw/Tg(Th-MYCN)41Waw
(involves: BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:41126
Tg(TRAMP)8247Ng/0
(involves: C57BL/6) 		increased prostate gland adenocarcinoma incidence J:217920, J:65303
Tg(TRAMP)8247Ng/0
(involves: C3H * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:125633
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
Tg(TRAMP)8247Ng/0
Usp11tm1Tac/Y
(involves: 129 * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:270214
Tg(TRP53)4Dgj/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * FVB) 		increased osteosarcoma incidence J:162466
Tg(TRP53*R72P)7Dgj/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * FVB) 		increased hemangiosarcoma incidence J:162466
Tg(Trp53A135V)L3Ber/0
(involves: C57BL/6 * CD-1) 		increased lung adenocarcinoma incidence J:73757
Tg(Trp53R172H)8512Jmr/0
(involves: FVB) 		increased mammary adenocarcinoma incidence J:46426
Tg(Tyr-BRAF*V600E)470Fgh/0
(involves: C57BL/6J * CBA) 		increased malignant tumor incidence J:151455
Tg(Tyr-BRAF*V600E)476Fgh/0
(involves: C57BL/6J * CBA) 		increased malignant tumor incidence J:151455
Tg(UPII-SV40T)2Xrw/0
(involves: FVB/N) 		increased urinary bladder carcinoma incidence J:56305
increased urinary bladder transitional cell carcinoma incidence J:56305
Tg(UPII-SV40T)9Xrw/0
(involves: FVB/N) 		increased urinary bladder carcinoma incidence J:56305
Tg(UPII-SV40T)29Xrw/0
(involves: FVB/N) 		increased urinary bladder carcinoma incidence J:56305
increased urinary bladder transitional cell carcinoma incidence J:56305
Tg(Upk2-TAg)1Rkl/0
(involves: C57BL/6) 		increased urinary bladder carcinoma incidence J:173505
increased urinary bladder transitional cell carcinoma incidence J:173505
Tg(Utg-TAg)7593Fjd/?
(involves: FVB) 		increased lung adenocarcinoma incidence J:70785
Tg(Utg-TAg)7736Fjd/?
(involves: FVB) 		increased lung adenocarcinoma incidence J:70785
Tg(Utg-TAg)#Fjd/?
(involves: FVB) 		increased lung adenocarcinoma incidence J:70785
Tg(Vav1-Asxl1*Y588X)#Fcy/0
(C57BL/6-Tg(Vav1-Asxl1*Y588X)#Fcy) 		increased myeloid sarcoma incidence J:257690
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J) 		increased histiocytic sarcoma incidence J:88565
Tg(Vil1-Lin28b,-tdTomato)HiAru/0
(involves: C57BL/6J * SJL) 		increased small intestine adenocarcinoma incidence J:202923
Tg(Vil1-Lin28b,-tdTomato)MedAru/0
(involves: C57BL/6J * SJL) 		increased small intestine adenocarcinoma incidence J:202923
Tg(Wap-Hgf)402Mig/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:86776
Tg(Wap-Hgf)402Mig/0
(FVB/N-Tg(Wap-Hgf)402Mig) 		increased mammary adenocarcinoma incidence J:206839
X/Tg(Wap-HRAS)69Lln
(involves: C57BL/6 * SJL) 		increased adenocarcinoma incidence J:72262
increased salivary adenocarcinoma incidence J:46458
Tg(Wap-TAg)1Depp/0
(involves: BALB/c * C57BL/6) 		increased mammary gland ductal carcinoma incidence J:61012
Tg(Wap-tAg)1Gmn/?
(involves: NMRI) 		increased mammary adenocarcinoma incidence J:69711
Tg(Wap-TAg)NP8Depp/0
(involves: BALB/c * C57BL/6) 		increased mammary gland ductal carcinoma incidence J:61012
Tg(Wap-Tsg101)4389Kuw/0
(FVB/N-Tg(Wap-Tsg101)4389Kuw) 		increased mammary adenocarcinoma incidence J:121475
Tg(WapMyc)212Bri/0
(involves: C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:56318
Tg(WapNotch4)10Rnc/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:33193
Tg(WapTAg)1Knw/0
(C57BL/6J-Tg(WapTAg)1Knw/J) 		increased mammary adenocarcinoma incidence J:53175
increased sarcoma incidence J:53175
Tg(WapTAg)3Knw/0
(C57BL/6J-Tg(WapTAg)3Knw) 		increased adenocarcinoma incidence J:53175
increased mammary adenocarcinoma incidence J:53175
increased osteosarcoma incidence J:53175
increased sarcoma incidence J:53175
Tg(WapTgfa)215Bri/0
(involves: C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:56318
Tg(Wnt1)1Hev/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:54215
Tg(Wnt1)1Hev/0
(involves: C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:61009
Tgfb1tm1Rif/Tgfb1tm1Rif
(either: (involves: 129) or (involves: 129S/SvEv * C57BL/6)) 		increased anal adenocarcinoma incidence J:142353
increased colon adenocarcinoma incidence J:142353
increased gastric adenocarcinoma incidence J:142353
increased large intestine adenocarcinoma incidence J:142353
increased rectum adenocarcinoma incidence J:142353
Tgfbitm1Zhao/Tgfbitm1Zhao
(involves: 129 * C57BL/6J) 		increased lung adenocarcinoma incidence J:143036
increased malignant tumor incidence J:143036
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:204736
Thbs1tm1Hyn/Thbs1tm1Hyn
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased adenocarcinoma incidence J:72391
increased carcinoma incidence J:72391
increased fibrosarcoma incidence J:72391
increased histiocytic sarcoma incidence J:72391
increased liver adenocarcinoma incidence J:72391
increased lung adenocarcinoma incidence J:72391
increased mammary adenocarcinoma incidence J:72391
increased osteosarcoma incidence J:72391
increased sarcoma incidence J:72391
increased squamous cell carcinoma incidence J:72391
Thbs1tm1Hyn/Thbs1tm1Hyn
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased adenocarcinoma incidence J:72391
increased carcinoma incidence J:72391
increased fibrosarcoma incidence J:72391
increased hemangiosarcoma incidence J:72391
increased histiocytic sarcoma incidence J:72391
increased sarcoma incidence J:72391
increased small intestine adenocarcinoma incidence J:72391
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		increased thyroid carcinoma incidence J:92629
Thrbtm1Df/Thrbtm1.1Syc
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		increased thyroid carcinoma incidence J:92629
Tiam1tm1Jgc/Tiam1tm1Jgc
(involves: 129P2/OlaHsd * FVB) 		increased malignant tumor incidence J:77148
increased squamous cell carcinoma incidence J:77148
Tle5tm1.1Mmt/Tle5tm1.1Mmt
Apctm1Mmt/Apc+
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S2/SvPas * C57BL/6 * DBA * SJL) 		increased colon adenocarcinoma incidence J:168065
increased small intestine adenocarcinoma incidence J:168065
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir) 		increased carcinoma incidence J:165105
Tnk1tm1Sksuf/Tnk1+
(involves: 129X1/SvJ * C57BL/6) 		increased carcinoma incidence J:140639
increased hepatocellular carcinoma incidence J:140639
increased intestinal adenocarcinoma incidence J:140639
increased malignant tumor incidence J:140639
Tnk1tm1Sksuf/Tnk1tm1Sksuf
(involves: 129X1/SvJ * C57BL/6) 		increased hemangiosarcoma incidence J:140639
increased hepatocellular carcinoma incidence J:140639
increased lung adenocarcinoma incidence J:140639
Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		increased basal cell carcinoma incidence J:133892
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J) 		increased hepatocellular carcinoma incidence J:184948
increased lung adenocarcinoma incidence J:184948
Trim24tm1.1Los/Trim24tm1.1Los
(involves: 129/Sv * C57BL/6 * SJL) 		increased hepatocellular carcinoma incidence J:130210
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg) 		increased carcinoma incidence J:232482
increased medulloblastoma incidence J:232482
Trim62tm1Akil/Trim62+
(involves: 129S/SvEv * C57BL/6) 		increased adenocarcinoma incidence J:204336
increased hepatocellular carcinoma incidence J:204336
increased liver adenocarcinoma incidence J:204336
increased lung adenocarcinoma incidence J:204336
increased mammary adenocarcinoma incidence J:204336
increased sarcoma incidence J:204336
increased spindle cell carcinoma incidence J:204336
Trim62tm1Akil/Trim62tm1Akil
(involves: 129S/SvEv * C57BL/6) 		increased adenocarcinoma incidence J:204336
increased liver adenocarcinoma incidence J:204336
increased lung adenocarcinoma incidence J:204336
increased mammary adenocarcinoma incidence J:204336
increased sarcoma incidence J:204336
increased squamous cell carcinoma incidence J:204336
Trp53Bbl/Trp53+
(C57BL/6JSfdAnu-Trp53Bbl/Anu) 		increased fibrosarcoma incidence J:104190
increased hemangiosarcoma incidence J:104190
increased osteosarcoma incidence J:104190
Trp53bhy/Trp53+
(C57BL/6JSfdAnu-Trp53bhy/Anu) 		increased fibrosarcoma incidence J:104190
increased hemangiosarcoma incidence J:104190
increased osteosarcoma incidence J:104190
increased teratocarcinoma incidence J:104190
Trp53tm1.1Awbr/Trp53tm1.1Awbr
(involves: C57BL/6) 		increased fibrosarcoma incidence J:169434
increased histiocytic sarcoma incidence J:173271
increased osteosarcoma incidence J:173271
Trp53tm1.1Thst/Trp53tm1.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased carcinoma incidence J:198482
increased hemangiosarcoma incidence J:198482
increased leiomyosarcoma incidence J:198482
Trp53tm1.2Awbr/Trp53+
(involves: C57BL/6) 		increased osteosarcoma incidence J:173271
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6) 		increased histiocytic sarcoma incidence J:173271
increased osteosarcoma incidence J:173271
Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased carcinoma incidence J:73757
increased osteosarcoma incidence J:73757
increased sarcoma incidence J:73757
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd) 		increased carcinoma incidence J:51661
increased osteosarcoma incidence J:51661
increased rhabdomyosarcoma incidence J:51661
increased sarcoma incidence J:51661
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased hemangiosarcoma incidence J:1999
increased osteosarcoma incidence J:1999
increased sarcoma incidence J:1999, J:126497
Trp53tm1Brd/Trp53tm1Brd
Xrcc4tm2.1Fwa/Xrcc4tm2Fwa
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * SJL) 		increased medulloblastoma incidence J:109585
Trp53tm1Brd/Trp53tm1Brd
Xrcc5tm1Dbr/Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL) 		increased medulloblastoma incidence J:141515
Trp53tm1Brd/Trp53tm1Ldo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased sarcoma incidence J:73757
Trp53tm1Brn/Trp53+
Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd) 		increased mammary adenocarcinoma incidence J:170898
Trp53tm1Brn/Trp53+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * 129P2/OlaHsd * C57BL/6J * CD-1 * FVB/N) 		increased osteosarcoma incidence J:136693
Trp53tm1Brn/Trp53tm1.1Brn
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:86077, J:157319
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:86077, J:157319
Trp53tm1Brn/Trp53tm1Brn
Tg(Cdh16-cre)91Igr/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N * ICR) 		increased endometrial carcinoma incidence J:214850, J:215149
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT5-cre/PGR)1Der/0
(involves: 129P2/OlaHsd * C57BL/6N * FVB/N * ICR) 		increased skin squamous cell carcinoma incidence J:216813
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:116152
increased squamous cell carcinoma incidence J:116152
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)105Ayn/0
(FVB.Cg-Trp53tm1Brn Tg(MMTV-cre)105Ayn) 		increased carcinoma incidence J:165292
increased squamous cell carcinoma incidence J:165292
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:224955
increased spindle cell carcinoma incidence J:224955
Trp53tm1Brn/Trp53tm1Brn
Tg(Nes-cre/ERT2,-ALPP)1Sbk/0
(involves: 129P2/OlaHsd) 		increased medulloblastoma incidence J:237990
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		increased osteosarcoma incidence J:199542
Trp53tm1Brn/Trp53tm1Brn
Tg(Tyr-cre/ERT2)13Bos/0
Tg(Tyr-NRAS*Q61K)1Bee/0
(FVB.Cg-Tg(Tyr-cre/ERT2)13Bos Trp53tm1Brn Tg(Tyr-NRAS*Q61K)1Bee) 		increased cutaneous melanoma incidence J:222847
Trp53tm1Brn/Trp53tm1Brn
Tg(Wap-cre)51Nki/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:171765
Trp53tm1Brn/Trp53tm1Tyj
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:102702
Trp53tm1Elee/Trp53tm1Elee
Tg(GFAP-cre)25Mes/0
(involves: 129S4/SvJae * FVB/N) 		increased medulloblastoma incidence J:149662
increased sarcoma incidence J:149662
Trp53tm1Elee/Trp53tm1Elee
Tg(MMTV-cre)AElee/0
(involves: 129S4/SvJae * C57BL/6) 		increased mammary adenocarcinoma incidence J:90247
Trp53tm1Elee/Trp53tm1Elee
Tg(MMTV-cre)BElee/0
(involves: 129S4/SvJae * C57BL/6) 		increased mammary adenocarcinoma incidence J:90247
Trp53tm1Elee/Trp53tm1Elee
Tg(Wap-rtTA-cre)10Whl/0
(involves: 129S4/SvJae * C57BL/6) 		increased mammary adenocarcinoma incidence J:90247
Trp53tm1Elee/Trp53tm1Tyj
Tg(GFAP-cre)25Mes/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N) 		increased medulloblastoma incidence J:149662
increased sarcoma incidence J:149662
Trp53tm1Glo/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased carcinoma incidence J:61683
increased fibrosarcoma incidence J:61683
increased hemangiosarcoma incidence J:61683
increased osteosarcoma incidence J:61683
increased sarcoma incidence J:61683
increased squamous cell carcinoma incidence J:61683
Trp53tm1Glo/Trp53+
(involves: 129S7/SvEvBrd) 		increased carcinoma incidence J:129627
increased osteosarcoma incidence J:129627
increased sarcoma incidence J:129627
increased squamous cell carcinoma incidence J:129627
Trp53tm1Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased adenocarcinoma incidence J:171821
increased sarcoma incidence J:171821
increased spindle cell carcinoma incidence J:171821
Trp53tm1Thst/Trp53tm1Thst
(involves: 129S1/Sv * 129X1/SvJ) 		increased carcinoma incidence J:198482
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased adenocarcinoma incidence J:72391
increased carcinoma incidence J:72391, J:95318
increased fibrosarcoma incidence J:17728
increased hemangiosarcoma incidence J:72391, J:17728
increased histiocytic sarcoma incidence J:72391
increased leiomyosarcoma incidence J:17728
increased lung adenocarcinoma incidence J:72391
increased mammary adenocarcinoma incidence J:72391
increased osteosarcoma incidence J:72391, J:17728
increased rhabdomyosarcoma incidence J:17728
increased sarcoma incidence J:72391, J:17728, J:95318
increased squamous cell carcinoma incidence J:72391
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas) 		increased carcinoma incidence J:95316
Trp53tm1Tyj/Trp53+
Trp63tm1Fmc/Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased mammary adenocarcinoma incidence J:98958
increased osteosarcoma incidence J:98958
increased rhabdomyosarcoma incidence J:98958
increased squamous cell carcinoma incidence J:98958
increased urinary bladder transitional cell carcinoma incidence J:98958
Trp53tm1Tyj/Trp53+
Trp73tm1Fmc/Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:98958
increased lung adenocarcinoma incidence J:98958
increased pancreatic acinar cell carcinoma incidence J:98958
increased sarcoma incidence J:98958
Trp53tm1Tyj/Trp53tm1.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased carcinoma incidence J:228632
increased sarcoma incidence J:228632
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased carcinoma incidence J:72391
increased fibrosarcoma incidence J:72391
increased hemangiosarcoma incidence J:72391, J:17728
increased osteosarcoma incidence J:72391, J:17728
increased rhabdomyosarcoma incidence J:17728
increased sarcoma incidence J:72391, J:17728, J:95318
increased squamous cell carcinoma incidence J:72391
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased hemangiosarcoma incidence J:95316
increased medulloblastoma incidence J:102702
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Prrx1-FUS/DDIT3)1Mete/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		increased liposarcoma incidence J:184491
increased sarcoma incidence J:184491
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc2tm1Pmc/Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:111068
increased sarcoma incidence J:111068
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc2tm2Pmc/Xrcc2tm2Pmc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
Trp53tm1Tyj/Trp53tm2.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae) 		increased carcinoma incidence J:95316
increased hemangiosarcoma incidence J:95316
Trp53tm1Tyj/Trp53tm2.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased carcinoma incidence J:228632
increased sarcoma incidence J:228632
Trp53tm1Tyj/Trp53tm3.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae) 		increased carcinoma incidence J:95316
Trp53tm1Yjc/Trp53tm1Yjc
(B6.129S1-Trp53tm1Yjc) 		increased sarcoma incidence J:195018
Trp53tm2.1Thst/Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased carcinoma incidence J:282255
increased sarcoma incidence J:282255
Trp53tm2Glo/Trp53tm2Glo
(involves: 129/Sv * C57BL/6) 		increased sarcoma incidence J:87501
Trp53tm2Thst/Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased carcinoma incidence J:282255
increased sarcoma incidence J:282255
Trp53tm3.1Glo/Trp53+
(B6.129S7-Trp53tm3.1Glo) 		increased carcinoma incidence J:317504, J:95318
increased osteosarcoma incidence J:317504
increased sarcoma incidence J:317504, J:95318
Trp53tm3.1Glo/Trp53tm3.1Glo
(B6.129S7-Trp53tm3.1Glo) 		increased sarcoma incidence J:95318
Trp53tm3.1Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased adenocarcinoma incidence J:171821
increased sarcoma incidence J:171821
increased spindle cell carcinoma incidence J:171821
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae) 		increased carcinoma incidence J:95316
increased hepatocellular carcinoma incidence J:95316
increased lung adenocarcinoma incidence J:95316
increased squamous cell carcinoma incidence J:95316
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae * SKH1) 		increased mammary adenocarcinoma incidence J:121734
Trp53tm3Tyj/Trp53+
Tg(Wap-cre)11738Mam/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:101617
increased sarcoma incidence J:101617
Trp53tm4Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased adenocarcinoma incidence J:171821
increased sarcoma incidence J:171821
increased spindle cell carcinoma incidence J:171821
Trp53tm4Tyj/Trp53tm4Tyj
(involves: 129S4/SvJae * C57BL/6) 		increased sarcoma incidence J:92917
Trp53tm4Xu/Trp53tm4Xu
(Not Specified) 		increased sarcoma incidence J:126497
Trp53tm7.1Xu/Trp53tm7.1Xu
(Not Specified) 		increased sarcoma incidence J:160414
Trp53bp2tm1Xlu/Trp53bp2+
(involves: 129S6/SvEvTac * C57BL/6J) 		increased hemangiosarcoma incidence J:108701
increased rhabdomyosarcoma incidence J:108701
increased squamous cell carcinoma incidence J:108701
Trp63tm1Fmc/Trp63+
(involves: 129S4/SvJae * C57BL/6) 		increased histiocytic sarcoma incidence J:98958
increased malignant tumor incidence J:98958
increased squamous cell carcinoma incidence J:98958
Trp63tm1Fmc/Trp63+
Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased carcinoma incidence J:98958
increased hemangiosarcoma incidence J:98958
increased lung adenocarcinoma incidence J:98958
increased mammary adenocarcinoma incidence J:98958
increased squamous cell carcinoma incidence J:98958
Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased hemangiosarcoma incidence J:98958
increased lung adenocarcinoma incidence J:98958
increased malignant tumor incidence J:98958
Trp73tm1Fmc/Trp73tm1Fmc
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:98958
Trp73tm1Mak/Trp73+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased carcinoma incidence J:142848
increased hemangiosarcoma incidence J:142848
increased lung adenocarcinoma incidence J:142848
Trp73tm1Mak/Trp73tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J) 		increased carcinoma incidence J:142848
increased lung adenocarcinoma incidence J:142848
Ts(1716)65Dn/0
(involves: C3H/HeJ * C57BL/6J * DBA/2J) 		increased malignant tumor incidence J:174270
Tsc1tm1.1Djk/Tsc1+
(either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J)) 		increased hemangiosarcoma incidence J:75243
increased renal carcinoma incidence J:75243
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * C57BL/6JOlaHsd) 		increased renal carcinoma incidence J:99796
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * Balb/cOlaHsd * C57BL/6JOlaHsd) 		increased renal carcinoma incidence J:99796
Tsc1tm1Hin/Tsc1+
(involves: 129S4/SvJae * C57BL/6J) 		increased leiomyosarcoma incidence J:70463
increased renal carcinoma incidence J:70463
Tsc2tm1Djk/Tsc2+
(either: (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6J)) 		increased extremity angiosarcoma incidence J:57631
increased renal carcinoma incidence J:57631
Tsc2tm1Tno/Tsc2+
(involves: 129S4/SvJae * C57BL/6J) 		increased renal carcinoma incidence J:52464
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J) 		increased hemangiosarcoma incidence J:119985
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J) 		increased hemangiosarcoma incidence J:119985
increased squamous cell carcinoma incidence J:119985
TxnipHyplip1/Txnip+
(involves: CAST/Ei * HcB19/Dem) 		increased hepatocellular carcinoma incidence J:112292
TxnipHyplip1/TxnipHyplip1
(HcB19/Dem-TxnipHyplip1) 		increased hepatocellular carcinoma incidence J:112292
TxnipHyplip1/TxnipHyplip1
(involves: CAST/Ei * HcB19/Dem) 		increased hepatocellular carcinoma incidence J:112292
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy) 		increased hepatocellular carcinoma incidence J:157049
Urahplt2/Urahplt2
(C57BL/6-Urahplt2) 		increased hepatocellular carcinoma incidence J:164423
Usp44tm1.2Pjgl/Usp44tm1.2Pjgl
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		increased sarcoma incidence J:193965
Vhltm1.1Wkr/Vhl+
(involves: 129S4/SvJae * C57BL/6) 		increased adenocarcinoma incidence J:157369
Wif1tm1Dmth/Wif1tm1Dmth
(involves: 129 * C57BL/6) 		increased osteosarcoma incidence J:149607
increased sarcoma incidence J:149607
WwoxGt(XG218)Byg/WwoxGt(XG218)Byg
(involves: 129P2/OlaHsd) 		increased malignant tumor incidence J:132078
Wwoxtm1Ria/Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6) 		increased osteosarcoma incidence J:120064
Xpatm1Tnka/Xpatm1Tnka
(involves: C57BL/6 * CBA) 		increased lung adenocarcinoma incidence J:62877
increased skin squamous cell carcinoma incidence J:28709
Xpctm1Ecf/Xpctm1Ecf
(involves: 129 * C57BL/6) 		increased lung adenocarcinoma incidence J:101421
Xrcc1tm1Pmc/Xrcc1tm1Pmc
Trp53tm1Tyj/Trp53+
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:152528
Xrcc1tm1Pmc/Xrcc1tm1Pmc
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:152528
Yy1tm2.1Yshi/Yy1tm2.1Yshi
Tg(Nkx2-1-cre)2Sand/0
(involves: 129S4/SvJae * C57BL/6J) 		increased blastoma incidence J:239777
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
07/05/2024
MGI 6.24 		The Jackson Laboratory